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(a thesis build on others)
In this thesis fMRI (functional
magnetic resonance imaging)
studies of cognition in multiple
sclerosis (MS) pat ients are
presented. Additionally, MRI
techniques to evaluate structural
pathology have been used to study
the relationship between cognitive
functioning and the presence of
structural brain damage in MS
patients. The relation between MR
visible lesions, brain activity as
depicted by fMRI, and neurological
impairment, especially with regards
to cognitive impairment, is not well
understood. Better understanding
and quantification of those
relationships can hopefully lead to
better understanding of symptoms,
their mode of occurrence and
perhaps even guide therapeutic
strategies.
As an introduction to the studies
described in this thesis a short
description of the disease,
cognitive impairment in MS and
the fMRI technique are given.
These themes have been the
subject of many previous PhD
theses from our Institute and
reference will be made to them.
Multiple sclerosis is a chronic
inflammatory demyelinating disease
of the central nervous system. In
the second part of the 19th century
it was clinically and pathologically
described by Charcot38. MS is
characterized histopatho logically
by multifocal lesions in the central
nervous system, consisting of
inflammation, demyelination,
gliosis and degeneration of axons.
In post-mortem studies, sclerotic
plaques, that have given the disease
its name, can be observed in many
places throughout the central
nervous system. The exact cause is
unknown, but environmental
factors (possibly including viral
infect ion) and autoimmune
processes (including reactions to
unknown autoantigens) play an
important role [Polman thesis190,
Uitdehaag thesis259, Killestein thesis118,
van Oosten thesis262; Schrijver thes is235];
also a genetic component is
suspected and some susceptible
genes have been investigated
[Hooper - van Veen thesis263].
MS mainly affects young adults
(age of onset is 20 - 40 years of
age) and is more prevalent in
females than in males. In about
two third of the cases MS starts
with episodes of neurological
problems, followed by intervals
with complete or partial recovery.
This is the so-called relapsing-
remitting form of MS, which may
be followed by a secondary
INTRODUCTION
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progressive course. In 10-15% of
the cases the disease has a
progressive course from onset on
(primary progressive type).
Because MS lesions can develop
throughout the whole CNS, both
in brain and spinal cord [Lycklama
à Nijeholt thesis144] a variety of
symptoms can occur in MS, of
which the most well known ones
are sensory disturbances, visual
problems and motor disturbances,
as well as micturition and
defecation problems and fatigue.
The last two decades have
witnessed a growing interest in
cognitive disturbances associated
with MS. Because MS affects such
primary (neurological) functions
necessary in daily living, it has a
tremendous impact on social life
[Polman thesis190, Pfennings thes is186].
Cognitive impairment probably
accounts for the most troublesome
of all handicaps because it is more
difficult to handle by the patient
and his or her surroundings.
The diagnosis of MS remains a
clinical diagnosis based on
symptoms in different neurological
systems and the t ime of
appearance of these symptoms, but
is greatly facilitated by ancillary
techniques, notably MRI. The role
of MRI in the diagnosis and
especially the contribution of
gadolinium has been reported
many years ago [Barkhof thesis 13].
Later, other characteristics like
hypointense T1 lesions, or so
called black-holes [Van Walderveen
thesis266], and the role of MRI in
disease severity (treatment trials)
were described. Poser et al.192
constructed diagnostic criteria in
which MRI played a minor role,
but recently the International Panel
on MS Diagnosis presented revised
diagnostic criteria in which MR
parameters play a more important
role151. In the McDonald criter ia,
the MR criteria described by
Barkhof14 have been included; one
of the constituting elements is the
presence of juxtacortical lesions.
MR  imaging allows the possibility
of quantifying atrophy and white
matter changes, which can be
correlated with clinical parameters.
This validation process has been
successfully completed for certain
diseases, e.g. the relation between
memory impairment and hippo-
campal atrophy in Alzheimer’s
disease [Scheltens thes is231]. For
different reasons, the correlation
of MRI and clinical findings has
been proven more difficult in MS,
the so-called the clinicoradiological
paradox in MS.
The most important difficulty in
this respect is probably the use of
the expanded disability status scale
(EDSS). This widely used clinical
measurement takes into account
especially motor, sensory and
autonomic functions. Most likely
INTRODUCTION
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spinal cord lesions, rather than
bra in  l e s io n s ,  d e t e r min e
disturbances in those functions.
Other scales, which take into
account cognitive impairment have
been proposed (the MS Functional
Composite, and the Guy’s
Neurological Disability Scale) and
show a better, though still not
optimal correlation with MR
parameters [Kalkers the sis115,
Hoogervorst  thesis98].
Secondly, MR only shows the top
of the iceberg of affected tissue.
Tissue looking normal on standard
MR images appear affected when
quantitative MR techn iques
(Magnetic Transfer Ratio, T1
relaxation time measurements,
spectroscopy, atrophy measure-
ments, subtraction of images from
different time points) are used
[Van Walderveen thesis266, Van
Waesberghe thesis264, Lycklema thesis144,
Kalkers thesis115, Tan thesis253].
Another problem with lesion load
measurement is the t im e
consuming aspect of it. Pattern
recognition systems can hopefully
deal with this in the future, as is
done in other brain research areas
[for example Jelles thesis107].
Cognitive functions are the ‘higher’
functions of the brain. Examples
of those functions are memory,
language, calculation and executive
functions (planning). Mental state
(depression) and physical state
(fatigue) strongly influence those
functions.  Charcot38 already
described cognitive impairment in
MS patients. Later it was thought
that chronic illness and fatigue
were the  ma in  problems
concerning cognitive difficulties.
Some years before the studies
described in this thesis started,
cognit ive  impairment wa s
reiterated as one of the main
problems in MS patients, especially
for functions of daily living. The
c o n t r ibut ing in f luence  o f
depression, fatigue etc. was also
observed [Pfennings thes is186].
Since MS lesions are usually
widespread throughout the brain, it
has been postulated that measures
of cognitive functioning correlate
better with brain MR parameters
than  for  example  motor
functioning which is mostly
dependent on spinal  cord
involvement.
A further introduction in cognitive
impairment in MS is given in an
introduction chapter (§ 2.1)
preceding the studies on cognit ive
impairment and MR parameters in
MS patients.
The study of impairment of
cognitive functions regained new
interest when a new MRI
technique became available, termed
functional MRI (fMRI)20. With this
technique, the functional active
brain parts can be examined non-
invasively, and it was expected to
find a better relation between
- 6 -
clinical and MR parameters in MS.
Implementation of the technique
and its post-processing is a
necessary first step. In our institute
this was performed by Rombouts
and Hoogenraad [Rombouts thes is224;
Hoogenraad thesis97]. To study a
cognitive domain with fMRI, it is
of the greatest importance to
develop a suitable task, and test it
in healthy controls. These steps are
the first to be described in this
thesis.
A further description of the fMRI
technique and the paradigms used
can be found in an introduction
chapter (§3.1), preceding the fMRI
related studies in MS patients.
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1.2 OUTLINE OF THIS THESIS
The basic aim of the presented studies was to investigate the relation
between cognitive functioning in MS and structural and functional MR
parameters.
In chapter TWO the relation between structural lesions and cognitive
impairment is studied. This was done in four different studies. The first
study focussed on (juxta)cortical lesions, the second study focussed on
brain atrophy and regional lesion loads. In the third and fourth study
focussed on the attentional aspects of cognitive functioning in MS and
the relation with structural MR parameters were analysed.
In chapter THREE two cognitive tasks, suitable for use with fMRI, are
described. The Tower of London task, an executive functioning
(planning) task, and the PASAT, an attentional task widely used in MS
research, were transformed in an fMRI task. Brain activation during both
tasks was analysed in healthy controls.
In chapter FOUR three studies of fMRI measured brain activation in
patients are described. One study uses a light flash paradigm in optic
neuritis patients, the second study used the fMRI Tower of London.
Furthermore a small study evaluating Cannabis effects with fMRI was
performed.
In chapter FIVE a review of the results and a discussion of the
interpretation and significance of the observed findings is given, ending
with ideas for future research.
- 8 -
CHAPTER 2  




COGNITIVE IMPAIRMENT IN MS
Charcot38 already described
cognitive impairment in MS
patients. In many MS patients
cognitive functions are affected,
especially when the patients have a
longer disease duration. In 1990
the cognitive function study group
of the National Multiple Sclerosis
society estimated the prevalence
54-65%185. The cognitive disability
is very serious in 5 - 10 % of the
patients63,182. With this knowledge
it can be safely said that cognitive
impairment, also because the
impact in daily life, is a major
problem in MS18,83,202,260.
MS patients fail a significantly
greater number of neuro-
psychological tests than controls202.
H o w e v e r ,  t h e  c o g n i t iv e
impairment is not uniform in MS
15,106,184,195,279,280. The heterogeneity
of the affected cognitive domains
is characteristic for MS. Because of
this heterogeneity, different
estimates of cognitive impairment
have been observed, a further
complicating factor is across
studies different cognit iv e
functions have been explored.
MS produces a cognit iv e
impairment that resembles that of
the a so-called subcortical dementia
52,281, characterized by specific
deficits in recent memory,
sustained attention, conceptual
reasoning, visuo-spatial functions
and information processing speed,
with most of the times preserved
language, gnosis, praxis 15,95,99,106,
14 0 , 1 9 5 , 1 9 9 , 2 0 2  and intel lectual
functions195198. The presence of this
subcortical dementia can be
explained by the involvement of
the frontal lobe in MS, and
therewith the impaired executive
functions44 ; the pattern of
cognitive decline seems to be the
result of the lesion locations in the
hemispheric white matter. It
remains to be established whether
cerebral demyelination disrupt a
wide range of cognitive operations
in a uniform manner or affects a
specific subset of cognit ive
operations.
Some other characteristics of
cognitive functioning (impairment)
in MS patients exist.
Although cognitive functioning is
in healthy individuals in general
terms not dependent of the
gender, it seems to be in MS16.
Slower reaction times in MS
patients have been frequently
reported64,108,112,126,140,204. Increase of
reaction time in MS patients with
task complexity, suggesting a
slowing of mental processing
independent of motor slowing, has
been observed126,204, but others
INTRODUCTION COGNITIVE IMPAIRMENT IN MS
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failed to find suc h inter-
actions108,140. Such inconsistencies
might be explained by differences
in applied tasks, severity of the
disease, disease course, disease
duration, and cognitive status of
the MS patients127.
The time of occurrence of
cognitive impairment, star ting
either at the onset of MS or only in
the later stages of the disease, has
been studied also. Some studies
found higher prevalence rates as
well as severity of cognitive
dysfunction in chronic progressive
patients2,41,83,95,128,159,201 ,202. But
cognitive impairment is also seen
in patients with minimal physical
disability (in RR patients)194.
Studies failed to find substantial
correlations between cognitive
deficits and disease duration, and
also correlations between the
degree of physical disability as
measured with the EDSS and
severity of cognitive impairment in
MS are weak228 or virtually
absent104,105,128 . Most studies
reported a relation between
cogn itive  funct ioning an d
structural MR parameters. Many
studies have reported a correlation
between total brain lesion load and
overall cognitive impairment5,39,83,
96,133,203,227,244,250, but not all studies
did so (for example 99,146,177).
Several earlier studies did report a
correlation between the total lesion
load or total lesion score (defined
in many different ways) and
general cognitive impairment
(scored as an index of more than
one cognitive domain, evaluated
with different tests, or as the score
of one of the  cognitive
areas)83,203,250. In some studies the
total lesion load or score showed a
relation with the following
cognitive domains: intelligence5,203,




so lv ing8 3 , 2 0 3  and  l ingui s t ic
problems203. In a few studies no
correlation between cognitive
impairment and lesion load was
f o u n d 8 3 , 9 9 , 1 4 6 , 2 0 3 , 2 5 0 .  T h e
inconsistency of these findings
probably relates in part to the
marked differences in techniques
and definitions.
Correlations with regional lesion
load or score have been described
for abstract reasoning3,250 with the
number of frontal lesions; for
visuo-spatial problem solving,
attention and verbal memory with
the number of parietally localized
lesions250 and frontal lobe
impairment with the frontal lobe
lesion load80,227. Some studies
described a relation between
existence of periventricular lesion
and different aspects of cognitive
impairment152,194.
INTRODUCTION COGNITIVE IMPAIRMENT IN MS
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The influence of regional lesion
loads and brain atrophy on more
specific cognitive problems is far
less known, especially for the
widely used Brief Repeatable
Battery5,21,42,80,96,165,227,250. 
Sperling et al.244 also found
significant correlations between
those test scores and regional
lesion loads. The correlations they
found were for all but one of the
subtests always correlations with
the same areas, namely total brain
and the frontal and parietal lobes,




2.2 MAGNIMS A1.2 study
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Neuropsycho logical impairment in multiple
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In this study we evaluated the correlation between neuropsychological
impairment (measured with the Brief Repeat able Battery
Neuropsychological Tests) and (juxta)cortical lesions detected with
FLAIR and the relative sensitivity of the FLAIR sequence compared to
spin-echo MRI sequences in detecting (juxta)cortical MS lesions.
METHODS
A total of 39 patients with definite MS were evaluated by MRI with a
conventional and fast spin echo sequence and fast FLAIR sequence, and
neuropsychological tests of the Brief Repeatable Battery
Neuropsychological tests were performed. The Z score of all subtests
were used to calculate a Cognitive Impairment Index.
RESULTS
The results show that a high number of (juxta)cortical lesions is detected
with thin slice FLAIR (30% of all lesions seen). This percentage was not
superior to spin-echo, reflecting the thin slice thickness (3 mm) we used.
The lesions detected with FLAIR were to a certain degree different ones
than the lesions detected with the other techniques. While the number of
non-cortical lesions correlated with the expanded disability status scale
(r=0.32, p=0.045), the number of (juxta)cortical lesions detected with the
FLAIR showed a correlation (r=0.34, P=0.035) with the Cognitive
Impairment Index.
CONCLUSION
Our study underlines the high number of (juxta)cortical lesions in MS and
the value of thin slice FLAIR sequence to detect such lesions with MRI.
It also stresses the importance of (juxta)cortical lesions on determining
neuropsychological impairment.
THE MAGNIMS A.1.2 STUDY
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INTRODUCTION
Multiple sclerosis (MS) is a
multifocal demyelinating disease of
the central nervous system.
Magnetic Resonance Imaging
(MRI) is very sensitive in showing
cerebral  les ions in MS1 57 ,
characteristically located in the
periventricular region and corpus
callosum. The pattern of cognitive
impairment in MS is characterised
by specific deficits in recent
memory, sustained attention,
conce ptual  reasonin g and
information processing speed, with
preserved language and intellectual
functions1.  This so-called pattern
of subcortical dementia202,281 is
usually attributed to the presence
of extensive white matter
involvement.
(Juxta)cortical lesions have long
been under-recognized as part of
MS, but pathological studies31,143
have shown that gray matter is
frequently affected. Using high
resolution MRI (juxta)cortical
lesions can be demonstrated,
particularly with the use of
gadolinium117; increased detection
of (juxta)cortical lesions has also
been reported using FLAIR (fluid
attenuated inversion recovery
sequences)27,88,139,288. This is perhaps
due to the heavy T2-weighted
contrast created with FLAIR,
without partial volume effects due
to CSF signal (which has been
nulled out). While there have been
reports about the frequency of
(juxta)cortical lesions and epilepsy
in MS, the clinical relevance of
(juxta)cortical lesions in MS is
largely unknown117,156; especially in
relation to cognitive impairment.
The purpose of our study was to
investigate the correlation between
the amount of (juxta)cortical
lesions detected with FLAIR and
cognitive impairment, as measured
by the Brief Repeatable Battery
Neuropsychological Tests, a
cognitive screening battery
composed by Rao et al.203. In
addition we wanted to reassure that
the FLAIR sequence is more
sensitive than spin-echo sequences
in detecting (juxta)cortical lesions
when thin (3 mm) slices are used,
and especially whether lesions
detected with FLAIR correlate
better  with the cogn it ive
impairment.




We examined 39 pat ients
(Amsterdam 19, London 10, Milan
10) with clinically definite MS
according to the Poser criteria192;
24 patients had a relapsing
remitting,  13 a secondary
progressive and 2 a primary
progressive course (according to
the criteria of Lublin and
Reingold142). MRI and clinical and
neuropsychological evaluations
were performed on separate days,
but within a week of each other.
The subjects had mild to moderate
disability (EDSS range 0-6).
Patients with clinically manifest
dementia, speech disturbances,
poor visual acuity or other physical
symptoms interfering with the test
performance were excluded.
Pat ients characteristics are
summarised in table I. The subjects
of the control group (39 persons)
w e r e  s e l e c t e d  f r o m  a
neuropsychologically evaluated
group of healthy subjects and were
matched as much as possible by
age, sex and educational level. The
educational level was scaled
according to a ranging system in
which 1 reflects no education and
7 education at university level.
Table I




Age (yrs) 40 10.6 21 71
EDSS1 Median:       3 — 0 6
Educational level2 4.1 1.5 2 7
Disease duration (yrs) 10.3 8.7 2 43
1) EDSS: Expanded Disability Status Scale of Kurtzke129.
2) The education level is a scale from 1 to 7; in which 1 reflects no education and 7 an
education at university level.
THE MAGNIMS A.1.2 STUDY
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MR Imaging
MR imaging included conventional
(CSE) and fast (FSE) dual echo
spin-echo, and a fast-FLAIR; the
s c a n n i n g pa r ame t e r s  a r e
summarized in table II. All the
scans were performed on a 1.5T
system and planned the same way.
We used two interleaved sets of 23
slices, resulting in a contiguous data
set of 46 slices with a thickness of
3 mm, and a 1 mm in-plane
resolution. For analysis, the 3 types
of scans were evaluated in a
randomized fashion. Lesions were
marked on hard copies by one
exper ienced observer, an d
classified according to regions and
relation with the cortex. A
(juxta)cortical lesion was defined as
a lesion in or in contact with the
cortex.
Table II
Timing parameters of MR sequences per study site.
Amsterdam (n = 19) London ( n = 10) Milan (n = 10)
TR TE TI TR TE TI TR TE TI
CSE 2500 20-80 ------ 2000 20-90 ----- 2500 20-80 -----
FSE 3300 16-98 ------ 3200 15-90 ----- 3300 16-98 -----
FLAIR 9500 105 2000 11000 143 2200 9500 105 2200
Shown are the TR (repetition time), the TE (echo time) and the TI (inversion time) for
conventional spin echo (CSE), fast spin echo (FSE) and fluid attenuated inversion
recovery (FLAIR).
Neuropsychological tests
The neuropsychological tests were
administered by  a skilled
psychologist, and consisted of the
Brief Repeatable Battery developed
by Rao et al.202. This battery
consists of the Selective Reminding
Task (remember and reproduce a
list of items), the Spatial Recall
Task (remember the position of 10
counters in a 6x6 grid), the Symbol
Digit Modalities Test (matching
numbers to symbols in 90 sec), the
PASAT (listening to a tape,
remembering the last number
heard and summing it with the
previous number heard, with two
different presentation speeds) and
the Word List Generation (a verbal
fluency task). The test was
THE MAGNIMS A.1.2 STUDY
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administered in the native
language. For the first two tasks a
delayed task is also part of the
Brief Repeatable Battery.
From these tests, a Cognitive
Impairment Index (= CII) was
calculated by adding up the
number of standard deviations the
patient differed from the mean of
the control group (Z-scores) on all
subtests of the Brief Repeatable
Battery; the method used is
comparable with that used by
Camp et al.35. Furthermore, we
divided our group on the basis of
the CII into a subgroup with
minimal  or  no cognit iv e
impairment (CII < 9) and a
subgroup with mild to moderate
cognitive impairment (CII > 9).
This cut-off was chosen to reflect
the fact that on average the
“impaired subgroup” scores were
more than 2 standard deviations
from the mean on an average of
four of the five cognitive tests.
Statistics
Because this was an explorative
st udy to  de tec t  poss ib le
relationships between MRI data
and neuropsychological measures,
we did not correct for multiple
comparisons and the different MS
types were not evaluated
separately. Correlations between
MRI data and clinical measures
were calculated with the two-tailed
Spearman’s rank correlation
coefficient (r), the comparison of
the two cognitive subgroups was
performed with the Mann-Whitney
test, a non-parametric test for two




The CII ranged from 1 to 22
(mean 6.18). The frequency
distribution (figure 1) shows that
the cut-off value of 9 separates a
subgroup of 31 patients with no or
minimal impairment from a
subgroup of 8 (21%) patients with
more severe cognitive impairment.
All subtests were performed
almost equally well, although the
symbol digit modalities test
revealed a slightly more abnormal
pattern (mean Z-score 1.67 against
all other Z-scores on average lower
than 0.85).
THE MAGNIMS A.1.2 STUDY
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Table III


















SRT - ltr 72 42.9 5 64 13.7 69
SRT - cr 72 30.4 0 59 13.5 69
SPR 30 18.9 11 27 4.5 29
SDMT 110 44.9 10 81 14.4 81
PASAT (3'' + 2'') 120 72.3 7 111 27.2 118
Word fluency 24.5 13 43 6.1 44
* selective reminding task (SRT), long term retrieval (ltr) and consistent retrieval  (cr);
the 10/36 spatial recall test (SPR); the symbol digit modalities test (SDMT); the paced
auditory serial addition task (PASAT), the 3 seconds and 2 seconds item interval
together; verbal fluency (VF).
Table IV
Mean, minimum, and maximum number of lesions observed with the
different sequences, according to location.
Sequence*
Total number of lesions (Juxta)cortical lesions Non-cortical lesions
Mean Min Max Mean Min Max Mean Min Max
CSE 110 12 296 32 1 158 77 9 168
FSE 116 22 305 32 2 164 78 19 179
FLAIR 110 14 239 33 2 133 82 12 225
* conventional spin-echo (CSE), fast spin echo (FSE) and flu id attenuated inversion
recovery (FLAIR). Note that the values for (juxta)cortical and non-cortical  areas don't
add up to the ‘total' since they could occur in diffe rent patients.
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Figure 1
Frequency table of the Cognitive Impairment Index scores.
The Cognitive Impairment Index was calculated by adding up the number of standard
deviations the patient differed from the mean of a healthy control group (Z-scores) on
all subtests of the Brief Repeatable Battery. The mean score is 6 with a standard
deviation of 4.75. Note that eight patients (21%) had a score of 9 or more ("cognitive
impaired").
Detection of lesions using various
techniques   (see table IV)
All scans were of good quality. The
total number of lesions we
observed ranged from 12 to 305
per patient and the number of
(juxta)cortical lesions from 1 to
164. The three different techniques
showed no significant differences
in detecting MS lesions. FSE
showed slightly more, and fast-
FLAIR slightly fewer lesions than
CSE, but the differences were not
significant (p > 0.05). Although
most lesions could be seen on all
three sequences, some lesions were
only seen on one or two of the
sequences (see for an example
figure 2). There were minor
differences with respect to the
relative sensitivities across the
three centres, but these differences
were not statistically significant.
There were no differences between
the three sequences in the amount
of (juxta)cortical lesions detected
(although not necessarily the same
les ion s ) .  Les ions  in  the
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Figure 2
An example of the difference between three MR sequences in detecting
lesions.
The same slice (proton density image on the left, T2 weighted image in the middle and
FLAIR image on the right) is shown. Apart from several other (white matter) le sions,
the lesion in the left hemisphere indicated by the arrow is well seen on the FLAIR
image, but was not identified on the other sequences. The opposite  is true for the lesion
in the right hemisphere indicated by the arrow, which is not seen with FLAIR.
(juxta)cortical area were sometimes
difficult to detect on CSE and FSE
on the first echo, and frequently
became more evident on the
heavily T2-weighted images. In
such cases, the proton density
weighted images are important to
exclude partial volume effects with
CSF and in determining the
position of the gray matter.
Most lesions were found in the
frontal lobe, followed by the
temporal and parietal lobes. This
pattern was also seen for
(juxta)cortical lesions. The total
number of lesions measured with
different sequences was highly
correlated (all r values > 0.77). The
percentage of (juxta)cortical lesions
as a percentage of all lesions was
30% (6- 59%) for fast FLAIR, 29%
(2 - 64%) for CSE and 28% (3 -
61%) for FSE.
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Figure 3
Scatter plot of the number of (juxta)cortical lesions detected with the
FLAIR versus the Cognitive Impairment Index.
The correlation coefficient
is 0.32 (p = 0.045). The
number of non-cortical
lesions did not correlate
w i th  the  Cog nit i v e
Impairment Index.
Figure 4
Scatter plot of the number of non-cortical lesions detected with FLAIR
versus the Expanded Disability Status Scale (= EDSS).
T h e  c o r r e l a t i o n
coefficient is 0.34 (p =
0.035). The number of
(juxta)cortical lesions did
not correlate with the
Expanded Disab i l i ty
Status Scale (= EDSS).
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Correlation of neuropsychological
test  resul ts  and c l inica l
parameters with MR parameters
The CII is significantly correlated
(figure 3) with the overall number
of (juxta)cortical lesions on fast-
FLAIR (r = 0.34; p = 0.035), and
w i t h t h e  p e r c e n t age  o f
(juxta)cortical lesions on fast-
FLAIR (r = 0.36; p = 0.024).
However, the CII did not
significantly correlate with the
number of lesions measured by the
other two techniques, nor with the
non-cortical or the total number of
lesions measured with any of the
three techniques. None of the
individual subtests of the Rao test
battery correlated with the total
number of ((juxta)cortical or non-
cortical) lesions neither for the
whole brain nor for any particular
area. The EDSS correlated with
the number of non-cortical lesions
on fast-FLAIR (r = 0.32, p =
0.045) (figure 4), especially those in
the basal ganglia (r = 0.37; p =
0.02).
No significant differences in
contribution of the RR and SP
patients was found for those
results.
Compared to those with a score
less than 10 on the CII, subjects
who scored higher (eight patients)
showed significantly higher scores
on the EDSS (p = 0.017) and its
Functional System Mental subscore
(p < 0.001).
DISCUSSION
The goal of our study was to
evaluate the correlation between
the number of (juxta)cortical
lesions as depicted by FLAIR and
cognitive impairment. The CII, as
i n d i c a t o r  o f  c o g n i t i v e
dysf u n ct ioning,  showed a
correlation with the number of
(juxta)cortical lesions in the whole
brain (FLAIR sequence), while the
total number of lesions and the
CII showed no correlation. Several
earlier studies did report a
correlation between the total lesion
load or total lesion score (defined
in many different ways) and
general cognitive impairment
(scored as an index of more than
one cognitive domain, evaluated
with different tests, or as the score
of one of the  cognitive
areas)83,203,250. In some studies the
total lesion load or score showed a
relation with the following
cognitive domains: intelligence5,203,
attention96,227, verbal and nonverbal
memory83,96,177,227, abstract and
conceptual reasoning83,203, recent
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memory203, visuo-spatial problem
so lv ing8 3 , 2 0 3  and lingu i s t ic
problems203. In a few studies no
correlat ion between cognitive
impairment and lesion load was
f o u n d 8 3 , 9 9 , 1 4 6 , 2 0 3 , 2 5 0 .  T h e
inconsistency of these findings
probably relates in part to the
marked differences in techniques
and definitions; a fact that is well
illustrated by the lack of a statistical
significant correlation between the
number of (juxta)cortical lesion
and cognitive impairment using
CSE or FSE. Our results indicates
a possible role of (juxta)cortical
lesions measured with FLAIR in
determining cogn itive dys-
functioning; further research is
needed to evaluate this possible
relation in greater depth.
We found a significant (but not
very strong) correlation between
the (juxta)cortical lesions detected
with the thin slice FLAIR and
cognitive impairment measured
with the Brief Repeatable Battery.
This is despite the fact that the
Brief Repeatable Battery was
developed as a cognitive screening
tool. It is not especially suitable for
assessing focal cognitive deficits
and calculating correlations with
regional lesion load. The Selective
Reminding Task and the 10/36
Spatial Recall Test are verbal and
visual memory tests respectively,
the PASAT and the Symbol Digit
Modalities Task are attentional
tasks and Verbal Fluency tests
executive skills. All of those
functions are probably more
spread throughout the brain, rather
than being localised in a single
region. The fact that  the overall
number of (juxta)cortical lesions is
well correlated with the CII and
none of the regional lesion loads
did, underlines this hypothesis.
Correlations with regional lesion
load or score have been described
for abstract reasoning3,250 with the
number of frontal lesions; for
visuo-spatial problem solving,
attention and verbal memory with
the number of parietally localised
lesions250 and frontal lobe
impairment with the frontal lobe
lesion load80,227. Some studies
described a relation between
existence of periventricular lesion
and different aspects of cognitive
impairment152,194. In further
research more specific tests should
be used to evaluate correlations
between number of (juxta)cortical
lesions in a certain area and
cognitive dysfunctioning in MS
patients. Functional MRI, which
can locate brain act ivity in stead of
brain lesions can play a role in this
research field.
Besides the correlation between
the CII and the number of
(juxta)cortical lesions, the number
of non-cortical lesions showed a
significant correlation with the
EDSS. The latter phenomenon has
been described a number of times
[e.g. by Huber et al.99], although
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there is no consensus about the
relation between physical disability
and cognitive impairment3,76,146
,176,182,200,249,260. It thus seems that
non-cortical lesions are more
important for physical disability,
while (juxta)cortical lesions have
m o r e  i m p a c t  o n neu ro-
psychological functioning.
Our findings are in line with those
recently reported by Miki et al.156,
where the presence of U-fibre
involvement was found to be
assoc i a t ed w i th cogn it ive
impairment, regardless of physical
disability.
Our study showed no significant
differences between the number of
les ions on FLAIR image s
compared with CSE or FSE. This
was the case for both the
(juxta)cortical and the non-cortical
lesions. This is in contrast to most
earlier work, which reported more
(juxta)cortical lesions using the
FLAIR sequence75 ,88 , 139 ,2 4 8 , 2 8 8 ,
although some studies256 did not
find more lesions on FLAIR than
on spin echo images. We feel that
the relatively high number (30% of
all lesions seen on fast FLAIR) of
(juxta)cortical lesions in our study
relates to the use of thin slices (3
mm). This results in reduced partial
volume averaging effects with
sulcal CSF and favours the
detection of typically smaller
lesions in the cortical region117.
Interest ingly, many lesions
detected by FLAIR were not seen
with CSE and FSE, and vice versa.
In the absence of a gold standard,
it remains highly speculative what
may have caused this discrepancy.
CONCLUSIONS
While MS is typically considered to
be a pure white matter disease with
a subcor t i c a l  pa t te rn  of
dementia195, recent publications
have renewed the interest of
(juxta)cortical lesions. Our study
suggests that such lesions may be
important in determining cognitive
decline in MS. The FLAIR
sequences proved to be significant
in detecting those (juxta)cortical




2.3 THE PSYLIQ STUDY
Adapted from: Multiple sclerosis
Brain atrophy and lesion load as explaining
















Multiple sclerosis (MS) is a multifocal demyelinating disease of the central
nervous system, with lesions widespread through the brain and spinal
cord. An important manifestation is cognitive impairment, which, though
difficult to measure, may have a major social impact.
METHODS
To better understand the relationship between structural tissue damage
and cognitive impairment, we examined the extent and spatial distribution
of brain lesions, as measured by magnetic resonance imaging (MRI), in
relation to abnormal cognitive performance as measured by the Brief
Repeatable Battery (BRB) in 82 MS patients. Possible confounders, like
fatigue, pain and depression were also assessed. Brain MR image analysis
included hyperintense T2 and hypointense T1 lesion load in the whole
brain and the four lobes separately,  as well as whole brain volume
measurements.
RESULTS
Cognitive impairment (defined as more than two abnormal tests) was
found in 67% of the patients. Moderately strong correlations were found
between the subtests of the BRB and the lesion loads in the brain regions
hypothesized to be associated with that cognitive test, although  these
correlations were in general not much stronger than those between the
subtests and the overall lesion load (due to strong interrelationships). The
Spatial Recall Test correlated best with parietal lesion load; the Symbol
Digit Modalities Test, the Paced Auditory Serial Addition Task (PASAT)
and the Word List Generation best with frontal, parietal and temporal
lesion load, while the Verbal List Generation Test Index correlated only
with atrophy.
CONCLUSION
Atrophy and lesion load were the main factors determining the test
scores, explaining 10 to 25% of the variance in the test results, and were
more important than fatigue, pain and depression; only depression had a
minor, but significant, additional effect on the PASAT.
In conclusion, cognitive impairment in MS, is moderately dependent on
amount (and distribution) of structural brain damage, especially in the




Multiple sclerosis (MS) is a
multifocal demyelinating disease of
the central nervous system, that
leads to cognitive dysfunctioning in
many patients. The pattern of
cognitive impairment in MS is
characterized by deficits in recent
memory, sustained attention,
conceptual  reasoning an d
information processing speed, with
preserved language and intellectual
functions202.
To assess neuropsychological
problems in MS, the Brief
Repeatable Battery (BRB) was
developed by the MS Cognitive
Function Study Group198 and is
since then widely used11,77,96,242,243,244.
Table I
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frontal and parietal lobes47,285
Word List Generation
test (WLG)
verbal fluency test frontal and temporal lobes  for
example175
The final BRB version consisted of
five test [table I].  Those tests had
the greatest power, of the 24 tests
evaluated, in discriminating MS
patients from healthy subjects.
Hence the BRB allows the
examination of (general) cognitive
functioning in a comprehensive
and time-efficient way, although
not all domains are tested equally.
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The purpose of our study was to
investigate in a group of MS
patients the relation between MR
abnormalities (total extent as well
as spatial distribution across the
different brain regions) and the
prese n ce and  pa t te rn  of
neuropsychological impairment.
For this study we analysed patients
from two study samples, who
underwent identical cognitive
testing, except for the Selective
Reminding Task (SRT), which was
replaced by another verbal
memory task in one of the
samples.
While the brain regions subserving
the functions necessary to perform
these tests are not known in detail,
we hypothesized some correlations
between impaired cognit ive
function and location of lesions,
based on the presumed active brain




We evaluated 82 patients (33 men,
49 women) with definite MS
according to the Poser criteria192,
they all were patients in our
hospital at time of the study. Each
patient underwent a clinical
examin a t ion , fo l lowed b y
application of the BRB and finally
an MRI scan. The clinical
evaluation consisted of assessment
of the type of MS, disease
duration, level of education (in
years) and a physical examination
to determine the EDSS and the
functional  system scores129.
Possible confounders included
were pain, fatigue and depression.
Pain was scored by means of a
Visual Analogue Scale (rated by
placing a point on a scale of 0 - 100
mm). Fatigue was measured by
applying the fatigue severity scale125
(FSS; a nine item questionnaire of
fatigue related statements, every
item scored 1 (full disagreement
with the statement) to 7 (full
agreement)), extended with a six
item questionnaire of statements
specifically related to fatigue in MS
patients236 (MS-FS; with the same
scoring method).  Depression was
assessed through the Beck
Depression Inventory19 a self-
rating depression scale.
The ethical review board the Vrije
Universiteit  Medical Center
approved of the study and all
patients gave informed consent.
Neuropsychological testing
As the current sample was drawn
from two originally separate
sources, to produce a large sample,
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the SRT test33 originally used in the
BRB, was replaced, in the majority
of patients (n = 56 (23 men, 33
women)), by the Dutch Verbal
Learning and Memory Test
(VLGT)61, a comparable test for
which normative scores were also
available. Both tests are verbal
memory tasks: they are item lists to
measure wordspan. The outcome
parameter of the VLGT is the
global performance index (GPI),
which is the total recall score; for
the SRT the number of recalls is
scored for each trial.
The Spatial Recall Task (SPRC)
used is an adapted versions200 of
the original 7/24 Spatial Recall
Test developed by Barbizet12. In
the BRB version, the checkerboard
is wider (6 x 6) and more checkers
(ten) are used than in the original
version. The SPRC score is the
total number of correct responses
for all three trials separately
(SPRC1, SPRC2, SPRC3), their
total (SPRC TOT) and a separate
score for the delayed recall trial
(SPRC DEL).
The Symbol Digit Modalities Test
(SDMT) was developed by Smith
in 1973241. It is a test measuring
many cognitive domains, but
especially sustained attention and
concentration. The outcome
parameter is the total number of
correct substitutions.
The Paced Auditory Serial
Addition Task (PASAT) was
developed by Gronwall90 in 1977.
It measures attentio n and
concentration. The outcome score
of the PASAT is the number of
correct responses per trial (three
seconds and two seconds number
interval trial). The Word List
Generation (WLG), also known as
the Controlled Oral Word
Association Task245, is a semantic
verbal fluency test to evaluate the
spontaneous production. The
score is the total number of
correct responses.
MR imaging acquisition and
analysis
MR imaging included T1 weighted
(TR 620/ TE 15) and T2 weighted
(TR 2500/ TE 45-90) sequences.
Slice thickness was 3 mm with 1
mm in-plane resolution. Lesions
were identified by visual inspection
and were marked. Lesion load and
brain volume measurements were




based on local thresholding (Show-
Images), a method with high
reproducibility, as described earlier
by Van Walderveen et al.267. The
total lesion load of hyperintense
lesions as seen on the T2 images
and of hypointense lesions on T1
weighted images were calculated, as
were regional lesion loads in the
four main brain areas (frontal,
parietal, temporal and occipital;
both left and right side; division
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was performed by applying global
landmarks by a trained and
experienced operator) [figure 1].
Figure 1
The anatomical subdivision of the lobar regions as applied on this study. 
On the highest slices a line halfway anterior and posterior was used to separate frontal
and parietal. At the lower levels, once the splenium was visible, the posterior half was





volumes were measured on T1-
weighted images and intracranial
volume was measured on the
corresponding slices of the heavily
T2-weighted images. Those
volumes were used to calculate the




Individual test results were
considered abnormal when the
score was more than 2 SD below
the average score of a gender, age
and education comparable control
group28. To get a global index of
neuropsychological performance,
the Z-scores of all individual tests
were, after  s i gn ing them
concordan t ly  to cognit iv e
performance,  added to derive the
Cognitive Index.
As MR data are typically not
normally distributed, Spearmann’s
rank test was used to correlate
(regional) lesion load and RBV
with the test results. For none of
the tests, with the exception of the
SDMT, a significant correlation
between the test score and the
occipital lesion load was expected.
Still the correlation between test
score and occipital lesion load was
calculated to reject the null-
hypothesis that there is always a
significant correlation between
regional lesion load and cognitive
test, because of the strong
intercorrelations of tests and MR
parameters.
For each neuropsychological test, a
linear regression analysis was
performed with the test score as
the dependent  variable. The
independent variables were T2
lesion load, T1 lesion load and
relative brain volume (as the MR
parameters), EDSS, FSS, MS-FS,
VAS pain and the Beck
Depression Inventory (as the
clinical scales), and years of
education, age and gender (as
possible confounders). To correct
for skewness, the lesion load
m e a s u r e m e n t s we r e  l o g -
transformed before entering them
in the model. A forward stepwise
approach was chosen and the





The patients had a mean age of
47.0 years (range 27 - 73); median
level of the education was 11 years
(range 4 - 20). Their EDSS scores
ranged from 0 to 8.5, with a
median of 4, and a typical bimodal
distribution (figure 2)275,276. Of the
82 patients, 31 had a relapsing-
remitting type of MS (mean age 42
years), 33 a secondary progressive
form (mean age 47 years) and 18 a
primary progressive form (mean
age 55 years). Mean disease
duration from the time of first
symptoms was 15.3 years (range
3.3 - 35.0), and from the time of
diagnosis 10.5 years (range 1 -
26.6).
Figure 2
Frequency distribution of the EDSS scores.
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On the Beck Depression Index,
the scores ranged from 1 to 26
(mean 10.6). The pain score on the
Visual Analogue Scale ranged from
0 to 75 mm (mean 20 mm). The
FSS scores ranged from 9 to 68
(mean 44.5) and the MS-FS from 6
to 39 (mean 23.3).
Results of the individual cognitive
tests are represented in table II.
Most test scores are, as the
skewness  shows,  norm al ly
distributed. Each test of the BRB
correlated significantly with most
other tests (r from 0.32 to 0.87),
with the exception of the PASAT
and some of the subtests of the
SPRC. The SRT was discarded for
calculating correlations with
specific brain regions, because too
few people performed the SRT to
have enough statistical power.
Table II
Neuropsychological test results.
Test Mean Min Max SD skewness
SPRC1 5.42 1 9 1.81 -0.255
SPRC2 6.54 1 10 1.98 0.027
SPRC3 7.60 3 10 2.07 -0.431
SPRC TOT 19.56 7 29 4.86 -0.061
SPRC DEL 6.88 1 10 2.52 -0.480
SDMT 45.22 17 83 13.67 0.114
PASAT 3 39.70 0 60 18.93 -1.048
PASAT 2 29.44 0 55 15.36 -0.536
WLG 24.13 9 38 5.68 -0.056
GPI (n = 56) 47.50 22 66 11.20 -0.373
SRT (n = 26) 6.75 .83 11.0 3.04 -0.434
The mean, range, standard deviation (SD) and skewness of the test results of the Spatial
Recall Test (three runs (SPRC1, SPRC2, SPRC3), together the SPRC TOT, and the
delayed test (SPRC DEL)), the Symbol Digit Modalities Test (SDMT), the Paced
Auditory Serial Addition Test (PASAT, the three seconds (PASAT 3) and two seconds
version (PASAT 2)), the Word List Generation Task (WLG), the Global Performance
Index of the VLGT (GPI) and the Selective Reminding Task (SRT).
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In 6 - 44% of the patients, the
individual test results were more
than two SDs below the results of
normal healthy controls; the
SDMT was most often affected
[table III]. For all tests, the group
with an EDSS $ 4 had a greater
percentage of patients with test
results under the norm scores than
the group with an EDSS < 4 [table
III]. Cognitive impairment, defined
as abnormal scores in two or more
tests (or as a Cognitive Index
below -2) was found in 67 % of the
patients, only 18 (22%) patients
scored less than 1 SD below the
normative value.
No significant correlations were
found between the possible
confounders and the cognitive test
results, except for the PASAT and
the SDMT with the confounder
MS-FS.
The MR parameters (RBV, total
and regional lesion loads) are
described in table IV. The greatest
lesion load was found in the frontal
lobes and smallest in the occipital
lobes, both for the T2 and T1
lesion load. All regional lesion
loads correlated well with each
other (for T2 range 0.31 - 0.90; for
T1 range 0.31 - 0.91) and with the
total lesion load (for T2 range 0.66
- 0.90; for T1 range 0.61 - 0.91, all
with a p < 0.001). The RBV ranged
from 0.65 to 0.90 (mean 0.80). This
RBV showed a correlation of -0.61
with the T2 total lesion load and
-0.57 with the T1 total lesion load
(p < 0.001).
Table III
Percentages of the patients which had a test result of more than 2 SDs
below the mean scores in a healthy control group28.
 > 2SD below mean  > 1 SD below mean
Test Total group EDSS < 4 EDSS >= 4 Total group
SPRC Total 12 % 10 % 14 % 33 %
SDMT 44 % 33 % 55 % 61 %
PASAT3 23 % 10 % 36 % 29 %
PASAT2 16 % 5 % 26 % 24 %
WLG 6 % 5 % 7 % 20 %




Mean T2 and T1 lesion loads (SD) in total brain and different brain
regions (in cm3).
Lesion load (cm3) T2 T1
Total 11.40 (14.40) 3.10 (5.70)
Frontal lobe right 2.24 (3.16) 0.65 (1.22)
left 2.10 (3.17) 0.53 (0.97)
Parietal lobe right 1.14 (1.61) 0.19 (0.34)
left 1.08 (1.45) 0.16 (0.33)
Temporal lobe right 1.03 (1.32) 0.35 (0.41)
left 0.99 (1.29) 0.28 (0.46)
Occipital lobe right 0.72 (0.81) 0.25 (0.33)
left 0.66 (0.72) 0.24 (0.31)
The total T2 lesion load ranged from 0.11 to 93.05 cm3 (mean 11.40 cm3) and the total
T1 lesion load ranged from 0 to 41.97 cm3 (mean 3.10 cm3).
MR lesion load measurements were
correlated with the test scores
[table V]. The Cognitive Index
correlated with the lesion load of
the total brain for both T2 (-0.418;
p < 0.001) and T1 lesions (-0.389;
p < 0.001), and with the RBV
(+0.427; p < 0.001). When the
group was dichotomized at a
Cognitive Index of -2, the
cognitively more impaired group
showed  a significantly greater
lesion load on T2 and T1 images
than the cognitively more intact
group (for T2: 13.29 vs 7.19 cm3, p
= 0.029; T1: 3.83 vs 1.48 cm3, p =
0.020); the RBV was lower (0.79 vs
0.82 ; p = 0.012) in the cognit ively
more impaired group. All tests
correlated significantly with the
RBV [table V].
In general terms it could be said
that the correlations between the
cognitive test and the areas
hypothesized to be associated with
that test were higher than with the
other brain areas, although the
differences are not very high. As
hypothesized the lesion load in the
occipital cortex did not correlate




Correlations of lesion loads and test scores.
LL SPRC
tot
SDMT PASAT3 PASAT2 WLG GPI
T
2
total -0.226 * -0.503 g -0.405 g -0.374 g -0.430 g
frontal r -0.459 g -0.345 ] -0.297 ] -0.486 g
l -0.558 g -0.319 ] -0.311 ] -0.380 g
parietal r -0.403 g -0.323 ] -0.330 * -0.360 g
l -0.269 * -0.448 g -0.335 ] -0.350 g -0.421 g
temporal r -0.318 ] -0.294 ] -0.254 * -0.298 ]





total -0.485 g -0.312 ] -0.332 ] -0.347 ]
frontal r -0.391 ] -0.382 * -0.334 * -0.353 *
l -0.540 g -0.339 * -0.304 *
parietal r -0.388 ] -0.320 * -0.449 ]
l -0.358 * -0.400 ] -0.360 * -0.482 *
temporal r -0.438 ] - 0.386 * -0.403 ]
l -0.416 ] -0.336 *
occipital r -0.317 *
l
Relative   brain
volume
0.247 * 0.537 g 0.339 ] 0.360 ] 0.272 ] 0.409 ]
Results of the correlations of lesion load and test scores. Non parametric (Spearman
rank) results. For the occipital region lesion load correlations were calculated as a
negative control.




Regression analysis results for the neuropsychological tests.
Test Main significant fac tor Covariates (other signifi cant) adj. R2
SPRC tot T2 lesion load - 0.110
SDMT Rel. Brain Vol. T2 lesion load 0.367
PASAT3 T2 lesion load BDI 0.281
PASAT2 Rel. Brain Vol. BDI 0.208
PASAT tot T2 lesion load BDI 0.270
WLG Rel. Brain Vol. - 0.490
GPI Rel. Brain Vol. - 0.237
Regression analysis was performed after a log transformation of the lesion load
measurements. A forward stepwise model was used, with the test score as the
dependent variable and MR parameters (RBV, log transformation of T2 lesion load, log
transformation of T1 lesion load), clinical scales and other possible confounders (pain,
FSS, MS-FS, depression (BDI), age, sex and education) as independent variables. The
probability for a variable to enter the model was set to 0.05. The adjusted R2 represents
the explained variance of the total model.
lesions, while for the T1 lesions
only the right side correlated
significantly with the SDMT score;
we thus feel right to reject the null-
hypothesis that correlations of
other regions with cognitive
measures are due to chance.
The statistically sign ificant
correlations between MR lesion
load measurements and test scores
were mainly driven by the patients
with a high EDSS score (> 3.5)
who in general showed higher
correlations than those with a low
EDSS score.
Regression analysis [table VI]
showed that for all individual tests
the main significant factor, i.e. the
factor that explained most of the
variance in the test score, was
always one of the MR parameters.
T2 lesion load and RBV explained
most of the variance, and addition
of other explanatory variables only
made small differences in the
adjusted R2 of the model. For the
SDMT, both MR parameters
independently explained variance.
For the models of the PASAT, the
depression rating was of minor
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importance in explaining the test
score variation. The other
confounders considered in this
study (age, sex, pain, fatigue,
education) showed no independent
contribution to any of the
associations examined.
DISCUSSION
Cognitive impairment is a major
problem in MS18,83,202,260. In our
study, consisting of patients not
selected for cognitive problems,
67% of the patients had a
Cognitive  Index below -2
(indicating cognitive impairment).
For the individual tests, 6-44% of
the patients scored 2 or more SDs
below the normal mean score.
When a less conservative threshold
than two SD is used, even more
MS patients could be considered
cognitively impaired. Only 22% of
the patients scored in the normal
range for all tests.
Many studies have reported a
correlation between total brain
les ion load and cognitiv e
impairment39,83,133,203,244,250. The
influence of regional lesion loads
and brain atrophy on more specific
cognitive problems is far less
known, especially for the widely
used BRB5,21,42,80,96,165,227,250. Our
main finding was that per test
certa in  regions cor re l a ted
significantly with the test score,
roughly in keeping with the
hypothesized regions based on
(neuropsychological) literature.
Although not very high differences
were observed, those correlations
do not represent an overall
intercorrelation state, e.g. occipital
lesion load did not significantly
correlate with most test scores.
Relative brain volume correlated
well with lesion loads and with
most of the test results. Moreover,
it proved to explain a substantial
part of the variance in test results.
We used the BRB as test
i n s t r u m e n t f o r  cogn i t i v e
functioning,  with a smal l
adaptation for the verbal memory
task in part of the group. The BRB
is a good instrument in
discriminating MS patients from
healthy subjects. The tests in this
battery are selected for that
purpose, not to investigate all
cognitive domains equally well.
This situation makes it harder to
find a relation between cognitive
test scores and regional MR
parameters.  Because we put
together two data samples, to get a
bigger sample volume, we had the
disadvantage of two different
verbal memory tests. Although
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they are supposed to test the same
cognitive domain, the differences
makes it more difficult to interpret
the results of those two tests
together. The two cohorts did not
differ in source or disease specific
parameters.
The verbal memory tests probably
need brain activity that has its main
side of activity in the (left)
temporal lobe and the frontal
lobes. These hypothesized regions
indeed showed a correlation with
the VLGT test scores; however
these were not stronger than for
overall lesion load nor were there
strong differences between left and
right. The SPRC was expected to
correlate with the (right) parietal
lobe and the temporal lobes;
however, correlations were only
found with the left parietal lobe.
The other areas did not reach
significancy, as was the case for the
overall lesion loads. The SDMT
was expected to correlate with
lesions in the whole brain and our
results corroborated this notion,
both for T2 and T1 lesions.
Attention as is needed in the
PASAT is believed to be located in
the frontal and parietal lobes. A
significant correlation of the test
score with the lesion load in the
frontal lobes, parietal lobes and
whole brain was shown; in
addition, a correlation with the
temporal lobes was demonstrated.
The WLG was also hypothesized
to be a ‘whole brain test’, which
was substantiated by our results,
again with exception for the
occipital lobes.
Sperling et al.244 also found
significant correlations between the
BRB test scores and regional lesion
loads. The correlations they found
were for all but one test (the
WLG) always with the same areas,
namely total brain and the frontal
and parietal lobes. The WLG did
not correlate with the total lesion
load, nor with any regional lesion
load in their study244. Because in
their study the frontal and parietal
regional lesion loads formed
almost the complete total lesion
load, and (therefore) correlated
very strongly with the total lesion
load (r > 0.97), we feel that the
anatomical definitions or the MR
imaging technique and analysis
used in that study, may have
precluded a more differentiated
result.
Our main issue in this study,
establishing the relation between
(regional) lesion load and test
scores, was as hypothesized for
most  tests.  However,  the
correlations were not very strong,
indicating other contributing
factors. The strength of the
correlations was comparable to a
previously published study244,
although some small differences
existed. We observed the greatest
lesion load in the frontal lobes, but
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all regional lesion loads and the
total brain lesion load had strong
intrinsic correlations, as was found
by others244,250. That not all areas
are, at least on a functional level,
equally involved, is reflected in the
cognitive dysfunction profile in MS
patients. Language disorders, for
example, are rare, while attention
and recent memory are often
affected.
Establishing the impact of regional
lesion load on test scores depends
a great deal on the specificity of
the tests used. All tests of the BRB
are selected on the basis of a high
incidence of abnormal scores in a
MS group202, and the tests used are
tests in which more than one brain
area is involved. That more or less
the whole brain is involved in
those tests is partly represented by
the presence of strong correlations
with the RBV. However, for most
tests one or a few brain areas can
be identified that are thought to be
more involved in the tasks needed
to perform the test than other
brain areas. The regional analysis,
as defined in this study, may not
have been precise enough to reveal
more specific spatial relations.
However, in the absence of well
defined functions and spatial
restrictions,  it is practically
impossible to address these in
more detail.
The third major factor that could
have influenced the observed
correlations, are other parameters,
like pain, fatigue, depression, age,
sex and education, that might have
an impact on cognit ion. In our
data set, regression  analysis
revealed that those parameters
were of marginal importance [table
IV]. The regression analysis also
showed that even the main factors
(RBV, lesion load measurement)
only predicted at best 25% of the
variance in test score.
In our study we put together the
results of all MS subtypes, although
there is more and more evidence
that PP type patients have a
distinct cognitive impairment
pattern (for example 17,58,101,290). In
this study we were unable to find
differences between subtypes,
probably because the subgroups





In conclusion, our study confirms
the frequent occurrence of
cognitive dysfunctions in MS
patients, as well as the moderately
strong relation with structural brain
damage (atrophy and regional
lesion load), across the disease
s u b t y p e s .  T h e  r e g i o n a l
relationships with each test score
reflect the fact that certain brain
areas are more involved in one test
than other areas. Nevertheless,
strong intercorr elations were
found, illustrating the widespread
distribution of the disease and the
(resulting)  general cognitive
dysfunctioning as captured by the
BRB. However, even though in
this study cognitive impairment in
MS is dependent on amount (and
distribution) of MR abnormalities,
structural brain damage explains
only about 25% of the variance in
the cognitive test results.
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2.4 THE ANT TASK IN MS
Adapted from: Neuropsychologia
Informat ion processing characterist ics in
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The purpose of this study was to evaluate information processing
characteristics in patients with multiple sclerosis (MS).
METHODS
We selected 53 patients with MS and 58 matched healthy controls. Using
computerized tests, we investigated focussed, divided, sustained attention,
and executive function, and attempted to pinpoint deficits in attentional
control to peripheral or central processing stages.
RESULTS
The results substantiate the hypothesis that cognitive slowing 
attention-demanding (controlled) information processing underlying
more complex cognitive skills is general, i.e. irrespective of type of
controlled processing, with MS patients being 40% slower than controls.
MS patients may suffer from focussed, divided and sustained attention
deficits, as well as from compromised central processing stages, with
secondary progressive (SP) patients showing the most extensive range of
deficits, closely followed by primary progressive (PP) patients, while
relapsing–remitting (RR) patients appear to be much less affected.
General slowing appears to be highest in PP and SP type MS patients
(50% slower) versus relapsing–remitting MS (24% slower). In contrast to
most previous results, (complex) processing speed appeared to be
robustly correlated with severity of MS as measured by the expanded
disability status scale and with disease duration.
CONCLUSION
Patients did much less differ in accuracy of processing from controls,
suggesting the importance of using time strategies in planning everyday
life and job activities to compensate for or alleviate MS-related speed
handicaps.
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INTRODUCTION
Several reviews of neuro-
psychological studies in multiple
sclerosis (MS) indicate the frequent
occurrence of deficits in various
domains of cognitive function such
as recent memory, attention,
information processing speed,
executive function and visuo-
spatial perception, whereas general
in tel l igence, language, and
short-term memory seem to be
preserved183,195,196. However, a
recent meta-analysis of 36 studies
focussing on  per formance
differences between MS patients
and healthy controls showed that
general cognitive ability, in
particular  performance IQ,
discriminates between MS patients
and healthy controls, and that
language and verbal intellectual
ability may be affected by MS284. A
significant effect of rapid
processing demands was seen
across neuropsychological tests,
suggesting the importance of
processing speed and working
m e m o r y  d e m a n d s  i n
neuropsychological investigations
wi t h  p a t i e n ts  w i th  MS.
Vulnerability to increased demands
for speed and working memory
might be manifestations of a
reduced processing capacity. MS
patients therefore seem to suffer
from deficits in controlled
information processing which is
serial, attention-demanding, and
limited by the capacity of the
working memory233,240 MS results in
multiple focal areas of axonal
demyelination with lesions54,274,
occurring especially in the white
matter surrounding the ventricles,
within the deep white matter of
the frontal lobes, and within the
corpus callosum31. In the neural
efficiency model of intelligence,
differences in performance on
intelligence tests are attributed to
differences in the speed and
efficiency with which acquired
neurophysiological processes are
executed269. There are several
theories suggesting a relation
between intelligence level and
c e n t ra l  nerve  conduc t io n
speed211,212. Miller postulated the
hypothesis that nerves with thicker
myelin sheaths are faster and more
accurate in signal processing158 and
Peters suggested that myelin
b r e a k d o w n  s l o w s  n e ur a l
conduction along an axon and may
influence problem solving speed181.
If the slower information
processing in patients with MS is
indeed associated with neural
demyelination, it appears likely that
the slowing would be global rather
than restricted to a few tasks.
Data on the generality of cognit ive
slowing are still scarce as, to date,
only three relevant studies have
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been published. Kujala et al.126
reported widespread slowing on
speeded tasks in patients with MS
with mildly deteriorated cognitive
functioning. Kail and Salthouse113,
using Brinley plots29 as a method
to study cognitive aging37,230,
examined the extent of cognitive
slowing in MS by fitting reaction
time (RT) data of MS patients and
healthy controls to the regression
equation RTMS = a + b RTC which
states that the mean RT of a group
of MS patients will increase linearly
as a function of the mean RT of a
group of healthy controls. Kail et
al.111,112 confirmed this hypothesis
in a meta-analysis of archival data
from 12 studies and another study
in which original data were
collected. Meta-analyses, however,
are flawed by the use of archival
data from different studies, which
implies that regression equations
might be confounded by sample
characteristics, and limitations in
sample size (11 female MS
patients) and data set (only 15 data
points from three tasks). As argued
by Kail et al.112, firmer conclusions
about  the general slowing
associated with MS will require a
larger and more representative
sample of MS patients and a wider
range of cognitive tasks.
We performed a study to compare
the speed and accuracy of
performance on a comprehensive
set of information processing tasks
designed to evaluate basic
processes underly ing more
complex cognitive skills, i.e.
attention-demanding (controlled)
information processing, in MS
patients and healthy volunteers.
Further, we explored whether the
rate of slowing varies as a function
of  s u b t y p e  o f MS,  i . e.
relapsing-remitting (RR), secondary
progressive (SP), and primary
progressive (PP). Following the
assumption that cognitive slowing
is general, we expected this slowing
to be reflected in a fit of the data




Patients with clinically definite
multiple sclerosis according to the
criteria of Poser et al.192 were
randomly selected at  the
secondary/tertiary referral centre
for MS of the Vrije Universiteit
Medical Center, and SP, PP, and
RR MS subtypes were classified
according to the criteria of Lublin
and Reingold142. Patients with any
other CNS disorder, or metabolic,
psychiatric, learning disorders or a
condition other than MS that
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might have interfered with tests
were excluded. The recruitment
procedure resulted in a population
that is quite typical for a
hospital-based series, which is of
course  d i f fe r e n t  f r o m  a
population-based series. Healthy
controls were chosen from the
community to match the patient
group according to age, gender,
and level of education. Age at
testing and at diagnosis, disease
duration (years passed since
diagnosis and years passed since
occurrence of first subjective
symptoms), and education level
derived from a three-point scale in
which 80, 100, and 120 denoted
#8, 9 - 10, or > 10 years of
education, respectively, were
recorded. The Extended Disability
Status Score (EDSS)129, used to
estimate severity of MS, was
obtained by a physician, according
to standardized procedures, who
was blind to the test performances
and had received special training
for this purpose. All patients were
tested when they were clinically
stable and had a level of visual
acuity that would not interfere with
task performance. The Medical
Ethics Committee of the Vrije
Universiteit  Medical Centre
Amsterdam, approved the research
protocol, and informed consent
was obtained from all participants.
Tasks
Eight tasks from the Amsterdam
Neuropsy c h o log i ca l  Task s
program56 were administered in
approximately 1h 10 minutes in a
fixed order as indicated below. The
paradigms, designed to tap skills
ranging from basic reaction speed
and simple perceptual-motor
processes to neuropsychological
functions underlying the more
complex cognitive processes, have
been used extensively in patient
populations and have proven to be
sensitive to the effect of medical
treatment programs that are well
known to influence brain
function32,60,188,232.
The reaction time paradigms are
modelled according to the
attention theory of Shiffrin and
Schneider233,240 who postulated
attention as a limitation in the rate
at which information can be
processed in the working memory.
The tasks also allow the application
of the additive factor method of
Sternberg247  who defined cognitive
processing as a set of independent
component mental processing
stages that  represent  the
subsequent transitions from
stimulus input to response output,
e.g. encoding, memory search,
d e c i s i o n ,  a n d  r e s p o n se
o r g a n i s a t i o n .  T h r o u g h
manipulation of appropriate task
variables, the duration of the
information processing stages can
be influenced. Deficits associated
with these stages can be identified
by showing that task effects are
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Figure 1
Examples of the signal types in the neuropsychological tasks.
The panels in depict examples of the signal types in: the visuo-spatial task (upper le ft)
and part 3 of the memory search task (upper right), the response organisation task
(centre left) and the sustained attention task (centre right), an example of three
consecutive trials in part 3 of the attentional flexibility task (lower left), and the pursuit
task (lower right).
larger in the experimental group(s)
than in a control group, i.e. testing
the task effect x group interaction.
Processing deficits can thus be
pinpointed to limitations in
peripheral stages (perceptual and
response processes) and central
stages (memory and decision
processes)  o f  in formation
processing.
All test stimuli were presented on a
computer screen and subjects were
required to respond by pressing a
mouse key, or to use the mouse as
tracking device. 'Yes' and 'no'
answers were assigned to the right
and left mouse keys, respectively,
for right-handed subjects, and the
other way around for left-handed
subjects. Practice runs were given
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prior to each test, and subjects
were instruc ted verbally in
combination with a display of
probes and stimulus types on the
screen before practising. The same
trained instructor t ested all
subjects. In all reaction time (RT)
tasks the evaluation parameters
were speed and accuracy of
responses per signal type, the
employed post-response interval
(PRI: period between response and
next stimulus onset) was 1200 ms
unless indicated otherwise, and
signals were presented in
pseudo-random order.
Baseline Speed
In the baseline speed task, subjects
have to press a key with the index
finger whenever a square appears
in the centre of the screen (32
trials for each hand). The PRI
randomly varies between 500 and
2500 ms to prevent anticipatory
strategies. As cognitive demands
are restricted to the mere detection
of a stimulus, this task measures
simple response speed.
Divided attention: visuo-spatial processing
(encoding)
After memorizat ion of a
predefined target pattern (see
figure 1, upper left panel) subjects
have to detect this target pattern in
a signal consisting of four patterns.
Half the signals contain this target
pattern (target signals) requiring
the subject to press the ‘yes’-key,
the other half do not (non-target
signals) in which case the ‘no’-key
should be pressed. For 50% of the
target signals the other three
patterns look very similar to the
target, and in the other 50% the
other patterns are very dissimilar to
the target. Likewise, 50% of the
non-target signals consist of four
patterns that look similar or
dissimilar to the target pattern. The
similarity manipulation in this
pattern recognition task affects the
duration of the encoding stage of
processing. The task consists
of 4 × 20 = 80 trials.
Divided attention: Memory search
The memory search task employs a
display load of four letters (see
figure 1, upper right panel) and
consists of three parts in which
target set size (memory load) is
increased from one to three target
letters: k (part 1), k+r (part 2), and
k+r+s (part 3). Signals that contain
the complete target set require a
‘yes’-response. All other signals,
a lso  those containing an
incomplete target set, require a
‘no’-response. RT to target signals
is predicted to increase linearly
with memory load, reflecting the
prolongation of the memory
search stage, with the slope of RT
denoting the rate of memory
search. In part 3, the presence of
an insufficient number of target
letters in non-target signal affects
response time in that RT will
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increase with the number of these
‘distracters’ (0 or 1 in part 2, and 0,
1, or 2 in part 3). Each part
consists of 50% target and 50%
non-target signals with 40, 72, and
96 trials in parts 1–3 respectively,
with non-target trials evenly
divided across distracter type.
Response-organisation
A left- or right-pointing arrow is
presented in the centre of the
screen (see figure 1, centre left
panel). When the arrow is green, it
requires a compatible response
(arrow to the left: press left; arrow
to the right: press right) and when
it is red an incompatible response
(arrow to the left: press right;
arrow to the right : press left).
Stimulus-response (SR) mapping is
assumed to affect the duration of
the response organization stage.
The task consists of 4 x 15 = 60
trials.
Focussed attention
This task employs a similar
four-letter display load as in the
memory search task, but now only
two diagonal locations are relevant
(known in advance to the subjects)
and subjects should attend to those
positions only. A target signal is
defined as a signal that contains a
target letter on the relevant
diagonal. Upon its presentation the
‘yes’-key should be pressed.
Irrelevant target signals, i.e. with a
target letter on the irrelevant
diagonal, and non-target signals
(target letter absent) require the
subject to press the ‘no’-key. It is
expected that the processing of an
irrelevant target signal takes
longest, or causes more errors,
than of other signals. The task
consists of two parts with a
memory load of one and three
target letters, respectively. Each
task part consists of 40 target trials,
20 irrelevant target trials and 20
non-target trials.
Sustained attention
In this task, 50 series x 12 patterns
(600 signals) are presented in a
continuous fashion with a PRI of
250 ms. Each series contains an
equal number of signals consisting
of three, four or five dots (see
figure 1, centre right panel),
presented in random order. On
four dots (target signal) subjects
should press the ‘yes’-key, on three
and five dots (non-targets) they
should press the ‘no’-key. Main
parameters are tempo (mean
completion time per series),
fluctuation in tempo and the
change  (de te r iora t ion)  of
performance level with time-on-
task. During performance, subjects
were informed about errors by a
beep signal. Correct responses
following an error were separately
registered enabling the measure-
ment of the effect of feedback,
which is defined as the difference
RT after feedback - RT regular.
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Attentional flexibility
The signal consists of a horizontal
bar that is permanently present
(see figure 1, lower left panel).  On
this bar, a coloured square jumps
randomly from left to right or vice
versa. Depending on the colour of
the square after the jump, the
subjec t shou ld  copy  the
movement, i.e. press right (left)
when the square jumped to the
right (left), or is required to
‘mirror’ the movement, i.e. press
left (right) at a right (left)
movement. The task consists of
three parts. In part 1 the subject is
required to copy the movements,
in part 2 only trials that require
‘mirror’ responses are presented,
but in part 3 the square may
change colour upon each jump in
random fashion which forces the
subject to adjust his response
behaviour.
Parts 1 and 2 consist of 40 tr ials
charac te r is ed  by a  f ixed
SR-mapping condition, either
c o m p a t ib l e  ( p a r t  1 )  o r
incompatible (part 2), that does
not require attentional flexibility.
The 80 trials of part 3, with a
random mix of the SR-mapping
types, do require attentional
flexibility. It is expected that the
‘mirror’ responses in part 2 are
executed slower than the responses
in part 1, and that those in part 3
are slower than those in part 1 and
2 because shifting attentional set
takes its toll in terms of processing
speed. In all parts a PRI of 250 ms
is used.
Pursuit
This task assesses the quality of
eye–hand co-ordination and fine
motor control, constituting a
measure of psychomotor speed.
The subject has to track a small
star, which moves continuously in
a random fashion across the
screen, by trying to position the
mouse cursor as closely as possible
on the moving star (see figure 1,
lower right panel). Subjects have to
constantly adjust their movements,
as future movements of the star
cannot be anticipated. The task
time is 60 s. During task
performance the mean distance
between the moving target and
mouse cursor per second task time
is registered. The outcome
measures are the percent of
time-on-task that the subject
satisfies the accuracy criterion, i.e.
stays within 3, 6, and 12 screen
units from the star, the mean
distance to the moving target and
the within-subject S.D. of this
distance during time-on-task.
Disease severity
Neurological  impairment was
measured using the Extended
Disability Status Score (EDSS), the
most commonly used marker of
severity of MS129. The evaluation of
s even f u n c t ional  s y s t ems
(pyramidal, cerebral (or mental),
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brainstem, sensory, bowel and
bladder, optic, and “other”) and
ambulation contribute to the total
EDSS score.
Data analyses
Results were evaluated per task by
analysis of variance with group
(contro ls, RR, PP, SP) as
between-subjects factor using the
SPSS 10 statistical program.
Helmert contrasts were chosen to
compare controls with the total
MS group (first contrast), RR with
the PP + SP group (second
contrast), and PP with SP patients
(third contrast). The logic of these
contrasts lies in our aim to (1)
determine the existence of
processing differences between
controls and MS patients, (2) to
investigate whether the RR patients
meet our expectation that they are
relatively better off than PP and SP
patients, and (3) to test differences
between the latter two groups. The
various task manipulations were
used as levels of within-subject
factors in a repeated measures
design and are indicated per task:
Visuo-spatial analysis: stimulus type
(‘similars’, ‘dissimilars’) and signal
type (target, non-target); memory
search: memory load (parts 1–3),
distraction within part 3 (0–2
distracters); response organization:
S R - m a p p i n g ( c o m p a t i b l e ,
incompatible); sustained attention:
feedback (regular, after feedback);
focussed attention: signal type
( t a rge t ,  i r r e l evan t  t a r ge t ,
non-target); attentional flexibility:
attentional flexibility (not-required,
requ i red) and SR-mappin g
(compatible, incompat ib le );
pursuit: accuracy criterion (level 3,
6, 12). Separate runs were made
with reaction time and with
accuracy (error percent) as
dependent variable. As reaction
time is correlated with age, and the
RR group is younger than all other
groups (including the controls, see
table I), this variable was entered as
a covariate in the reaction time
analyses. Mean tempo and
fluctuation in tempo in the
s u s t a i n ed a t t en t ion  t a sk ,
respectively mean distance and
fluctuation in distance from target
in the Pursuit task were entered in
a mult ivariate analyses of
covariance as the respective sets of
variables are correlated. Subjects
were excluded from task analysis
when their error rate was >50% or
in case of extreme mean RT values
(>3× the interquartile range). The
number of excluded subjects in the
control group and MS group varied
between zero and four per task (in
total 15 exclusions across all eight
tasks in the control and in the MS
sample). The association of
severity of MS and disease duration
with task performance was
investigated by perfor ming
multiple regression analyses.
Because age, disease duration and
neurologic disability are all
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correlated with one another the
EDSS total score, disease duration,
age, and education level were used
as predictors. For disease duration
we entered two variables: years
passed since diagnosis and years
passed since occurrence of first MS
symptoms as the former parameter
is a conservative and the latter a
probably more accurate measure of
this predictor. The chosen method
was backward in which all
predictors were entered and then
removed successively in case the
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Fifty-three patients with clinically
definite multiple sclerosis were
selected, comprising 18 SP (11
women, 7 men), 19 PP (12 women,
7 men), and 16 RR patients (11
women, 5 men). Age at testing and
at diagnosis, EDSS scores, years
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passed since occurrence of first
subjective symptoms and years
passed since diagnosis, and
education level are summarised in
table I.
The controls did not differ in age
from the total MS group (p =
0.94). The RR patients were
younger than the SP and PP
patients (p <0.001) who did not
differ significantly from each other
(p = 0.46). Education level of the
controls was lower compared to
the total MS group (p = 0.046).
Differences in education levels
between MS subgroups were
marginally significant with the RR
patients having the highest scores
and PP patients the lowest scores
(0.06 < p < 0.09). The RR patients
had a lower EDSS total score
compared to the other groups (p <
0.001) while the PP and SP groups
did not differ (p = 0.92). Time
passed between occurrence of first
MS symptoms diagnosis and
assessment was lower in RR
patients compared to the other
groups (p = 0.015) while the latter
two groups did not differ on this
measure (p = 0.17). A similar
outcome was obtained as regards
time passed since diagnosis (p =
0.014, p = 0.07).
Baseline speed
Mean reaction speed was 282 ± 37
ms for the controls and 361 ± 74
ms for the MS patients. The
groups differed in speed (F(3, 104)
= 18.90, p <0.001], with controls
faster than the total MS group (p
<0.001) and faster than the RR
group (p <0.001). The SP patients
were marginally slower than the PP
patients (p = 0.079).
Processing stages
Encoding (visuo-spatial task)
Figure 2 (left panel) shows that
processing of ‘similars’ was much
slower than of ‘dissimilars’ (F(1,
91) = 12.30, p = 0.001).
Furthermore, stimulus type
interacted with signal type:
responses to non-targets were
slower than to target signals in case
of ‘similars’, while the opposite was
true in case of ‘dissimilars’ (F(1, 91)
= 7.88, p = 0.006). Groups
differed in speed of processing
(F(3, 91) = 4.74, p = 0.004) with
total MS group (p < 0.001) with
differences between MS subgroups
being absent. Group interacted
with stimulus type (F(1, 91) = 3.33,
p = 0.023): differences in speed
between groups were larger for
‘similars’ than for ‘dissimilars’.
Post-hoc analyses, comparing the
separate MS subgroups with
controls, confirmed this effect in
the RR (p = 0.011) and PP (p =
0.021) groups. Accuracy of
processing depended on signal and
stimulus type. Error rates were
larger for ‘similars’ than for
‘dissimilars’ (F(1, 92) = 62.19, p <
0.001), and differences were larger
for target signals compared with
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Figure 2
Performance on visuo-spatial processing and memory search tasks: le ft panel, RT as a
function of signal type (target, non-target) and stimulus type (“similars”, “dissimilars”);
centre and right panel, RT as a function of func tion of memory load, respectively as a
function of distraction.
Figure 3
Performance on response organisation and sustained attention tasks: left panel, RT as a
function of stimulus-response mapping; centre panel, tempo (mean completion time per
series), fluctuation in tempo, and error rate on the sustained attention task; right panel,
increase in RT following feedback on errors as a function of signal type.
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non-target signals (F(1, 92) =
65.03, p <0.001), with error rates
of 4.7 and 0.5% for ‘dissimilar’
targets and non-targets, and 15.4
and 3.6% for ‘similar’ target and
n o n - t a r g e t s  r e s p e c t i v e l y .
Differences in accuracy between
groups were absent (F(3, 92) =
0.68, p = 0.57).
Response organization
Figure 3 (left panel) shows that
SR-mapping affected reaction time
in that compatible responses were
faster than incompatible responses
(F(1, 101) = 31.63, p < 0.001).
Groups differed in speed (F(3, 101)
= 8.43, p < 0.001), with MS
patients being slower than controls
(p < 0.001), and PP + SP patients
slower than RR patients (p =
0.044) who were not slower than
controls (p = 0.12). Group
interacted with SR-mapping (F(3,
101) = 3.3, p = 0.024), indicating
that speed differences between MS
patients and controls increase
under incompatible SR-mapping
conditions. This effect must be
attributed to the SP group as was
confirmed in a post-hoc analysis (p
= 0.004). Mean error rate varied
between 1.7 and 3.0% for all
response types. There were no
significant differences in accuracy
between MS patients and controls
(0.31 < p < 0.82).
Memory search
Figure 2 (centre panel) depicts the
response latency to target signals as
a function of memory load as
imposed in part 1, 2 and 3
respectively, and the response
latency to non-target signals in part
3 as a function of the presence of
distracters (right panel). Both
manipulations imposed high
demands on the working memory
system. Reaction time increased
linearly with load (F(2, 204) =
247.8, p <0.001). Groups differed
in speed (F(3, 101) = 11.32, p <
0.001) with total MS group being
slower than controls (p <0.001)
but differences between MS
subgroups were not significant.
Group interacted with memory
load (F(6, 202) = 4.64, p <0.001),
reflecting that differences in speed
between MS patients and controls
increased with load. Post-hoc
analyses confirmed this interaction
effect in all MS subgroups
separately (P # 0.007). Mean error
rates across response types varied
between 3.0 and 7.0%. Overall
group differences in accuracy were
marginally significant (F(3, 102) =
2.21, p = 0.092) but the contrast
analyses indicated that MS patients
(total group) were less accurate
than controls (p  = 0.022).
Differences in accuracy between
MS subgroups were not significant.
The analysis of the data of task
part 3 shows that reaction time
increased with distraction (F(2,
204) = 439.7, p < 0.001). Groups
differed in speed (F(3, 101) =
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13.33, p < 0.001] with MS total
group (p < 0.001) but differences
between MS subgroups were not
significant. Group interacted with
distraction (F(6, 202) = 2.78, p =
0.013) indicating that differences
between MS patients and controls
became larger with increasing
distraction. Post-hoc analyses
confirmed this interaction effect
for the RR and SP groups (P #
0.035). Mean error rates across
response types were low and varied
between 0.2 and 2.5%. Accuracy
decreased with distraction (F(2,
204) = 9.93, p < 0.001), but
differences in accuracy between
groups were absent.
Decision
The difference between responses
to target and non-target signals in
part 1 of the memory search task
was taken as an index of decision
speed. ‘No’-responses took longer
than ‘yes’-responses (F(1, 102) =
174.66, p < 0.001), Groups
differed in speed (F(3, 101) =
15.05, p <0.001), with MS total
group being slower than controls
(p < 0.001). The RR patients were
also slower than the controls (p =
0.012) but faster than the PP + SP
patients (p = 0.027). Signal type
interacted with group classification
(F(3, 101) = 8.19, p <0.001)
reflecting that decision speed was
slower in MS patients. This
interaction was significant for the
comparison of PP patients (p =
0.025) and of SP patients (p
<0.001) with controls.
Sustained attention
Tempo and fluctuation in tempo
varied significantly between groups
(F(6, 196) = 6.88, p < 0.001).
Contrast analyses showed that MS
patients were slower and had a
higher fluctuation in tempo (p
<0.001) (see figure 3, centre panel)
than controls, RR patients were
slower than controls (p = 0.009)
but faster than the PP + SP
patients (p = 0.029), and PP
patients were slower than SP
patients (p = 0.024). As regards
fluctuation in tempo, contrast
analyses revealed a higher
fluctuation in MS patients
compared to controls (p < 0.001),
RR patients were more stable than
PP + SP patients (p = 0.05) but
did hardly differ from controls (p
= 0.073). Accuracy was high, error
rate varied between 0.7 and 3.8%
only. Differences between groups
i n  a c c u r a c y  a p p r o a c h ed
significance when the MS total
group was contrasted with the
controls (p = 0.053), showing
lower accuracy in MS patients.
Figure 3 (right panel) shows the
mean delay following feedback on
errors ,  ca lculated as  the
within-subject difference between
RTs following error responses and
RTs of similar responses following
correct responses. This measure
was taken to reflect the adequacy
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of behavioural adjustment, i.e.
taking more time after an error to
process the next signal. Feedback
caused a significant drop in
response speed (F(1, 92) = 8.61, p
= 0.004), and this delay varied
between groups (F(3, 92) = 13.15,
p < 0.001), with MS patients
slowing down much more than
controls (p < 0.001), RR patients
did not differ from controls in this
regard but RR patients slowed
down less than PP + SP patients (p
= 0.008).
Attentional flexibility
Figure 4 (left panel) shows that
compatible responses were faster
than incompatible responses (F(1,
95) = 127.44, p < 0.001), and that
reaction time of both type of
responses increased further under
random SR-mapping conditions
(part 3) (F(1, 95) = 263.31, p <
0.001). Group differences in speed
were significant (F(3, 94) = 10.73,
p <0.001), with total MS group (p
< 0.001) but differences between
MS subtypes were not significant.
Differences in speed between
groups were relatively larger for
incompatible responses (F(3, 94) =
3.36, p = 0.022), and when
attentional flexibility was required
(F(3, 94) = 6.98, p < 0.001).
Subsequent analyses indicated that
the group × compat ibility
interaction was significant when
contrasting SP patients and
controls (p = 0.003) and the
group×flexibility interaction was
significant when contrasting PP
patients with controls p <0.001).
Groups differed in accuracy (F(3,
95) = 2.61, p = 0.051) with total
MS group (p = 0.012) being less
accurate than controls (p = 0.012,
mean error rate across task parts
was 4.5% versus 2.8%) and RR
patients being less accurate than
controls (p = 0.026), while
differences between MS subgroups
were not significant.
Focussed attention
Figure 4 (centre panel) shows that
reaction time depended on signal
type (F(2, 208) = 196.58, p <
0.001), i.e. non-target signals take
longer than target signals, reflecting
the cost of exhaustive search, and
the rejection of irrelevant target
signals is slower compared to
non-target signals which reflects
the impact of the presence of the
irrelevant target breaking through
the process of focussed attending.
Groups differed in speed (F(3, 103)
= 14.39, p < 0.001), with MS total
group slower than controls (p <
0.001) and RR patients faster than
PP+SP subtypes (p = 0.021).
Differences in speed between
groups depended on signal type
(F(6, 103) = 9.98, p < 0.001), with
largest differences for the
i r r e l e va n t  t a r ge t  s i gna l s .
Contrasting PP and SP patients
with controls, these interactions
were confirmed for the groups
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Figure 4
Performance on attentional flexibility task, focussed attention task, and pursuit: left
panel, RT as a function of attentional flexibility requirements (1, 2: fixed SR-mapping
vs. 3: random SR-mapping) and type of SR-mapping (c: compatible SR-mapping, i:
incompatible SR-mapping). Centre panel: RT as a function of signal type; right panel,
accuracy as a function of criterion (staying <12, 6 or 3 screen distance units from the
target).
separately (p < 0.001). Groups
differed in accuracy (F(3, 104) =
3.43, p = 0.02) with overall mean
error rates varied between 0.8 and
4.5%. Controls were more accurate
compared to the MS total group (p
= 0.025) and RR patients were
more accurate than the SP + PP
patients (p = 0.039) but they did
not differ in accuracy from
controls.
Pursuit (Eye-hand co-ordination)
Groups differed in accuracy (F(3,
96) = 9.71, p < 0.001). The MS
total group was less accurate in
meeting the criterion than controls
(p < 0.001), SP + PP patients were
less accurate than RR patients (p =
0.035) and RR patients were
marginally less accurate than
controls (p = 0.09). Differences
between groups increased when
the criterion was set at a stricter
level (F(6, 192) = 8.38, p < 0.001)
[figure 4, left panel]. This
interaction was confirmed when
contrasting PP and SP patients
with controls separately (p <
0.001). Multivariate analysis of
mean distance and fluctuation of
distance with time-on-task revealed
significant differences between
groups (F(6, 192) = 3.93, p =
0.001) [see figure 5, right panel].
Subgroup analyses confirmed these
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differences for the PP (p < 0.001,
p = 0.003) and SP groups (p <
0.001, p = 0.05) separately. The RR
group did not differ significantly
from the controls on all measures
(P $ 0.13).
Regression analysis of cognitive
slowing
The administered tasks provided
37 pairs of mean reaction times
with values ranging from 0.35 to
2.80 s. Initial analysis made clear
that more optimal solutions would
be reached when the data from the
visuo-spatial task (six pairs) would
be fitted separately (see also
discussion). This meant that two
regression equations were fitted,
one for the 31 pairs representing
the data from all tasks except the
visuo-spatial task and one for the
six pairs from that task. This was
done for the total MS group and
per subtype. With R2 varying
between 0.96 and 0.99, there was a
strong fit of the linear models. The
values of the linear regression
coefficient imply that MS patients
take about 40% more t ime to
respond than controls [figure 5,
left panel]. For the MS subtypes
these values were 51% (PP), 50%
(SP) and 24% (RR), respectively
[figure 5, right panel]. The slowing
rate for the visuo-spatial task was
much less with values of 20% (MS)
[figure 5, left panel], 26% (PP),
15% (SP) and 21% (RR).
Figure 5
General slowing in (subtypes of) MS. Mean RT for subjects with MS as a function of
mean RTs for controls, along with the line depicting the equation RTMS = a + b RTC,
for all RT data without the vi suo-spatial task (left and centre panel), and for the RT data
of the visuo-spatial task, respec tively (right panel ). CTRL: control group.
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Severity of MS (EDSS) and
disease duration
The multiple regression analyses
with the EDSS score, disease
duration, age, and education level
as potential predictors of task
performance [see table II] show
that disease duration and severity
of MS (EDSS score)  are
substantially associated (on their
own, or in combination with each
other - memory search, response
organisation, shifting attent ional
set) with speed of processing (0.30
# r # 0.66). The highest values are
f o u n d  f o r  v i s u o - m o t o r
coordination pursuit: 0.56 # r #
0.75). Age in itself plays a minor
role as this parameter was removed
in 24 out of the 27 analyses, and it
occurs only in combination with
disease duration. Level o f
education plays a role, in
combination with severity of MS
or disease duration, only as regards
the sustained attention task. The
number of significant outcomes is
much greater for reaction time
measures than for accuracy
measures (as regards the pursuit
task, it is noted that the four
outcome measures concerns
parameters in which accuracy is a
‘distance-from-target’ parameter
instead of error percentage).
DISCUSSION
Processing deficits
The present study shows that there
are deficits in various attentional
domains, i.e. divided, focussed and
sustained attention, in patients with
MS. They demonstrated a slower
response speed compared to
controls when they simply had to
detect the mere presence of a
stimulus. When higher cognitive
demands were imposed in the
more complex tasks, differences in
speed between controls and MS
patients increased dramatically. It
was clearly shown that MS patients
were slower in processing visually
presented information. Significant
task x group interactions revealed
that differences between groups
increased under more complex task
conditions, indicating deficits in
the two central processing stages
“memory search” and “decision”.
Defic i ts in the peripheral
processing stages were also present
as indicated by the group x
stimulus type (visuo-spatial task)
and the group x SR-mapping
(response organisation task)
interactions.
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Table II
Summary of regression analyses (backward method) for variables
predicting outcome on the primary task performance indices
Predictor variables entered: age at testing, education level, EDSS total score, and two
disease duration indices: years since occurrence of first symptoms of MS (yrs 1st
symptoms) and years since diagnosis of MS (yrs diagnosis). RT: reaction time.
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MS patients were more susceptible
to distraction than controls: speed
of performan ce deteriorated
disproport ionately in the presence
of distracters (memory search task)
and irrelevant targets (focussed
attention task), both results
reflecting a focussed attention
deficit. Inordinate slowing in
response speed when switching
between two attentional sets was
required (attentional flexibility task)
strongly  suggests executive
function deficits that have been
found on earlier occasions6,80.
Fluctuation in performance level,
i.e. the S.D. of tempo during
s u s t a i n e d a t t e n t io n  t a s k
performance, was almost twice as
high in MS patients, which is
indicative of a sustained attention
deficit. The MS patients slowed
down much more after making an
error than controls, the extent of
th i s  de l a y suggest ing an
interruption of the ongoing
process rather than an adequate
adjustment, underscoring the
existence of executive control
weaknesses. This behavioural
response to feedback has been
studied with the same task
paradigm in children with minor
neurological dysfunction and
children with ADHD. It is
interesting to note that the MS
patients in their response resemble
children with minor neurological
dysfunction who showed a similar
type of behavioural adaptation on
the same task59  and strongly
deviate from subjects with ADHD
who hardly adjusted their
processing speed following
feedback on errors60.
Slower reaction times in MS
patients have been frequently
reported 6 2 , 6 4 , 1 0 8 , 1 1 2 , 1 2 6 , 1 3 1 , 1 4 0 , 2 0 4 .
Inordinate increase of reaction
time in MS patients with task
complexity, suggesting a slowing of
mental processing independent of
motor slowing, has been observed
elsewhere4,126,204, but others failed
to find such interactions109,131,140.
Such inconsistencies might be
explained by differences in tasks,
severity of the disease, disease
course, disease duration, and
cognitive status of MS patients127,
o r  a  d ifferent  s tat is t i c a l
approach131. In the eye–hand
co-ordination task (pursuit) MS
patients were less successful in
staying close to the moving target
and showed larger variation in
distance from the target, both
results being indicative of poorer
f i n e motor  co nt ro l  a nd
psychomotor speed.
The analyses of error rates in the
reaction time tasks clearly indicate
that differences in accuracy
between MS patients and controls
are much smaller and less
widespread than differences in
speed. MS patients were as
accurate as controls on tasks
assessing peripheral processing
stages (visuo-spatial task and
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response organisation task), but
less accurate on tasks assessing
aspects of central processing
stages, focussed and sustained
attention and attentional flexibility.
Overall differences in accuracy on
the latter tasks were significant but
the accuracy itself was high with a
mean error rate varying between
less than 4.5 (most tasks) and 7%
(memory search task). The results
are important in two ways: they
suggest that not-timed tasks are far
less sensitive to pick up functional
decline, and secondly, they suggest
the importance of using time
strategies in planning daily life and
job activities to compensate for or
alleviate MS-related cognitive
limitations. It is, however,
conceivable that under too much
time pressure MS patients might
only be able to complete tasks by
trading accuracy for speed, i.e. at
the cost of a high error rate. It
would  of  course  be  an
oversimplification to attribute the
cognitive deficits in MS solely to
slowing as this would not explain
e.g. the highly prevalent failures on
measures of free recall from
long-term memory in this patient
group124,255,290. As regards the issue
of counselling and rehabilitation,
the above results stress the
importance of developing and
improving suitable attentional
strategies in patients with MS to
cope with daily life requirements
and task or job demands. We
found support for this notion in a
study by Demaree et al.62 who
recently demonstrated improve-
ment in performance accuracy in
MS patients when they were given
more time to process information,
and in a treatment study by
Jonsson et al.110 who found similar
results after manipulating time
pressure.
General slowness
T h e  r e g r e s s i o n  a n a l y s e s
unequivocally substantiate the
hypothesis that in MS patients the
slowing of attention-demanding
( c o n t r o l l e d )  i n f o r m a t i o n
processing underlying more
complex cognition is general
(irrespective of type of controlled
processing). The use of this
regression technique has not been
without criticism78,180, but others
have convincingly disputed these
claims36,164. As Myerson et al.163
recently  argued that these
techniques are neither flawed nor
inappropriate as long as outliers in
the dispersion of data and residuals
are absent, it appears reasonable to
use the regression analyses to
determine the degree to which the
effects of multiple sclerosis on
processing speed is task-
independent as well as to assess the
magnitude of general slowing.
Using a wider range of tasks in a
larger and more representative
sample of MS patients and
controls, the results of the present
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study confirm those of the study
by Kail112.
Irrespective of type of required
behaviour  in all  but the
visuo-spatial task, the equation
RTMS = -0.04 + 1.40 RTC implies
that MS patients are 40% slower
than controls. This slowing rate is
very close to the figure (46%)
found by Kail et al. when his data
were fit to a linear function
through the origin RTMS = 1.46
RTC). The slowing rate in the
visuo-spatial task was “only” 20%,
indicating that speed of processing
of visuo-spatial information was
relatively less affected in MS
patients. An explanation might
possibly be found in that stimulus
encoding, the prime assessment
focus of the employed visuo-spatial
task, is associated with automatic
processing rather than with
controlled or effortful information
p r o c e s s i n g 1 6 1 .  A u t o m a t i c
processing is fast, runs in parallel,
and requires a limited amount of
mental effort. It is speculated that
this type of processing is less
susceptible to MS related changes
in the brain. This suggestion is
consistent with previous89,93 and
recent investigations124 that showed
preservation of implicit  (or
automatic) processing in patients
with MS as opposed to explicit (or
controlled) processing.
Whereas the slope of the
regression line provides an estimate
of the cognitive slowing factor, the
intercept reflects the difference
between sensorim otor an d
cognitive slowing factors162,278. The
intercept is positive when
sensorimotor processes are slowed
more than cognitive processes, it is
negative when cognitive processes
a r e  s l o w e d  m o r e  t h a n
sensorimotor processes, and zero
when both types of processes are
equally slowed. In all our equations,
the intercepts are very close to
zero (constant # 0.06), thus
indicating that cognit ive and
sensorimotor processes are equally
slowed in our MS sample.
Together with the evidence of
deteriorating performance under
more complex task conditions, we
take the posi t ion,  unl ik e
Jennekens-Schinkel et al.108 and
Laatu et al.131 that patients with MS
not only exhibit motor or
perceptual slowness but also
cognitive slowness, such as also
demonstrated by others4,126,204. A
word of caution regarding the
interpretation of general slowing
phenomena in MS patients is
appropriate. The extent of this
slowing, at the group level, is surely
considerable. At the individual
level, however, these unfavourable
conditions may work out
differently, in particular on the
various (higher) cognitive skills,
also in relation to the strategies the
patient is able to develop to cope
with the problems.




between groups can be impeded by
the “speed versus accuracy
confound”62. This holds in
particular for speeded tasks, such
as e.g. the traditional paced
auditory serial addition task
(PASAT) in which fas ter
presentation rate results in
decreased accuracy. Demaree et
al.62 demonstrated that when
patients with multiple sclerosis are
provided additional time to process
information they perform as
accurately as healthy controls. In
the ANT task paradigms, the
stimulus remains on the screen
until a response has been given and
the next stimulus follows a fixed
interval thereafter. The self-paced
character of the tasks might
explain the fact that accuracy
differences between groups are less
frequent. Differences in processing
strategies between groups may also
confound group comparisons.
Trading accuracy for speed results
in fast but relatively inaccurate
performance whereas the opposite
strategy would result in accurate
but rather slow performance.
Correlat ions between mean
reaction time and mean error rate
per task were found to be not
significant in controls and in
patients with multiple sclerosis they
were positive (0.30 < r < 0.47,
0.036 < p < 0.004), indicating that
both groups did not trade accuracy
for speed (reflected in negative
correlat ions) . The positiv e
correlations in the MS group
suggest that the slowest patients
are also the ones that are least
accurate, obviously reflecting more
extreme levels of impairment
associated with MS.
MS disease subtypes
The results of this study suggest
that subtype of MS disease is
associated with severity of
a t t en t ion and informat io n
processing deficits. Whenever MS
patients were less accurate than
controls, between the MS
subgroups differences in accuracy
were absent, except on the
focussed attention task in which
RR patients were less accurate than
the other patients. As regards
speed of processing, differences
between MS subgroups were
absent on baseline speed, memory
search, and attentional flexibility.
Response  organisa tion and
visuo-motor coordination seem to
be unaffected only in RR patients.
SP +PP patients were, compared
to RR patients, slower on response
organisation, sustained attention,
and focussed attention, showed
more fluctuation (instability) during
sustained attention, slowed down
more after making an error, and
p e r f o rmed  l e s s  we l l  o n
v i s u o -motor  co o r d i n a t i o n.
Between PP and SP patients
significant differences in speed of
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processing were restricted to
tempo on the sustained attention
task, to the disadvantage of the PP
patients.
In RR pat ients, increased
processing demands associated
with the presentation of irrelevant
targets,  attentional flexibility
requirements, and incompatible
stimulus-response mapping did not
result in an inordinate RT increase
while memory load, distraction,
and stimulus similarity did. In the
other MS subgroups all task
manipulations did result in over
additive effects on RT except for
stimulus similarity and attentional
set shift ing (SP patients) ,
respectively distract ion and
stimulus-response mapping (PP
patients). The PP and SP patients
thus stand out as the most
seriously compromised groups,
which corroborates with earlier
observations4,64,95.
As regards general slowing similar
conclusions can be drawn. The
linear function coefficients support
the notion that general slowing
occurred in all MS subtypes with
higher slowing rates for the SP and
PP subtypes. Judging from the
regression coefficients (1.50 versus
1.24), the RR patients seem to hold
a position halfway between the
controls and the PP/SP group.
Overall, RR patients are relatively
better off, which is not surprising
as they are, on the average,
characterised by a younger age and
shorter disease duration. Multiple
sclerosis may start with a
relapsing–remitting phase RR),
which is followed by a transition to
the secondary progressive phase
(SP), and as a consequence SP
patients are in general older and
have been ill longer. Alternatively,
the disease may take a primary
progressive (PP) form from the
start. To date, see review by
Hämäläinen and Ruutiainen92 ,
there have been surprisingly few
studies focussing on the role of
disease subtype or course with
regard to cognitive decline, but
from these studies it is clear that
RR patients are relatively spared
(for example. 91,95,127,209). In our
study, PP patients equal at least the
cognitive decline found in SP
patients. This result contrasts that
of Comi et al. who reported
significantly greater cogn itive
impairment in SP patients41.
Recent comparative studies of
n e u r o p s y c h o l o g i c a l  t a s k
performance suggest only few and
subtle  differences  to  the
d i s advan tage  o f  t h e  SP
patients79,251. Brain magnetic
resonance imaging (MRI) metrics
have been found to be associated
with cognitive findings92,96,227, but
others could not confirm this
association79. A recent MRI and
magnetisation transfer (MT) study
focussing on the pathology of the
three clinical phenotypes, showed
that all subtypes of MS patients
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had lower MT metrics than
controls, with SP patients showing
the lowest MT measures and
highest lesion loads92. The PP
patients showed in addition
microscopic damage in normal
appearing white matter, which may
be a major contributor to disability
in PP MS. It is perhaps in light of
this finding, that we may
understand that information
processing of PP patients appears
to be at least as compromised as in
the SP patients, even though their
disease duration (since occurrence
of first symptoms) was almost 4
years less.
Disease duration and severity of
MS
Previous studies failed to find
substantial correlations between
cognitive deficits and disease
durat ion 4 , 1 7 , 1 8 5 , 2 0 2  and also
correlations between the degree of
physical disability as measured with
the EDSS and severity of cognitive
i m p a i r m e n t  i n  M S  a r e
weak17,68,202, 228 ,270 or virtua lly
absent4,79,92,105,128. These negative
results are explicable in that a long
duration of symptoms is not
necessarily synonymous with brain
pathology while physical disability
may relate to spinal as opposed to
cerebral lesions, the former sparing
cognition. The results of the
multiple regression analyses,
dealing with the existence of
substantial reciprocal correlations
between age, disease duration and
physical disability, show that
disease duration and severity of
MD (EDSS score) are suitable and
sometimes strong predictors, on
their own or in combination, of
task performance. It goes without
saying, however, that even more
convincing evidence for a
contin uous deterioration of
functions with age might emerge
from longitudinal studies that allow
for within-subject comparisons of
d i s e a s e - r e l a t ed  f u n c t i o n al
decline96,128. As regards speed of
processing it is interesting to note
that lowest values of R are found
in relation to tasks with a low
cognitive load (baseline speed and
visuo-spatial perception), moderate
values in relation to focussed and
sustained attention tasks, and
highest values for RT tasks that are
characterised by high working
memory demands or requiring
executive function skills. Highest
R-values ($ 0.70) are found for
visuo-motor performance, which
of course was to be expected as
performance on this part icular task
depends not only on visual
processing speed but also on
motor (hand) dexterity. Although
differences in accuracy between
MS patients and controls appeared
to be limited and less widespread
than differences in speed, the
analyses demonstrate that accuracy
of processing in all RT tasks is
unfavourably influenced by disease
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duration with R-values varying
between 0.28 (memory search task)
and 0.48 (response organisation
task). At first sight it might look
odd that the effect of flexibility
requirements (shifting attentional
set task) are best predicted by both
disease duration parameters with
beta being positive for “yrs since
1st symptom” and negative for
“yrs since diagnosis”. The former
parameter has an unfavourable
effect on speed while the latter
seems to have a favourable effect.
This inconsistency is clarified when
the difference score yrs since 1st
symptom - yrs since diagnosis is
entered in the regression equation.
This score might be considered to
reflect a “delay” in treatment
(larger difference then later
treatment onset). The new analysis
resulted in a solution with this
parameter (beta = 0.373) and age
of subject (beta = 0.260) as
predictors with r = 0.55. Later
treatment, as calculated since
occurrence of 1st subjective
symptoms, and older age are thus
associated with a larger effect of
flexibility requirements, i.e.
unfavourable affects aspects of
executive function. As this
outcome suggests that early
treatment may postpone or
attenuate unfavourable effects of
the disease, we have redone the
regression analyses with inclusion
of this difference score but the
final models did not deviate from
the ones found earlier.
Cognitive  deterioratio n and
physical disability may develop in
parallel. To the extent that multiple
sclerosis associated pathology in
our patients also extends to the
cerebral hemisphere areas, and the
premise that attentional deficits are
sensitive indicators of cognitive
dysfunction, it does explain our
findings quite well. In patients with
optic neuritis, representing early
demyelinating disease, significant
correlations between total lesion
area in the brain and some tests of
attention were found66. A recent
study273 revealed total lesion load
to be positively correlated with
impairment in attention, memory
and executive functioning in RR
patients. Hohol et al.96 studying the
relation between disease burden
and cognitive dysfunction, found
that patients who demonstrated
cognitive decline did so primarily
on tests of attention and
information processing speed, and
those tests showed the most
robust correlation with baseline
MRI parameters and worsening
atrophy. Probably, the accumu-
lation of demyelinating changes in
wide areas of the cerebrum
interferes with the function of
distributed neural networks in deep
cortical and subcortical structures.
In a disease that can be as
widespread in the brain as MS,
attentional functions that rely on
the integrity of complex neural
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formations are thus extremely




disorders that might h ave
interfered with tests were excluded.
As depression scores were only
scarcely available we could not
directly control our data for the
possible influence of depression or
depressive symptoms on speed of
processing.  MS-related fatigue
might also have a systematic effect
on task results in that it could
manifest itself relatively more in
later tasks as compared to earlier
tasks. A fixed task order was
chosen above a counterbalance
procedure because we prefer to
deal with a systematic rather than
with an unsystematic source of
variation, such as may be caused by
the occurrence of crossover effects
from one task to another and not
v i ce  v e r s a .  F ur t h e r m o r e ,
counterbalancing would be hardly
practical with the number of tasks
and participants per group in the
study and would not remediate
such crossover effects. Following
the data collection phase we found
no relation between task order and
relative differences in speed
between MS group and controls as
the task presentation order, ranked
from lowest to highest difference
appeared to be 1st, 2nd, 6th, 3rd,
7th, 5th, and 4th. Furthermore, we
would like to refer to a recent
study4 in which covariate effects of
fatigue and depression on speed of
processing were reported to be
absent.
One might wonder whether the
evidence for cognitive deficits in
patients with multiple sclerosis in
this study is confounded with the
influence of their physical disability
as it is well known that patients
with MS may suffer from impaired
vision, slowing of eye movement,
sensory motor slowing and hand
dexterity problems. The baseline
speed task demonstrated that MS
patients are about 80 ms slower
compared to controls. Assuming
that slowness of the peripheral
response system (from motor
cortex to index finger) is the major
contributor to this difference, it
cannot explain why differences in
speed between groups increase
5–20-fold in the other RT tasks, in
which the required response is a
similarly simple key press. Likewise,
slowing of eye movements can not
explain the observed slowing as
substantial differences in speed
between controls and MS patients
are also present in tasks, which do
not or minimally require eye
movements. On the response
organisation task, the MS patients
are much slower than controls, in
comparison to the difference in
speed on the baseline speed task,
suggesting that this is the influence
of a higher cognitive load in the
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former task. In the shifting
attentional set task the visual
scanning requirements for parts
1–3 are absolutely identical.
Nevertheless,  the differences
between MS and controls in speed
increase significantly from part 1 to
3. This can only be attributed to
the cognitive requirements (spatial
incompatibility and imposed
switching between response sets).
The regression coefficient for the
task with probably the highest
visual scanning requirements
(visuo-spatial task) was the lowest,
in other words: the relative speed
differences between controls and
MS patients were smallest on this
task. Finally, we would also like to
refer to a study that used a
comprehensive set of 31 binocular
spatial and non-spatial visual tasks
of which only four tasks yielded
significant rates of impairment in
only 26% of a representative
sample of patients with MS270.
None of these  four tasks
resembled our tasks as regards the
required demands, with the
possible exception of the FM-100
Test65 that demonstrated that those
patients had impaired colour
discrimination, particularly in the
blue-green spectrum. Impaired
colour discrimination, we have no
data on this of our patients, is
possibly relevant for the response
organisation and the attentional
flexibility task that use red and
green stimuli. The task effects,
associated with the colour
manipulation was significant in
controls but also in our MS
patients ,  which adequately
demonstrates that our MS patients
can discriminate between red and
green in these tasks.
Taken together, the present study
h a s  e l u c id a t e d  m a n i fo l d
information processing deficits in
patients with MS. Firstly, it
confirms the hypothesis that the
slowing in MS patients of
attention-demanding (controlled)
information processing is general.
Secondly, we have demonstrated
that MS patients may suffer from
deficits in divided, focussed and
sustained attention and executive
functioning. Thirdly, processing
speed appears to be compromised
most in PP and SP patients, in
particular under more complex
task cond i t ions .  Four th ly,
processing speed is substantially
correlated with disease duration
and disability, suggesting cerebral
pathology in our patients. It is
further noted that the magnitude
of these correlations is much
stronger than reported in previous
investigations. Fifthly, accuracy of
processing in MS patients in
self-paced tasks is much less
compromised compared with
speed, suggesting the importance
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In this study we investigated the influence of in vivo disease pathology
(measured as MRI lesion load and brain volume reduct ion) on cognitive
functioning, especially the speed of processing, in multiple sclerosis (MS)
patients. Since MS is characterized by cognitive slowing, rather than
impaired accuracy, we used the Amsterdam Neuropsychological Tasks
(ANT) program, a computerized test proven to be very sensitive to
cognitive slowing in MS patients.
METHODS
Thirty-two patients performed the ANT and underwent MRI scanning.
Using the ANT computerized tests , we investigated focussed, divided,
sustained attention, executive function and psychomotor function, and
examined associations of speed, speed fluctuation and accuracy of
performance of these tests with MRI lesion load and brain volume
parameters.
RESULTS
A decrease in speed of processing and response speed stability, and a
decrease in psychomotor accuracy and stability were clearly associated
with less brain volume, and with higher lesion loads, in particular at
frontal and occipital areas.  Correlations with brain volume reduction were
found for all domains, except for visuo-spatial processing. In particular
speed and speed fluctuation scores correlated with brain volume
reduction, while accuracy of performance, in general, did not correlate.
Only some test speed and speed fluctuation scores correlated with lesion
load measurements.
CONCLUSION
This study shows that in MS patients accuracy of processing is not
compromised unless high working memory demands are involved.
Problems in neurocognitive functioning in MS are mainly modulated by
speed and stability of speed processing, in particular when
attention-demanding controlled information processing is required.
Abnormalities in these domains are most strongly associated with brain
volume loss, confirming that pathology beyond focal lesions is important
in MS.
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INTRODUCTION
Multiple sclerosis (MS) can cause
deficits in all neurological systems,
including those sub serving
cognitive functions. Not all
neuropsychological functions are
affected equally. Working memory,
attention, information processing
speed and executive functions are
more often disturbed than
language functions and general
intelligence15,195,202,284. Many studies
have shown the impact of the
disease on processing speed and
working memory, including a
recent study58 which focussed on
those functions, using a set of tasks
f r o m  t h e  A m s t e r d a m
Neuropsychological Tasks program
(ANT)56,57. Studies by Kujala et
al.126, Kail et al.111,112 and our
group58 have clearly demonstrated
that cognitive slowing in MS
patients is general, i.e. various
attentional domains (divided,
focussed, sustained attention) all
show deficits. The ANT computer
test battery56 is a comprehensive
set of information processing
tasks, designed to evaluate basic
processes underly ing more
complex cognitive skills, i.e.
attention-demanding controlled
information processing. One of
the major advantages of the ANT
is that it allows for a quantitative
assessment of slowing in a variety
of cognitive processes. It has been
shown in MS patients that, even
though cognitive slowing is
general, the amount of slowing is
especially remarkable for tasks with
higher cognitive demands, where
MS patients were found to be 40-
50% slower than healthy controls58.
The slowing of the processing
speed in MS is believed to result
from fiber disconnection and
myelin breakdown. MS is
characterized by multiple focal
areas of axonal demyelination
4 3 , 5 4 , 1 1 1 ,  e spec ia l l y  in the
periventricular white matter, the
corpus callosum and the temporal
lobes. In areas of demyelination
conduction speed is diminished;
conduction can even be blocked
completely.
Magnetic resonance imaging (MRI)
is a highly accurate technique to
visualize MS lesions. In this study
we investigated the relation
between in-vivo disease pathology
(expressed as lesion load and brain
volume reduction on MRI) and
cognitive slowing as tested with the
ANT program.
We hypothesized that structural
brain abnormalities, both brain
volume reduction and lesion loads,
are the reason for cognitive
slowing, while accuracy of
performance is less affected.




Thirty-two randomly selected MS
patients performed the ANT and
underwent MRI scanning. Both
investigations were performed
within one week, in most cases on
the same day. The MS patients
were diagnosed as relapsing
remitting (RR, 11  patients),
secondary progressive (SP, 13
patients) or primary progressive
(PP, 8 patients). The patient
characteristics are summarized in
table I.
The mean age was 48.2 (27.9 -
72.3) years and the median EDSS
was 4.0 (1.5 - 7.5). The mean




Variable Mean Median SD
Age (yrs) 48.20 49  12.37
EDSS n.a. 4  1.80
Disease duration (yrs) 12.20 12  6.30
T2 Lesion Load (ml) 3.61 2.3 3.58
T1 Lesion Load (ml) 0.97 0.42 1.42
Relative Brain Volume 0.78 0.79 0.06
The ANT tasks:
Eight tasks from the ANT
program56 were administered to
assess speed and accuracy of
baseline speed, focussed, sustained




function. The test stimuli were
presented on a computer screen,
and the subjects were required to
press a mouse key or use the
mouse as a tracking device. The
right key was the ‘yes’ key and the
left key the ‘no’ key for patients in
which the right hand is the
dominant hand; and vice versa for
left dominant hand patients. A
short description of the tests used
in this study follows (see figure 1).
The ANT tasks were described in
more detail elsewhere56,100,114.
Baseline Speed:
This task measures simple
visuomotor  react io n t ime,
involving minimal cognitive effort.
The subject has to push the ‘yes’
key whenever a square appears in




Examples of stimuli and signal types of the selected tasks from the ANT program. In
the visuo-spatial processing task, the distractors (non-target patterns) resemble the target
quite well (similar condition) or look very different (dissimilar condition). In the
focussed attention task, a letter of the memory se t is only target letter when it is
presented on the relevant diagonal. The diagram of the attentional flexibility task
displays two trials of part 3 with indication of correct responses.
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the center of the screen. The post-
response interval (PRI), the time
between response execution and
next stimulus onset, is set
randomly between 500 and 2500
ms.
Sustained attent ion:
A continuous performance test,
r equ i r ing the sub j e c t  to
discriminate between signals
containing 3, 4 or 5 dots, presented
in 50 series of 12 signals each. The
PRI is 250 ms. Fluctuation in speed
of processing during time on the
task is considered the most
important outcome measure.
Memory Search:
A divided attention (letter
detection) task that assesses
working memory capacity. It
employs a 4-letter display load. The
memory load is increased across
task parts by increasing the
number of letters to be detected in
the presented signals from 1 to 3 in
part 1, 2 and 3 respectively. The
task parts consists of 40, 72 and 96
trials respectively, each with 50%
target trials (‘yes’ key) and 50%
non-target trials (‘no’ key).
Focussed attention:
This task uses a similar 4-letter
display load as the memory search
task, but now only two diagonal
locations are relevant (known in
advance to the subjects) and
subjects should attend to those
positions only. This test consists of
two parts, with a working load of
one and three target letters,
respectively. Both parts consist of
80 trials, 40 of which require a ‘yes’
response, 20 trials have the target
letter at the wrong location
(irrelevant target signals) and 20
trials contain no target letters.
Response organization:
This test requires the subject to
take two assignments into account.
A left- or right-pointing arrow is
presented in the center of the
screen. When the arrow is green, it
requires a compatible response
(left arrow - press left button, right
arrow - press right button) and
when it is red an incompatible
response (left arrow - press right
button, right arrow - press left
button). The task consists of 60
trials.
Shifting attentional set:
This task assesses attentional
flexibility, an aspect of executive
functioning. A coloured square
jumps randomly on a horizontal
bar to the right or left. Depending
on the colour of the square right
after the jump, the subject has to
execute a compatible response
(press the key towards which the
jump was directed) or an
incompatible response (‘mirror’
movement; press the right key
when the jump was to the left and
vice versa). This test consists of
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three parts. During the first two
parts of the task the colour is
constant (fixed stimulus response
mapping), but in the third part the
colour varies, requiring attentional
flexibility by continuously having
to adjust response type. The PRI is
250 ms in all parts of the test. The
first two parts consist of 40 trials,
the third part consist of 80 trials.
Visuo-spatial processing:
Divided attention and encoding
aspects of cognitive functioning are
tested. After memorization of a
visuo-spatial pattern (a 3x3 matrix
containing 6 white and 3 red
squares), subjects have to detect
this pattern in signals containing
four patterns. When the target
pattern is present, a ‘yes’ response
is required, otherwise a ‘no’
response. The test consists of 80
trials of which 50% are target trials.
Of the other 40 trials of non-target
patterns, the half look very similar
to the target pattern, the other half
look very dissimilar to the target
pattern.
Pursuit:
This task measures visuo-motor
control by requiring the participant
to continuously track a target
moving randomly on the screen.
As the trajectory of the target is
unpredictable, this task demands
the concurrent planning and
execution of movements, i.e.
executive function. During task
performance the distance between
the mouse cursor and the moving
target is continuously registered,
resulting in 60 distance (deviation)
scores.
Tracking:
A similar eye-hand coordination
task as the pursuit task, but
requiring less control as the subject
has to draw a circle by moving the
mouse cursor in-between two
concentric circles. During task
performance the distance between
the mouse cursor and the ideal
track l ine is  continuously
registered, resulting in 60 distance
(deviation) scores.
MR parameters:
Imaging was performed on a
Siemens 1.5 T scanner. For
identification of lesions a T2
weighted (TR 2500/ TE 45-90/ 1
excitation) spin-echo sequence was
used. The slice thickness was 3 mm
with a 1 mm in-plane resolution; in
total 42 contiguous slices were
scanned to cover the whole brain.
Lesions were identified by visual
inspection and marked. Lesion
load  meas u r e m e n ts  we re




based on local thresholding
differences (Show-Images), as
described earlier267. The total
volume of hyperintense lesions
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seen on the T2-weighted images
was calculated, as were regional
lesion loads in the four main brain
areas (frontal, parietal, temporal
and occipital) as was described
earlier132. On a T1-weighted (TR
620/ TE 15/ 2 excitations) scan
after gadolinium, in the same
manner the T1 hypointense lesion
load (total and regional) was
calculated.
Parenchymal volumes were
measured on T1-weighted images
(TR 620/ TE 15/ 2 excitations)
and intracranial volume was
measured on the corresponding
slices of the heavily T2-weighted
images with the same software
package. Those volumes were used
to calculate the relative brain
volume (RBV = total parenchymal
volume/ intracranial volume) as a
measure of atrophy116.
Data analysis:
The ANT tasks each provide a
speed score, a speed fluctuation
score and an accuracy of
performance (% errors) score. On
the basis of normative data,
obtained in various studies58,232,258
from healthy subjects and stratified
by age (mean age 30, 40, 50, 60
years old), the scores were
transformed into z-scores for each
response variable. In the pursuit
and tracking tasks the mean
distance and distance fluctuation
variables were subjected to a
similar Z-score transformation.
These distance scores were related
to speed and accuracy of eye-hand
coordination. Test-retest reliability
for the tasks used in this study
ranges between 0.75 < r < 0.95,
and sensitivity, expressed as the
effect size (partial eta squared, 02)
of group differences, ranges
between 0.11 < 02 < 0.45 57.
The ANT Z-scores and the EDSS
were correlated, using Spearman’s
rank correlation, with the MR
parameters for brain volume, T2
lesion load (total and per region)
and T1 lesion load (total and per
region). For the four main cerebral
regions the left and right area were
correlated separately as well as
both sides together.
To determine the relative strength
of the correlations, multiple linear
regression analysis was used, with
the ANT results as the dependent
variable, and brain volume, T2 and
T1 lesion load, EDSS, sex and
d i s e a se  d u r a t i o n  as  t he
independent variables. Since
previous studies on healthy
controls56 found no association
with age in adults, age was not
included as a predictor in these
models (certainly since it correlated
with disease duration). A forward
stepwise model was used with a
probability of F to enter of 0.05.
ANT IN RELATION WITH MRI
- 85 -
RESULTS
The mean speed and speed stability
of the MS patients was at least one
standard deviation below the norm
on all reaction time (RT) tasks
except for visuo-spatial processing
(see figure 2). By contrast, all
accuracy scores differ less than one
standard deviation from the norm.
Figure 2
ANT test Z-scores of speed, speed fluctuation and accuracy of
performance
The results from 32 MS patients on the ANT tests, represented as Z-scores (difference
of the result in SDs from mean of control group). From baseline speed (BS) the
Z-scores for speed and speed fluctuation are given. For this task no accuracy of
performance exists. For visuo-spatial processing  (VP), memory search (MS), response
organization (RO), focussed attention (FA), sustained attention (SA) and shifting
attention (SS) Z-scores of speed, speed fluctuation and accuracy of performance are
given. For the pursui t task (PU) and tracking (TR) the distance (comparable with sum of
speed and accuracy of performance) and fluctuation (comparable with speed
fluctuation) are given. Speed and speed fluctuation show higher Z-scores than accuracy
of performance, which tends to be in the more normal range.




T2 lesion load T1 lesion load RBV




speed .38 *  -.68 ***
fluctuation .39 *  -.41 *   






Memory search speed .50 ** .43 * -.63 ***









speed .37 *  .46 * -.45 *   
fluctuation
accuracy
Shifting attention speed -.53 **  
fluctuation -.39 *   
accuracy
Pursuit distance .41 *  -.68 ***
fluctuation .42 *  -.63 ***
Tracking distance
fluctuation -.45 *   
Correlations between the ANT tests and MR parameters are shown.
* indicates 0.01 < p < 0.05, ** indicates 0.001 < p < 0.01, *** indicates p < 0.001,
blank if not significant.; RBV = total parenchymal volume / intracranial volume.
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The mean T2 lesion load was 3.61
ml (range 0.19 - 14.30), the mean
T1 lesion load was 0.97 ml (range
0.00 - 7.12). The mean RBV was
0.78 (range 0.65 - 0.88). In this
sample of patients, the EDSS
showed a significant correlation
with RBV as a measure of atrophy
(r = -0.61; p = 0.001), but not with
T2 or T1 lesion load. We did not
find significant differences between
RR, SP and PP patients with
respect to ANT scores for speed,
speed fluctuation and accuracy.
All correlations between ANT
indices and MRI parameters are
given in table II.
ANT versus T2 lesion load.
Total T2 lesion load correlated
with baseline speed, speed of the
focussed attention, the memory
search and the sustained attention
tasks, with speed fluctuation of the
focussed attention and the
memory search task and with the
pursuit task scores. It did not
significantly correlate with any of
the accuracy scores (0.37 # r #
0.50, see table II).
The correlation analyses per region
showed that the overall T2 lesion
load was mainly driven by the
frontal lesion load, which also had
the highest correlations (regional
details not reported in table).
ANT versus T1 hypointense lesion load
Total T1 lesion load only showed
significant correlations with all
scores of the memory search task
and the speed score of the
sustained attention task. (0.41 # r
# 0.48, see table II). The analyses
per region resulted in correlations
for all main brain regions of similar
magnitude as the overall T1 lesion
load correlations, and showed
significant correlations of frontal
and occipital lesion load with speed
in the focussed attention task.
ANT versus brain volume
Relative brain volume reduction
(RBV) showed s ignif ican t
correlations with most of the
speed and speed fluctuation scores
of the different tasks (-0.38 < r < -
0.68). Not only were a higher
number of significant correlations
found for ANT versus brain
volume compared to ANT versus
lesion loads, correlations typically
were also stronger.
Multiple linear regression analysis
Multiple linear regression analysis
was used to further investigate the
relative strength o f various
relations (table III). Among the
MR parameters examined, brain
volume was the strongest predictor
in the model for most of the test
speed and test fluctuation scores.
None of the parameters was
significant in explaining (part of)
the ANT test accuracy of
performance in our model. Besides
the MR parameters, disease
duration was the other strong
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explanatory variable for the other
tests. Sex was a significant
independent variable in explaining
the visuo-spatial processing
f l u c t u at i o n s s core .  When
performing the same regression
analysis without EDSS and sex, no
different explaining variables were
found.
Table III








speed RBV .533 .252 8.74 .007
fluctuation Disease
duration





fluctuation Sex .532 .248 8.27 .009
accuracy -
Memory search speed RBV .614 .351 13.95 .001









speed T1 Lesion load .501 .217 7.39 .013
fluctuation Disease
duration




speed RBV .698 .464 20.49 < .001
fluctuation RBV .576 .302 10.94 .003
accuracy -
Pursuit distance RBV .717 .468 11.11 .001
fluctuation Disease
duration
.684 .443 19.30 < .001
Tracking distance -
fluctuation -
Multiple linear regression analysis was performed. The ANT score was set as the
dependent variable, the MR parameters for brain volume, T2 lesion load and T1 lesion
load, sex, age and disease duration as the independent variables. The model used was a
forward stepwise model with a probability of F to enter of 0.05.
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DISCUSSION
In this study we found strong
correlations between ANT scores
and MR measures. In general,
higher lesion load, but especially
progress ive  br a i n  v o lume
reduction, was associated with
slower speed of processing and
larger fluctuations in response
speed in the choice reaction time
tasks, and with an poorer
performance on the visuomotor
control tasks, in particular on the
pursuit task. With the exception of
the memory search task and
focussed attention task, choice
reaction time accuracy did not
correlate with MR measures.
Correlations were strongest as well
as most frequent for brain volume.
Moreover, T2 lesion load was
found to correlate more often with
task performance than T1 lesion
load. The memory search task, the
sustained attention task and the
focussed attention task all depend
on more than one MR parameter,
probably because all are highly
d e p e n d e n t on  cont ro l l e d
processing.
In a recent study applying the
ANT, a test that probes various
attent ion al  domains in  a
q u a n ti t a t i v e  f a s h i o n , we
demonstrated that MS patients
have a slower speed of cognitive
functioning than healthy controls,
with a largely maintained
accuracy58. This was especially true
for more complex tasks, in line
with previous studies108,109,112,126,204.
Cognitive slowing was found in
many studies, including our
previous study, to be more than
only motor slowing58,126,204. We
speculate how much of this
cognitive slowing in MS patients
could be explained by the
structural lesions and brain volume
reduction seen on MRI.
Previous studies on correlations
between cognitive functioning and
brain lesion loads show markedly
different results. Most studies
reported a relation between
cognitive functioning and MR
measurements (for example
5,83,96,133,203,227,250), but not all studies
did (for example 99,146,177). These
discrepancies can partly be
explained by differences in
cognitive tasks administered and by
the fact that some studies focussed
on accuracy of performance
without taking into account the
time needed to complete tasks.
Previous studies have clearly
shown that if test time is not
restricted, MS patients probably
can perform almost equally well as
healthy subjects on most cognitive
tasks22,58,62,110. In a previous study
by our  group we foun d
c o r r e l a t i o n s be tween  MR
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parameters (brain atrophy and
lesion load parameters) and a
screening test battery often used in
MS research, the Brief Repeatable
Battery132. The focus on attention
and processing speed shows that
those functions, essential for good
cognitive  functioning,  are
impaired. The present study also
shows, in this relatively small
population, that accuracy is less (or
not) compromised in comparison
with other aspects of cognitive
functioning (given a sufficient
amount of time).
In progressive stages of the disease
or under too much time pressure, a
decline in performance can be
expected to occur in MS patients.
In our current small sample,
meaningful differences between
MS subgroups could not be
evaluated. We did not find a
correlation between visuo-spatial
processing and brain volume
reduction or lesion load. The
reason for not finding such a
correla t ion, might be that
automatic processing activity,
associated with tasks involving low
processing loads, is less vulnerable
to consecutive MS lesions than
controlled processing, which is
required in tasks involving high
working memory load demands.
The ANT scores show better
correlations with brain volume
reduction than with lesion load
measures. The cognitive functions
tested by the ANT require the co-
operation between brain areas
located diffusely through the brain
rather than more localized areas.
This is also shown by our results
that regional brain lesion loads are
equally well correlated with MR
parameters as the overall lesion
load. The relation with brain
volume proved to be stronger than
with lesion load, suggesting that
abnormal i t ies  beyond the
resolution of the scanner (in the
normal appearing white or gray
matter) are important predictors of
worse test resu lts in MS
patients72,265.
Performances on tasks as used in
the ANT, require the integrity of
fu n c t i o n a l  n e t w o r k s  f o r
communication between different
brain areas. Lesions in MS lead to
slowing of transportation of
information and, therefore, we had
expected lesion loads to show
better correlations. Absence of
correlations with lesion loads
might be related to subtle, but
extensive, abnormalities in normal
appearing white matter, which was
not quantitatively interrogated in
this study. If connections between
brain areas are still intact, then
besides cognitive slowing, accuracy
should not necessarily be affected.
This might explain the relations
found for ANT scores on speed,
but not for accuracy. It also might
explain that whenever a correlation
was found, this was seen in all four
main brain regions most of the
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times, an observation also induced
by the fact that lesion loads in
these areas are highly interrelated
(results not shown). We found
correlations to be the highest for
the frontal regions, which is in line
with observations by Swirsky-
Sacchetti et al., who also described
that frontal lesions correlate best
with cognitive impairment250. In
another study in MS patients,
Benedict et al. also found
correlations between brain volume
reduction, even in regional areas,
and some cognitive tasks21. The
importance of atrophy, compared
to lesion loads, in relation to
clinical disability in MS was also
emphasized by Kalkers et al.116,
who found that brain atrophy
cannot simply be explained by
lesions alone.
With this study we further refined
the cognitive problems in MS in
relation to underlying structural
abnormalities (lesion load, brain
volume reduction) on MR. Our
observations convincingly show
that speed of cognitive functioning
is the main problem, and not
performance. Based on the
correlation analysis, we suggest that
such impairment is driven by
diffuse cerebral damage, beyond
focal lesions, and cerebral volume
loss.
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3.1 INTRODUCTION  FMRI
M RI is a non-invasive method
using magnetic fields to image
tissue, making use of the natural
properties of hydrogen protons.
When a magnetic field is applied to
a body, the (hydrogen) protons
align with the field lines; when the
magnetic field is turned off, the
protons redirect themselves and
t ran s f e r  e n e r gy  to  the i r
surroundings. Each tissue responds
differently, because of the different
amount of protons and the
chemical state of the protons in
that tissue. Thereby the different
tissues give another signal, with
contrast in the image as a result.
Normal brain tissue gives therefore
another signal than an MS lesion,
which can be detected in this way.
FMRI TECHNICAL ASPE CTS
Functional MRI (fMRI) was first
described in a study of brain
activation in humans in 1989 by
the group of Belliveau and Rosen20.
This first study made use of a
exogenous contrast agent. A few
years later fMRI studies without
exogenous contrast agents were
performed130,167. The basis of this
fMRI method is the difference in
magnetic  characteristic s of
oxygenated haemoglobin  and
haemoglobin  without oxygen
(deoxyhaemoglobin). Increased
neuronal activity increases oxygen
consumption. Blood flow is
increased to deliver the extra
oxygen, however to a higher extent
than the extra oxygen extracted
(overcompensation)187. Hence
paradoxically, neuronal activation is
assoc ia ted with  i n c r eased
concentrations of oxygenated
haemoglobin (and therefore a
decrease in deoxyhaemoglobin) in
the region of activation. This
increases phase coherence of
protons in the activated region,
increasing T2*, and therefore
increasing signal on T2* weighted
images. This is the so-called blood
oxygenation level dependent
(BOLD) effect167. The main
determinant of the signal is the
increased metabolic rate in and
around the synapse, rather than the
neuronal firing rate perse141,150.
This BOLD signal difference is
very small and much smaller than
that of the differences between
normal tissues. Many samples
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(images) have to be acquired to get
a sufficient signal-to-noise ratio to
statistically detect brain activation.
This can be achieved by using fast
sequences which image the whole
brain in only a few seconds, at the
cost of spatial  less resolution. The
technique mostly used is the echo
planar imaging (EPI) sequence. A
further description of the technical
aspects of fMRI is beyond the
scope of this thesis.
FMRI PRACTICAL ASPE CTS
In the MR room, a test is applied
to the subject by a beamer (outside
the room) projecting images on a
screen in the MR room, viewed by
the subject through a mirror placed
above the subject’s head in the MR
bore. If needed, the subject can
respond during the task by pushing
buttons. Speaking is problematic,
because it causes movement
artifacts and because of the noise
of the scanner.
Usually the images acquired during
two or more conditions are
compared statistically. It is
important that the difference
between conditions isolates the
function of interest. The difference
in the signal then represents a
difference in brain activation,
associated with the cerebral
function of interest. Practically,
problems are the small differences
in the signal and a good task
construction with two or more
conditions which differ in the
desired cerebral function only.
FMRI STA TISTICAL AN ALYSIS
Because of the many data samples,
adequate statistical methods are
needed,  compensa t ing for
c o i n c i d e n c e s .  S P M
[www.fil.ion.ucl.ac.uk/spm]86 and
AFNI [afni.nimh.nih.gov/afni] 50
are the software packages used to
analyse the data of the studies
described in this thesis. These
software packages offer methods
of image registration (realigning the
image differences caused by (small)
head movements during the
experiment), and preprocessing
tools such as (temporal and spatial)
filtering, and statist ics.
First for each individual voxel
(volume pixel) the signal changes
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are tested against a null hypothesis
(“no brain activation”) constructed
from the test characteristics and
the thereby exp ected signal
(activity) changes (a general linear
model of the expected signal). The
second step is a statistically
compensation for the many
comparisons (many voxels) and
thereby possible many false
positive test results. This step can
be performed with statistical tests
compensat ing for mult ip le
comparisons.
To study a cognitive domain, it is
of importance to develop a suitable
task, testing it in healthy controls
to see whether the results meet the
expectations. For the MS fMRI
studies in this thesis, this step had
to be performed first because no
ready-to-use tasks were available.
For the fMRI part of this thesis,
this first hurdle was taken. Also
some implementation studies of
the fMRI tasks were performed.
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3.2 FMRI ADAPTED TOWER OF
LONDON TEST
Adapted from: American Journal of Neuroradiology
Visualising brain activation during planning: The
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Recent positron emission tomography and single-photon emission CT
studies using the Tower of London test have shown that brain activation
during planning activities primarily resides in the prefrontal cortex. In this
study, we adapted the Tower of London test  for functional MR imaging.
METHODS
For use with functional MR imaging, a block design of the test was
created, in which planning stages were contrasted with counting of
coloured balls. For nine healthy participants, multisection echo-planar
functional MR imaging was performed to assess brain activation based on
changes in blood oxygen level. Activation maps for individual participants
and a group average map were created.
RESULTS
In the group average map, activation in the dorsolateral prefrontal cortex,
the anterior part of the cingulate cortex, the cuneus and precuneus, the
supramarginal and angular gyrus in the parietal lobe and the frontal
opercular area of the insula was seen. These findings are in agreement
with grouped data of previous positron emission tomography results.
Functional MR imaging enabled us to investigate brain activation during
planning activities with high spatial (and temporal) resolution in individual
subjects, showing that the dorsolateral prefrontal cortex was activated in
all individual participants studied.
CONCLUSION
Presented is a working functional MR imaging version of the planning
task. The high sensit ivity of functional MR imaging may allow the use of
this test in patients with possible (pre)frontal disorders.
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INTRODUCTION
Planning is defined as the ability to
organise cognitive behaviour in
time and space170. It is necessary in
situations in which a goal must be
achieved through a series of
intermediate steps, each of which
individually does not lead directly
towards that goal. A well-known
test to evaluate planning in
neuropsychological research is the
Tower of London test237. For this
test, the participant is instructed to
move three different coloured balls
to match a target configuration by
using a minimum number of
moves. Although this test needs
spatial processing abilities, it mainly
depends on planning. Patients with
f r o n t a l  l o b e  p a t h o l o g i c
abnormalities (e.g. frontal lobe
dementia,  multiple sclerosis)
perform worse than do healthy
control participants.
Neuropsychological studies have
shown that lesions in the frontal
lobe (mainly the prefrontal cortex,
which is located anterior to the
motor part), might cause problems
with planning237,238; for a review see
Owen170. Recent PET and SPECT
imaging studies9,53,160,171 that used
the Tower of London test
confirmed that brain activity
during planning is located mainly in
the prefrontal area, particularly in
the dorsolateral prefrontal cortex.
These data were based on averages
of several participants, because
these techniques usually have too
low sensitivity to detect activation
in individual participants reliably.
Functional MRI (fMRI) is a non-
invasive technique with which to
measure brain activity based on
changes in the blood oxygen
level130,168. Additional advantages of
this technique compared with
other functional brain imaging
techniques are its high spatial and
temporal resolution and the ability
to study individual subjects.
Paradigms applied in PET studies,
however, often can not be used
without major changes in fMRI,
because there are important
differences in the test situation of
the two techniques. In this study
the results of our, for fMRI
adapted, version of the planning
task are presented.




For application of the test with
fMRI, a block design was created,
in which an “active” condition
concerning planning and a
“control”  condition without
planning were alternated (36
seconds per block, including an
instruction; nine blocks in total).
With the active condition, the
participants are presented a
baseline and a target configuration
on a single screen [figure 1] viewed
through a mirror in the magnet
bore. Both configurations consist
of three differently coloured balls
(blue, yellow and red) placed on
three vertical rods which are one,
two and three balls in height,
respectively.
The minimum  number of
necessary moves to reach the
target has to be planned in mind.
One ball can be moved at a time,
and only when there is no other
ba l l  on  t op .  Some t i m es
counterintuitive moves ar e
necessary to reach the target; one
of the major aspects of planning.
The participant holds two air
bulbs, and answers by pressing the
one corresponding to the side
where the correct answer is shown;
one of two possibilities displayed at
the bottom of the screen. With the
control condition, participants
simply have to count the yellow
and blue balls together and again
choose the correct answer (total
number of balls) from two
possibilities. The display is almost
the same as with the active
condition, except that more balls
are displayed, with every time
another number of yellow and blue
balls [figure 1].
Every condition block starts with
an instruction of four seconds to
plan the moves (active condition)
or count the balls (control
condition). Easy (two to four
moves) and difficult (five to seven
moves)  configurat ions ar e
presented in separate blocks to
make it possible to compare two
different levels of planning activity
(difficult, easy) and a control
situation without planning. The
whole test is self-paced; a new trial
(in the same block) is presented
only after a response is obtained.
No feedback regarding the
correctness of the answer is
provided during the task. After 36
seconds the next block starts with
a new instruction [figure 2],
regardless of whether the last trial
has been responded to. In total 82
whole brain volumes (9 blocks
with 9 volumes each and one
volume preceding the start of the
test) were scanned (one scan was
made every 4 seconds) [figure 2].
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To ensure the participants were
familiar with the procedure, the
test was explained and practised
outside the MR room before
scanning.
Participants
Nine healthy students (five men,
four women; mean age 22 years
(range 20 - 27)) were evaluated.
The ethical review board of the
Academic Hospital of the Vrije
Universiteit Amsterdam approved
of the study and all participants
provided informed consent.
Data acquisition
Imaging was performed on a 1.5 T
MR system with a standard
circularly polarised head coil.
A n a t o m i c a l  imag in g  w a s
performed with a 3D gradient echo
T1-weighted sequence (15 ms
(TR), 7 ms (TE), 1 (excitation), flip
angle: 8/, matrix size: 256 x 256,
field of view: 220 x 220 mm, slice
thickness: 2mm, number of slices:
82).
Figure 1
Example of the Tower of London screen
Figure A Sample screen of one of the configurations of a planning problem. Upper part:
baseline configuration. Lower part: target configuration.
In this example the participant has to move first the blue ball to the right rod, which is
counterintuitive. Thereafter the subject has to place the yellow ball on top of the red
ball, the blue ball at its destination, the yellow ball on top of the blue ball, the red ball
on the right rod and finally the yellow ball at the target position (sixth move). Two
alternatives are presented on each side of the screen, f rom which the subject had to
choose the correct answer. The subject was asked to respond by pressing the air bulb at
the corresponding side.
Figure B Sample screen of  the control configuration. The subject has to count the
yellow and blue balls altogether. In this example, the answer is six, which is indicated on
the right side.
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Figure 2
Overview of the test, scanning and data analysis
Task paradigm: Easy, difficult planning and counting are performed in blocks. Every
block lasts 36 seconds, including a 4 seconds instruction. A total of nine blocks were
performed during the te st.
Scanning: A total of 82 scans were obtained, inc luding those of a dummy before the test
started.
Data analysis: To account for the haemodynamic response delay, a 4 seconds delay in
the analysis was used. The images obtained during the instruction (accounting for the
haemodynamic response delay) were not used for further calculations. The resulting 71
scans were used for the analysis (24 obtained during the difficult planning problems, 24
obtained during the easy  planning problems and 23 obtained during the control stage).
The slices were planned in the
coronal plane with a rotation of
approximately 30/ of the cranial
part in the anterior direction, to
cover the whole brain in the least
possible number of slices. For
fMRI scanning, a whole brain echo
planar imaging (EPI) sequence (4
seconds (TR), 64 ms (TE), 1
(excitation), flip angle: 90/, matrix
size: 64 x 128, interpolated to 128 x
128 mm, field of view: 220 x 220
cm, slice thickness: 6 mm,
interslice gap: 1.02 mm, number of
slices: 23) was used. The EPI slices
were planned parallel to the
anatomical slices.
Data analysis
The first step of the post-
processing was correction of
motion artefacts287, with the
consequence of corrupting the first
and last slice of each volume,
which were discarded from further
analysis. Next, the data were
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smoothed in-plane, resulting in a
full width at half maximum of 5
mm in plane. The following steps
were performed with AFNI
software50. Activation was detected
by correlating each time course of
each voxel with a box car function
representing the “active” and
“control” blocks of the paradigm
[figure 2]. Also the two levels of
planning difficulty were correlated
in the same way, without using the
control stage images. Voxels with a
signal increase during the active
cond i t ion had a posit ive
correlation coefficient and were
called positive activation. The
opposite was true for voxels with a
relatively reduced signal. The box
car function was delayed 4 seconds
(1 scan) in time to partly account
for the haemodynamic response
delay 1 2 2 .  T h e  s c a n s  t hat
corresponded with the time the
instructions were displayed, were
not used in the analysis [figure 2].
The scans were transformed into
Talairach coordinate space252 by
defining reference line landmarks
on the anatomic scans. Individual
activation maps were calculated
and also used to create a group
average. Correction for multiple
comparisons was performed,
accounting for the spatial extent of
activation51,81. Only voxels with at
least a p-value of 10-4 where
considered active and 3D-clusters
of at least 104 mm3 (i.e. five
connected active voxels) were
included, resulting in a mean
activation map of all participants
with an overall p-value < 0.05.
In all individual and group images
the macroscopic position of
significant activations was defined
based on the visible gyral - sulcal
pattern to specify the location in
more anatomic detail.
RESULTS
All nine subjects were studied
successfully. Because we used a
self-paced paradigm, the number
of answers varied, with a mean of
13.7 (range 9 - 17) answers during
both planning conditions together,
of which 78.7% were correct (66.7-
100%). For the easy configurations
a mean of 8.5 (6 - 11) answers were
given, of which 82% (57 - 100%)
were correct; for the difficult
configurations the results were 5.2
(3 - 8) answers, of which 71% (50 -
100%) were correct. With the
control condition (only counting)
the number of correct answers was
98% (89% - 100%), and the
participants gave 36.4 (29 - 48)
answers.
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Table I
Areas of fMRI activation during the Tower of London task; planning
condition (mean of all subjects).





RL AP IS N Individuals
Middle frontal gyrus and adjacent
part of inferior frontal sulcus, left
28 -11 59 7254 9 1,2,3,4,5,6,7,
8,9
..., right -28 -16 54 8741 9 1,2,3,4,5,6,7,
8,9
Cingulate gyrus, anterodorsal part,
left
9 -38 22 1836 6 2,3,5,6,7,9
Cuneus and precuneus, around
parieto-occipital sulcus, left and
right
1 70 33 10142 7 2,3,4,6,7,8,9
Supramarginal and angular gyrus
(parietal lobe), left
38 62 50 1141 7 2,3,4,6,7,8,9
Insula, anterior part, left 29 -23 7 1027 5 1,2,6,7,8
Cerebellum, left 39 66 -33 1164 7 1,2,4,5,7,8,9
..., right -39 56 -37 452 4 3,4,6,7
Lateral occipital gyrus, left 31 80 27 672 5 2,4,6,7,8
..., right -45 67 20 2684 7 1,2,4,6,7,8,9
* direction in Talairach space (from negative  to positive) RL = right / left; AP =
anterior/ posterior; IS = inferior/ superior
N = number of subjects which showed activity in the neighbourhood of the centre of
the peak activation
Figure 3
Activated areas during the active condition of the Tower of London task.
During the active condition (planning stage) of the task, activation (red) on the group
average map (shown in Talairach format with coronal orientation) is shown. In the brain
area from -3 anterior to +49 posterior no activation was seen.
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Fig 3A Frontal reg ions during planning
Coronal slices of
coordinates -44 to -
3 (anterior part of
the brain). Activity
was noted in the
d o r s o l a t e r a l
prefrontal cortex,
the anterior part of
t h e  c i n g u l a t e






s l i g h t l y  m o r e
activation than the
left side.






of  the bra in) .
Act ivat ion  was
noted in the cuneus
and  p recun e us
region, the marginal
and angular gyrus
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Activation in the group average
images during the active condition
(easy and difficult configurations
combined) was seen on both sides
in the frontal and parietal lobes,
the cerebellum and the insula
[figure 3 (a and b); table I]. The
frontal area showed activation
bilaterally in the middle frontal
gyrus and the adjacent part of the
inferior frontal sulcus (with some
prefe rence  for  the r igh t
hemisphere) and in the anterior
part of the cingulate gyrus [Figure
3a]. The parietal and occipital
regions involved were the
precuneus and cuneus and the left
supramarginal and angular gyrus
[figure 3b].
Most  part ic ipants  sh owed
activation in the same gyri that
were activated on the group
average [table I], and activation in
the middle  f ronta l  gyrus
(bilaterally) especially occurred in
all participants. We did not find
any significant differences in the
activation when comparing the two
levels of difficulty (easy and
difficult planning).
The areas observed with a higher
signal in the control condition
were the middle part of the
cingulate gyrus and the middle part
of the insula on both sides, the
fusiform gyrus and the pre- and
post-central gyrus. The majority of
cases (67-100%) showed activation
in the same gyri that were activated
on the group average. An
exception was the activation in the
fusiform gyrus, which had a higher
signal in the control condition
compared with the plann ing
condition,  in only 44% of the
participants [figure 3; table I].
DISCUSSION
A planning task, such as the Tower
of London, has proven to be a task
which is sensitive to prefrontal
lesions171,210,238. A new version of
the planning task, adapted for
fMRI, is presented. The group
analysis showed activation during
the planning stages in the
dorsolateral prefrontal cortex, the
anterior part of the cingulate
cortex, the cuneus and precuneus,
the supramarginal and angular
gyrus in the parietal lobe and the
frontal opercular area of the insula.
These findings ar e in full
agreement with previous PET
results on grouped data9,53,171. In
addition, fMRI enabled us to
investigate brain activation during
planning activities with high spatial
(and temporal) resolution in
individual participants, showing
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that the dorsolateral prefrontal
cortex was activated in all
individual participants studied.
Previous studies have indicated
that activation associated with this
task performance occurs especially
in  the  pref r onta l  cor tex
9,53,160,170,171,237. Three PET studies
that evaluated the Tower of
London test in healthy controls
9,53,171 will be discussed in
comparison with our results.
The PET studies of Baker et al.9,
Owen et al.171 and Dagher et al.53
used a block paradigm in which the
participants had to plan the moves
and press on a touch screen the
number of moves9 or perform
each move separately by pressing
on a touch screen the ball that has
to be moved and thereafter the
place to which it had to be
moved53,171. With the control
condition, the participants did not
need planning, but only had to
view the subsequent moves9 or
press the touch screen at the
highlighted locations corre-
sponding with locations pressed
during the planning condition53,171.
Dagher et al. not only analysed the
activation during planning, but the
planning stages were analysed also
in a parametric way, based on task
complexity53.
The three aforementioned PET
studies (group analysis) showed
frontal lobe activation, in the
dorsolateral prefrontal cortex
bilaterally (predominantly right
hemisphere), the anterior cingulate
gyrus bilaterally and some frontal
lobe motor areas. Activation was
also noted in other frontal areas,
but not with complete consistency
across the three studies; Owen et
al.171 activated the left  medial
frontal cortex, Baker et al.9
activated the right rostrolateral
prefrontal cortex. All three studies
also showed activation in the
caudate nuclei (the left one in the
study of Baker et al., the right one
in the other two PET studies). In
addition to the frontally located
activated areas, activation was also
seen in the right anterior insula
(frontal opercular area), the medial
parietal  cortex (precuneus)
bilaterally, the left inferior parietal
cortex, the right superior parietal
cortex bilaterally, the lateral
occipital cortex and the left
cerebellum and vermis9,53,171. Those
areas are probably activated not
only by the planning process itself,
but also by the motor and visual
processes needed to perform this
planning.
In the study of Dagher et al.53, the
activated areas during planning
could be divided, as a result of the
parametric analysis, into those that
did not correlate with the task
complexity, such as the areas
belonging to the dorsal stream of
visual input (visual and posterior
parietal cortical areas) and the
execution of arm movements
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(frontal lobe motor areas), and
those that correlated with the task
complexity, such as lateral
premotor cortex, rostral anterior
cingulate cortex, dorsolateral
prefrontal cortex bilaterally and the
right dorsal caudate nucleus.
In our fMRI study, we found
globally the same activated areas as
in the aforementioned PET studies
[table I]. Concerning the frontal
areas, we observed significant
activation in the middle frontal
gyrus and the adjacent part of the
inferior frontal sulcus, the
precentral cortex and the anterior
part of the cingulate gyri. As in the
PET studies, activation was also
seen in the caudate nuclei, but the
volume of this activation was
below our cluster size limit. We
found only one main difference
with the PET studies. In our
experiment, the occipital lobe and
the primary motor areas were
more active during the control
condition. This could be explained
by the fact that in the control
condition the total number of
configurations processed was
higher.
One of the main areas activated
during this planning task is the
dorsolateral prefrontal cortex.
Activation in this area is thought to
be associated with active
processing of both spatial and
nonspatial information. Left - right
differences probably exist, but
there is no consensus regarding the
nature of those differences. Baker
et al.9 refer to literature on PET
studies in which the spatia l
information is predominantly
represented in the dorsolateral
prefrontal cortex of the right
hemisphere, whereas nonspatial
working memory should be
positioned predominantly at the
left side. In our study, we noted
bilateral frontal activation with a
slightly larger activated area on the
right side. This may be taken to
indicate that spatial information
processing is a prominent feature
of the Tower of London paradigm.
Such a suggestion seems quite
logical in view of the test,
moreover activation of the
precuneus and inferior parietal lobe
has been associated with spatial
processes and is correlated with
prefrontal activity9,53.
In contrast with the study of
Dagher et al.53 who found
complexity related activation when
performing a parametric analysis
on five difficulty levels, including
one-move-problems (which require
a lmost  no p lanning) ,  no
differences in activation were
found in our study when
comparing the easy and difficult
conditions.  This could be
explained by the decreased amount
of data, our design of only two
levels and the too small a
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difference of the two levels of
planning.  Another possible
explanation is the difference in the
response to be given, in our test
one number, in the study by
Dagher et al. the whole planning
sequence, of which the last requires
probably more planning activities.
Regarding the interpretation of the
test score, for all except one
participant, the test score was
clearly beyond chance expectations
(i.e. more than 50% correct
answers). The test score is of
assistance only in determining
whether the particip ant has
performed the test, or when no
activation or activation in
unexpected areas is seen, which
was not the case in our
participants. With the non imaging
versions of the test, the reliability
of the test scores within individual
subjects is sometimes criticised.
Our study tried only to localise the
underlying brain areas activated, so
the test score, and thereby its
within subjects reliability, was less
important for our goal. The high
intersubject concordan ce for
prefrontal activation may relate to
the fact that for this test it is not
the number of correct answers, but
the process of planning (resulting
in a correct answer or not) that is
the most important determinant.
One of the main ideas regarding
the use of fMRI was to study
subjects individually [table I]. All
nine subjects tested showed
significant activation in the
dorsolateral prefrontal cortex when
analysed individually. The other
areas that showed activation in the
group analysis were also seen in
most participants. Future research
with fMRI will enable us to
correlate those findings with
individual parameters.
CONCLUSION
The Tower of London test was
successfully adapted for fMRI and
the activated areas found were
consistent with previous PET
studies, especially in the prefrontal
cortex. Also, fMRI allowed us to
demonstrate significant activation
in individual subjects. The
dorsolateral prefrontal cortex was
active in all individual participants.
The benefits of the fMRI
procedure could enable us to use
this adapted version of this test to
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The Paced Auditory Serial Attention Task (PASAT) is an attention and
information processing task used in patients with diffuse brain disorders,
like cerebral trauma and multiple sclerosis. Based on the PASAT we used
an adapted version of the test to assess several cognitive functions with
fMRI. In this study we investigated the activation pattern on a group and
individual level and upon parametric stimulation.
METHODS
Nine young, healthy, right-handed subjects (mean age 24 years) were
studied. The test contrasts an adding-and-memory stage with a control
stage in a block design, at two different speeds. Group average maps
(random effects analysis, p = 0.05) were created to identify the brain areas
subserving this task. For each area found active in the group map, the
percentage of individuals showing activation in that same anatomical area
was calculated.
RESULTS
Group activation was localized in the superior and inferior parietal lobe
bilaterally, the superior frontal gyrus bilaterally, the left medial frontal
gyrus, the left inferior frontal gyrus and adjacent part of the insula, the
anterior part of the cingulate gyrus and some cerebellar areas. For the
main activated areas, 78-100% of the individual subjects showed
activation in that same area.
Contrasting the low speed with the high speed condition yielded
activation with a considerable individual variation.
CONCLUSION
The group mean activated areas were located mainly in the frontal and
parietal lobes and those areas were also activated in the majority of the
subjects, indicating limited inter-individual variation, rendering this test
suitable for clinical applications in a variety of neurological disorders.
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INTRODUCTION
fMRI is used to study cognitive
processes. In certain diseases, like
multiple sclerosis (MS) and
traumatic brain injuries, diffuse
pathological processes are present.
Patients with diffuse cerebral
damage show a lower test score on
the Paced Auditory Serial Addition
Test (PASAT developed by
G ronwa l l 9 0 )  t h an  he a l t hy
controls 223, for example after
cerebral concussion90. The level of
performance on the PASAT is also
lower in patients with disorders
characterized by lesions diffusely
distributed over the brain, like in
MS202 . Attention demanding
( c o n t r o l l e d )  i n f o r m a t i o n
processing underlying more
complex cognitive skills is in
general more slowed in MS
patients58. To be able to assess
cognitive deterioration by means
of fMRI, we used a task based on
multiple cognit ive abi l i t ies,
requiring the support of various
brain areas throughout the brain.
Since the PASAT and the Paced
Visual Serial Addition Test
(PVSAT)82, a visual version of the
test, fits the above requirements,
we developed an fMRI version of
this task.
Figure 1
Projections on the brain of the active areas of the adding-and-memory
versus control stages (group map, random effects analysis).
Brain surface representation
of the activity, calculated
from the individual subjects
activation maps using a
random effects analysis (p =
0.05)
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The PASAT test consists of 60
random dig i ts  which are
sequentially presented from audio
tape. The subject is instructed to
add the last digit to the preceding
one, for every number heard. The
resulting sum has to be vocalized
before the next digit is presented.
Different presentation rates have
been used (typically 2 or 3 seconds
per digit)90. The PASAT imposes
high demands on the subject’s
working memory capac i t y,
requiring controlled information
processing (atten tion),  visual
m e m o r y ,  g o o d  a u d i t o r y
functioning and calculating
abilities239.
The purpose of our study was to
administer an attention task in an
fMRI setting, and to study the
inter-individual variation and the
parametric qualities of the brain
activity. We hypothesized that the
activated areas, when attending to
and processing visual stimuli,
would be located mainly in the
parietal and frontal lobes.
METHODS
Data acquisition
Imaging was performed on a 1.5 T
MR system with a standard
circularly polarized head coil.
Anatomical imaging included a
transverse 3D gradient echo T1-
weighted sequence (15/7/1
[TR/TE/excitations]; flip angle: 8/;
in plane resolution: 0.86 x 0.86;
slice thickness: 2 mm; number of
slices:  82). For fMRI, a whole
brain echo planar imaging (EPI)
sequence (4000/60/1; flip angle,
90/;  in plane resolution: 3.44 x
3.44 mm; slice thickness: 4.0 mm,
number of slices: 36) was used,
planned parallel to the anatomical
slices, which were used to
superimpose the fMRI data on.
The stimuli were projected on a
screen, viewed by the subject via a
mirror placed on top of the head
coil in the magnet bore.
Task
Different conditions, from which a
functional contrast can be
calculated, are needed in an fMRI
design. For this reason, our test
contrasts a “memory-and-addition”
(further called the adding) stage to
a control stage. During the adding-
stage the subject performs the
same task as during the original
PASAT. Every digit presented is
added to the one preceding it. The
auditory cues in the adding stage of
the original PASAT test were
replaced by sequentially presented
visual cues (digits) as in the
PVSAT82 and the subjects were
instructed to mentally process
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these digits but to refrain from
vocalizing the answers, which was
done to prevent motion artefacts.
We could not acquire answers,
because other types of answering
will interfere with the functions
tested. During the control stage,
subjects had to fixate on a cross, in
the centre of the screen and were
instructed to pay attention to the
moment a digit was presented
again, which was the moment the
adding stage resumed.
In the test, we applied two
different conditions, presented in
adding (A) and control (C) blocks.
Each block had a duration of 140
sec (35 scans). The presentation
rate of each block was either 2.5 or
3.5 seconds per item. The
presentation order of the blocks
was [A 2.5] - [C 3.5] - [A 3.5] - [C
2.5] - [A 2.5] - [C 3.5] - [A 3.5] - [C
2.5].
Subjects
Nine healthy students (6 men, 3
women; same educational level),
mean age 24 years (range 19 - 30)
were evaluated. All subjects were
right-handed and  had an optimal
visual acuity. The ethical review
board of the Vrije Universiteit
Medical Center Amsterdam
approved the study and all subjects
gave written informed consent.
Before scanning, the test was
explained and practised outside the
MR suite. In the magnet bore the
test was practised once more, this
time without answer registration
(as was the case during the
scanning session).
Data analysis
The data analysis was performed
with SPM99b [Available via
w w w . f i l . i o n . u c l . a c . u k /
spm/spm99.html]. The EPI data
were realigned and normalized
(and resliced 3x3x3 mm) into
standardized coordinate  space
approximated on the Talairach and
Tournoux space252. Next, the data
were smoothed using a Gaussian
filter set at 6 mm full width at half
maximum. The time series of each
normalized voxel was correlated
with a reference waveform
representing the test-model,
convolved with a haemodynamic
response function. We contrasted
in this way the attention/
information processing stages with
the control stages, and also the
high speed versus the lower speed
t a s k  c o n d i t i o ns  o f  t h e
attention/information processing
stage were contrasted.
Individual activation maps were
calculated applying per voxel a p-
value of 0.005, with a 3D-cluster
restriction of at least five adjacent
active voxels. The group results
were calculated using random
effects analysis286. For this analysis,
the activation map of each
individual was used in a one sample
t-test (p = 0.05, corrected for
multiple comparisons).
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Figure 2
Random effects analysis of the adding-and-memory versus control stages
(group map)
Transverse slices of the active areas calculated from the individual subjects activation
maps using a random effects analysis (p = 0.05). Left side of the images represents left
side of the patient (view from above).
THE FMRI ADAPTED PASAT TEST
- 119 -
Besides the contrast of the adding
versus the control stage, the
contrast between the high and low
speed condition was calculated. To
address the consistency of the
activated areas found in the group
analysis, for each anatomical area
found on the group map, the
number of individuals with
activation in that same anatomical
area was determined.
RESULTS
The whole group random effect
analysis of the pro cessing
information stages (both speeds
together) contrasted with the
control staged showed bilateral
(left size larger than right)
activation in superior and inferior
parietal lobe (BA 7/40), superior
frontal gyrus (BA 6) bilaterally ( L
> R), left medial frontal gyrus (BA
9), left inferior frontal gyrus (BA
44, 47) and adjacent part of insula,
the anterior part of the cingulate
gyrus (BA 32), and several areas in
the cerebellum. For details of the
activated areas see figure 1 and 2
and table I.
The whole group activation pattern
was globally the same for all
individual subjects [see table I]. For
all activated areas 56-100% of the
individual subjects sh owed
activation in that same area. This
percentage was even higher (78-
100% of all subjects) when
selecting only areas with more than
35 adjacent active voxels. Some
anatomical areas, like the left
superior and inferior parietal lobe,
the right superior frontal gyrus and
the cingulate gyrus, showed
activation in all subjects studied.
Group analysis comparing the high
versus the low speed of the adding
stage [A3.5 vs A2.5] showed some
small activated areas [see table II].
The largest area of activation was
seen in the right inferior frontal
gyrus (BA 44), while smaller
activated areas were seen in the
medial frontal gyrus (BA 6/10)
bilaterally, the right cingulate gyrus
(BA 24), the left superior parietal
lobe (BA 7), the r ight cuneus/
precuneus region, the left pulvinar,
the right caudate nucleus and the
cerebellum bilaterally. For this
contrast however, the individual
results did not compare well with
the group result: of all the areas
activated in the group map only
11-67% of the subjects showed
activity in that same area. The left
superior parietal lobe and the
cuneus/ precuneus region on the
right was the most consistently
activated area (67%).
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The reversed contrast (areas more
activated during the slower speeds)
did not show any activation in the
group analysis.
Table I
Activations for the adding versus control stages (random effects group
map)






Sup. parietal lobe (7), 
Inf. parietal lobe (40) [L]
-30 -60 48 170 14.76 100%
Inf. parietal lobe (40) [R] 63 -36 45 24 7.11 67%
Inf. parietal lobe (7/40) [R] 27 -60 45 14 6.29 56%
Sup. frontal gyrus (6) [R] 30 6 60 15 9.94 100%
Sup. frontal gyrus (6) [L] -3 -3 63 39 5.97 78%
Med. frontal gyrus (9) [L] -45 9 36 115 9.67 89%
Med. frontal gyrus (32/8) [R] 3 27 36 7 6.68 67%
Inf. frontal gyrus (45) /Insula [L] -33 21 3 13 9.56 78%
Cingulate (32) [L] -9 24 33 36 15.86 100%
Cerebellum [R] 33 -60 -27 13 10.34 89%
Cerebellum [L] -36 -66 -36 9 5.9 89%
Random effects analysis results.
The first two columns show the area and the SPM coordinates of the voxel with the
peak activity (the left number represents the lef t-right coordinate, where minus is left;
the middle number represents the anterior-posterior coordinate, where minus is
posterior; and the last number is the top-bottom coordinate where minus is the bottom).
The third column gives the number of active voxels of the cluster containing the "peak"
voxel, followed by the t-value. The last column shows the percentage of the individuals
with activation in that same area.
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Table II
High versus slow speed (random effects group map)






Sup. parietal lobe (7) [L] -15 -51 57 34 12.16 67%
Precuneus / Cuneus [R] 24 -60 18 37 9.23 67%
Med. frontal gyrus (6) [R] 33 3 57 9 12.38 44%
Med. frontal gyrus (6) [L] -12 15 48 45 8.62 44%
Inf. frontal gyrus (44) [R] 45 9 18 113 11.19 33%
Cingulate gyrus (24) [R] 12 33 -3 56 19.24 44%
Thalamus (Pulvinar) [L] -24 -15 9 15 8.31 22%
Caudate nucleus [R] 21 -6 18 12 8.31 11%
Cerebellum [L] -12 -42 -39 24 11.36 22%
Cerebellum [R] 27 -66 -51 24 9.87 22%
Two speeds contrasts, random effec ts analysis.
The first two columns show the area and the SPM coordinates of the voxel with the
peak activity (the lef t number represents the left-right coordinate, where minus is left;
the middle number represents the anterior-posterior coordinate, where minus is
posterior; and the last number is the top-bottom coordinate where minus is the bottom).
The third column gives the number of active voxels of the cluster containing the "peak"
voxel, followed by the t-value. The last column shows the percentage of the individuals
with activation in that same area.
DISCUSSION
We adapted a test that assesses
attention, information processing,
visual memory, working memory
and calculating abilities for fMRI.
Brain  ac t ivity,  supposedl y
associated with those functions,
was found in the following areas:
bilaterally in the superior and
inferior parietal lobe, bilaterally in
the superior frontal gyrus, in the
left medial frontal gyrus, left
inferior frontal gyrus and adjacent
part of the insula, the cingulate
gyrus (anterior part), and several
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cerebellar areas. The activated areas
were quite consistent, as evidenced
from the fact that for all areas
larger than 35 adjacent voxels, 78-
100% of the individual subjects
showed activation in that same
area.
The test is a fMRI-adapted version
of the PASAT, incorporating an
activation and control stage. The
original PASAT test requires
sustained and divided attention
capacity, information processing
and demands in terms of
calculating functions and working
memory. We expected the fMRI
version to address similar cognitive
processes. The results we found
are in line with this hypothesis. A
specific aspect of this task, adding
the last digit to the preceding one
for every number seen, draws
heavily on executive control,
because each addition has to be
suppressed and working memory
content has to be continuously
updated to produce the correct
answers. Brain networks associated
with executive control include the
anterior cingulate cortex and
supplementary motor area, the
orbitofrontal cortex, dorsolateral
prefrontal cortex, parts of the basal
ganglia and the thalamus23,67,178,193.
Visual information processing has
been found to activate the
precentral gyrus of the frontal
lobe, parietal lobe areas and part of
the temporal lobes46,47,189. Sustained
attention, also needed in this task,
is subserved by right frontal-
parietal areas (right parietal cortex
(BA 7), right dorsolateral and
middle frontal lobe and anterior
cingulate gyrus) and the locus
coeruleus48,49,102,137,174. Mathematical
functions are supposed to be
subserved by the left parietal lobe.
A recently published study of
Staffen et al.246, using the attention
task in a similar design and
scanning only a portion of the
brain, found only right cingulate
cortex (BA 32) activation in their
healthy subjects group. In contrast
with our results other frontal areas
did not show significant activation.
One of the reasons for this can be
that our task takes longer to
complete and demands more
information processing an d
working memory. However, in a
group MS patients, they also found
activation in some frontal cortex
areas (BA 6, 8 and 9, right side and
BA 39, left side), probably because
the relative demand in that group
was higher and therefore reached
significance. Their conclusion that
this meant an adaptative change in
the patients group, may however
be disputable. All sorts of
differences in the st udied
populations (age, educational level,
disease severity) can be a cause of
the difference in the results.
Bes ides those  ment ioned ,
neuroplasticity, neural changes in
reaction on the disease processes,
is also an explanatory factor.
THE FMRI ADAPTED PASAT TEST
- 123 -
To investigate changes in brain
activation patterns as a result of
increased task demands, i.e. when
the information processing system
is put under more pressure, we
have applied a parametric design in
which to different speeds of digit
(stimulus) presentation were used.
Comparing the two speed stages,
activation in the right inferior
frontal gyrus, the medial frontal
gyrus (BA 6/10) bilaterally, the
right cingulate gyrus (BA 24), the
left superior parietal lobe (BA 7),
the right cuneus/ precuneus
region, the left pulvinar, the right
caudate nucleus and the cerebellum
bilaterally was seen. However, the
individual variation of the speed
contrast was considerable. This
might indicate that processing
speed is important, but that
optimal processing speed may not
be the same for all individuals.
Further work is needed to clarify
which speed is most optimal and if
there are changes between healthy
and diseased subjects.
CONCLUSIONS
In conclusion, the fMRI-adapted
attention task, activates areas
involved in a broad set of cognitive
functions (including the attention
and working memory functions)
including the superior and inferior
frontal gyrus bilaterally, the left
medial frontal gyrus, the cingulate
gyrus, the superior and inferior
parietal lobe bilaterally, and some
areas in the temporal lobe and
cerebellum. The procedural
differences between our test and
the original PASAT test (no overt
responding, different speeds in one
test, existence of a control stage)
are most likely not essential for the
attentional and memory aspects of
the test. The consistency of the
results in individuals compared to
the group random effects analysis
indicate that the test is suitable for
further research of cognitive
functioning in patients with
widespread brain damage, such as
multiple sclerosis.
Contrary to evaluating one selected
cognitive sub process, studying
patients with widespread brain
damage is better done with tests
which need the ‘whole brain’. The
changes in time of the activated
areas and their volume can be used
as an indicator of the disease
process or recovery. For further
implementation and understanding
these changes, more research is
needed into inter-individual
reproducibility and factors that are
involved in explaining the
variation.
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4.1 TOWER OF LONDON TEST
IN MS PATIENTS
Adapted from: Multiple sclerosis
An fMRI study of planning-related brain activity
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Cognitive impairment occurs in a substantial number of multiple sclerosis
(MS) patients and often includes frontal lobe dysfunction. We used
functional magnetic resonance imaging (fMRI) to study planning, an
executive function, in moderately impaired MS patients.
METHODS
An fMRI version of the Tower of London test was used to study patterns
of brain activation in 23 MS patients and 18 healthy controls. The median
score on the expanded disability status scale for the MS patients was 4.
fMRI data were analysed using whole brain random effects analysis as
well as region of interest (ROI) based methods to assess group effects.
Within the MS group, associations with behavioural data and measures of
disease severity (lesion load from structural MRI) were examined.
RESULTS
Test performance in MS patients was significantly worse than in controls.
Group analysis for the MS patients and the controls showed for both
groups globally the same areas of activation, located in the frontal and
parietal lobes bilaterally and the cerebellum. Although visual inspection
suggested a larger extent of activation in the MS group, no statistically
significant differences between groups were found. In the ROI analysis,
statistically significant larger extent of activation was only found  in the
cerebellum. No association between disease severity and brain activity
could be determined in the MS group.
CONCLUSION
In MS patients with moderate disability and structural damage, the
pattern and extent of brain activation during planning were maintained
despite poorer performance. In contrast to other studies showing
increased activity, the failure to do so in our group may reflect exhaustion
of adaptative mechanisms.
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INTRODUCTION
Cognitive dysfunction is common
in multiple sclerosis (MS) patients,
occurring in 30 - 60% of all
patients18,202,260. Cognitive functions
primarily dependent on the frontal
lobes, like planning, are more often
affected than, for example,
language. Previous studies have
shown a relation between total
lesion load on magnetic resonance
imaging (MRI) scans and cognitive
impairment, with significant albeit
not very high correlations83,203,244,250.
Some studies also found a relation
between regional lesion loads and
certain test scores133,244,250. The
functional basis of cognitive
impairment, and the role of the
lesions, however, is largely
unknown.
Functional imaging studies of MS
patients so far have mainly
c o n c e n t r a t e d  o n  m o t o r
function24,25,40,70,136,205. Only a few
studies focussed on cognitive
f u n c t i o n s ,  f o r  e x a m p le
memory178,282,283, attention179,246 and
language functions194. Functional
imaging studies on planning, an
executive function known to be
impaired in MS patients80, have not
been reported.
Recently we adapted the Tower of
London (ToL), a well-known
planning task, for use with fMRI135.
In the present study we applied the
ToL task using fMRI in MS
patients. The goal of our current
study was to evaluate whether
cognitive fMRI research applying
this task is feasible in MS patients,
and if so a) which brain areas are
used by MS patients during this
planning task, b) whether this is
different from controls and c)
whether there is a relationship
between lesion load, test results,
and brain activation patterns.
METHODS
Subjects
We studied 23 MS patients and 18
healthy controls, comparable for
age, sex, education (years of
schooling) and handedness [table
I]. The subjects were selected for
adequate hand function and vision
as well as sufficient understanding
of the instructions given prior to
the test. The patients were selected
from a larger group of MS patients
(n = 33) who had undergone more
deta i l ed cogn it i ve  t e s t ing
previously; 10 MS patients could
not be included in the present
study because they had inadequate
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hand function or vision or did not
understand the test; by contrast,
only one subject considered for the
control group had to be excluded.
The level of disability as measured
by the expanded disability status
scale (EDSS) score indicated mild
to moderate disability. The ethical
review board of th e Vrije
Universiteit Medical Centre
Amsterdam approved of the study
and all subjects gave written
informed consent.
Table I
Descriptive data of the study groups.
Patients Controls
sex 12 men / 11 women 12 men / 6 women
age 44.9 years (SD 9.7) 36.6 years (SD 10.6)
education 9.8 years (SD 2.3) 10.9 years (SD 3.1)
handedness 20 right / 3 left 14 right / 4 left
disease duration 2 - 15 years n.a.
EDSS median 4.0 (1.0 - 6.5) n.a.
The EDSS is the expanded disabil ity status scale score for MS patients in which 0-3
represents mild disability and 3-6 moderate to significant disability.
SD is the standard deviation. n.a. is not applicable.
Task paradigm
In the fMRI version of the Tower
of London task135, the subjects are
presented a baseline and a target
configuration on a single screen
[figure 1a]. Both configurations
consist of three differently
coloured balls (blue, yellow and
red) placed on three vertical rods
which are one, two and three balls
in height respect ively. The
minimum number of necessary
moves to reach the target has to be
planned in mind. One ball can be
moved at a time, and only when
there is no other ball on top.
Sometimes counterintuitive moves
are necessary to reach the target;
one of the major aspects of
planning.
Two possible answers were
displayed at the left and right lower
corners of the screen. Subjects
were instructed to respond by
pushing a button corresponding
with the side the answer was
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displayed. Six different levels of
planning depth were randomly
presented in two groups: 2-4
moves (‘easy’) and 6-8 moves
(‘difficult’), presented in separate
blocks. This planning condition
was alternated with a control
condition, during which the
subjects simply had to count the
total of the yellow and blue balls
and again choose the correct
answer from two possibilities. The
display is almost the same as in the
active condition, except that more
balls are displayed [figure 1b], with
every time a different total number
of yellow and blue balls.
The test is divided in blocks, each
starting with an instruction,
displayed on the screen. The test is
self-paced, with a maximum block
length of 40 seconds. More specific
details of the tests have been
described elsewhere135. In total 122
whole brain volumes (12 blocks of
10 volumes each and two volumes
preceding the start of the test)
were scanned (one volume was
scanned every 4 seconds). Before
scanning, the test was explained,
and in addition all subjects
practised with easy examples until
they fully understood the
procedure, and answered correctly.
Data acquisition
Imaging was performed on a 1.5 T
MR system with a standard
circularly polarized head coil. A
whole brain gradient-echo echo
planar imaging (EPI) sequence (TR
4 seconds, TE = 64 ms, 1
excitation, flip angle 90/, matrix
size: 64 x 128, interpolated to 128 x
128, field of view: 220 x 220 cm,
slice thickness: 4 mm, interslice
gap: 1.02 mm, number of slices:
23) was used. The stimuli were
projected on a screen, viewed by
the subject via a mirror placed on
top of the head coil in the magnet
bore.
For identification of lesions,
structural MR imaging was
performed including a T2 weighted
(TR 2500/ TE 45-90/ 1 excitation)
spin-echo sequence. The slice
thickness was 3 mm with a 1 mm
in-plane resolution, with 42
contiguous slices being scanned to
cover the whole brain.
Data analysis
The test scores were calculated for
the easy stages, the difficult stages,
both planning stages together and
the control stages. The score was
the number of correct answers
minus the number of incorrect
answers divided by the total
answers given and multiplied by
100%. With an ANOVA test the
MS and control group scores were
compared with each other.
Lesion load measurements were
derived from the structural MR
scans. Lesions were identified by
visual inspection and marked.
Lesion load measurements were
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based on local thresholding
differences (Show-Images), as
described earlier267. The total
volume of hyperintense lesions
seen on the T2 images was
calculated, as were regional lesion
loads in the four main brain areas
(frontal, parietal, temporal and
occipital).
fMRI data were analysed with
SPM99b [www.fil.ion.ucl.ac.uk/
spm/spm99.html]. The EPI data
were realigned and normalized
(and resliced to 3x3x3 mm) to the
standard SPM EPI template
coordinate space approximating
the Talairach and Tournoux
space252. Next, the data were
smoothed using a Gaussian filter
set at 8 mm full width at half-
maximum (FWHM). The data of
each subject were modelled using a
box-car function, representing the
easy and difficult planning and the
control stages, convolved with the
standard SPM haemodynamic
response function85. For each
subject the following contrasts
were calculated: a) planning versus
control stages, b) easy planning
versus control stages (EP > C), c)
difficult planning versus control
stages (DP > C) and d) difficult
planning versus easy planning
stages (DP > EP) and e) easy
planning versus difficult planning
stages (EP > DP). Each subject’s
“contrast images”, representing the
d i f f e rence  maps  be tween
conditions, were then used for
further statistical group analysis.
For each contrast (a,b,c,d and e)
the group average brain activation
was calculated with a one sample t-
test in MS patients and controls
using the individual contrast
images, known as random effect
analysis. For each contr ast,
comparison of groups (MS versus
controls) was performed with a
two-sided two sample t-test. A p-
value of 0.005 (at voxel level,
unco r r e c t ed  for  m u l t i p le
comparisons) was considered
significant for all tests.
The individual contrast images
were also used in correlation
analyses with lesion load and test
score as regressor, to test for either
positive or negative correlations
between regressor and signal
difference in a specific contrast.
In a second analysis, the same
contrasts as calculated for the
group were also calculated for each
subject separately, af ter a
smoothing with FWHM of 6 in
stead of 8 mm. The individual
activation maps were calculated
applying a p-value of 0.005 per
voxel, with a 3D-cluster restriction
of at least five adjacent active
voxels. For the five areas with the
highest volume of activation in the
group analysis, the percentage of
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subjects showing activity in that
particular area was determined.
In a third analysis, we used a region
of interest (ROI) approach to
analyse the data. We defined ROIs
corresponding with the active areas
of the group activation map of the
healthy controls. For all voxels
contained in a given ROI, the
number of active voxels of the
contrast image was determined in
each individual, with AFNI9850.
The number of voxels in MS
patients and controls, which were
normal l y distr ibuted, were
compared with Student’s t -test
(w i th p < 0 .05) .  Those
measurements were also correlated
with the test score and the lesion
load measurements and entered
into a multiple regression analysis
with test score, age, disability score
and lesion load as regressors.
RESULTS
All patients and controls
performed the test without
t e c h n ica l  p rob le m s .  T h e
behavioural test scores of the
Tower of London test were
significantly worse for the MS
patients than for controls [table II].
This was most evident for the
scores of the easy planning stage (p
= 0.006). The scores of the
difficult planning stage were
relatively low in both groups,
indicating a ceiling effect261.
Table II
Test results.
















16.1 70.46 % 18.14 % 22.0 79.48 %  7.51 % .039
       Easy 9.0 62.43 % 26.43 % 11.8 81.05 % 12.84 % .006
     Diffic 7.1 34.28 % 24.43 % 10.2 35.73 % 22.89 % .846
Control 38.0 75.92 % 24.11 % 55.4 85.25 %  6.49 % .088
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The mean total lesion load of the
MS group was 9.4 cm3 (range 0.6 -
36.4). The correlation of the total
lesion load with the sum of the
frontal and parietal lesion load was
very high (R = 0.95, p < 0.001).
We did not find a correlation
between test score of easy and
difficult planning and total lesion
load, frontal lesion load or parietal
lesion load.
General effect of planning: main effects for
whole brain analysis.
The planning versus control stages
contrast (planning; (EP+DP) > C)
of the healthy control group
showed activity in the frontal and
parietal lobes as well as the
cerebellum. In the frontal lobe the
activation was located in the
middle frontal gyrus bilaterally and
the left superior frontal gyrus.
Activated areas in the parietal lobes
included the precuneus bilaterally
and the supramarginal gyrus/
inferior parietal lobe bilaterally. In
the cerebellum and the right
inferior temporal gyrus, some
smaller activated areas were found
additionally [table III, figure 2a].
In the MS subjects essentially the
same areas in the frontal and
parietal lobe were active. The
cerebellum showed quite extensive
activation. Smaller activated areas
w e r e  s e e n  i n  th e  l e f t
parahippocampal gyrus, the right
thalamus and the middle temporal
gyrus on the right side [table III,
figure 2b]. The apparently greater
activation in the MS group
suggested by visual inspection
(compare figure 2b with 2a) did
not reach statistical significance in
a direct comparison with controls
by means of a two sample t-test in
SPM. In a further analysis we
compared the quartile of MS
patients with the worst test score
against those with the best score.
Again, this comparison did not
reveal significant differences
between groups. Similarly, when
comparing the quartile of patients
with the lowest and those with the
highest lesion load, no significant
difference in activation was found.
Easy versus difficult planning.
We also investigated the influence
of the difficulty of the presented
planning problems. For the easy
planning versus control [EP > C]
as well as the difficult planning
versus control [DP > C] contrast
the same areas were active as was
the case for both planning stages
together [(EP+DP) > C]. This was
true for the healthy control group
as well as the MS patients. This
may reflect the ceiling effect
observed in the behavioural data,
and others have suggested studying
those levels of complexity in a
pa ramet r i c  des i g n 2 6 1 .  No
differences between the MS and
healthy controls groups were
found for these contrasts with a
two sample t-test.
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Table III
Activated areas in MS and controls: Planning (easy and difficult
combined) vs control stage. (transformed to Talairach coordinates)
Controls
cluster voxels Area
voxels max T p-value coordinates
287   6.17 .015 53 -57 33 R Parietal lobe, Supramarginal
Gyrus
339   6.09 .007 6 -62 34 R Precuneus
283   5.52 .016 -42 -71 39 L Precuneus, Inferior Parietal
Lobule
107   5.42 .315 -18 29 54 L Superior and Middle Frontal
Gyrus
178   4.88 .090 33 34 45 R Middle Frontal Gyrus
59   4.12 .689 -39 -69 -35 L Cerebellum, Inferior Semi-Lunar
Lobule
87   3.98 .445 36 -63 -38 R Cerebellum, Inferior Semi-Lunar
& posterior lobe
22   3.30 .972 48 -16 -27 R Inferior Temporal Gyrus
MS patients
cluster voxels Area
voxels max T p-value coordinates
317   6.16 .010 45 -62 39 R Inferior Parietal Lobule
560   6.04 .001 -36 17 43 L Superior and Middle Frontal
Gyrus
274   5.24 .019 39 -54 -39 R Cerebellum, Posterior Lobe,
Tonsil & Pyramis
1182   5.07 .001 3 -53 -19  R Cerebellum, Anterior Lobe,
Culmen
250   4.76 .027 -45 -53 47  L Inferior Parietal Lobule
434   4.44 .002 30 37 45  R Middle Frontal Gyrus
344   4.38 .007 9 -56 44  R Precuneus
122   4.02 .237 -24 -35 5  L Parahippocampal Gyrus
24   3.78 .958 0 -15 1  R Thalamus
11   3.35 .995 59 -4 -14  R Middle Temporal Gyrus
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The difficult versus easy planning
[DP > EP] contrast revealed
activation in the right superior and
middle frontal gyrus, the left insula
and the left and right superior
temporal gyrus for the control
group and only in the left superior
frontal gyrus for the MS group.
The reversed contrast (areas more
active during the easy than the
difficult stages [EP > DP]) showed
activated areas in right inferior
frontal gyrus, the right precuneus,
the left fusiform gyrus, the left and
right middle occipital gyrus and the
cerebellum bilaterally for the
control group and in the right
precentral gyrus, the middle
temporal gyrus bilaterally and the
left side of the pons for the MS
group. A two sample t-test
comparing the results of the two
groups did not reveal any
significant differences for any of
the contrasts. This was also the
case, when comparing only the 19
patients and the 17 healthy
controls which gave answers
during all stages of the test, leaving
out, based on the test score, those
persons that might not have
performed parts of the test as
expected.
Figure 1
Tower of London example screen
Example of the screens shown during the fMRI Tower of  London test. A) shows a
planning stage example; B) shows a control stage example. The figures at the bottom of
the screen represent the answers the subjects have to choose from by responding with
the hand indicated by the arrows.
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ROI based analysis.
To determine the inter-individual
variability, for each activated area
in the group mean, the number of
individuals with activation in that
same area was evaluated.
Considerable inter-indiv idual
variation is present in extent of the
activated areas, and the main areas
seen in the random effect analysis
are active in about half of the MS
subjects (50 %) and controls (> 55
%). When the p-value was set less
strict, more than 80% of the
subjects showed activation in all
the areas active in the group. The
extent of activation in individual
subjects in areas identified by the
group maps was also quite variable.
Subjects in both groups showed
this type of variation, but it was by
visual inspection more pronounced
for the MS subjects.
The results of the ROI analysis
(with AFNI) are shown in table
IV. There was a significant
difference between the MS and the
control group in a direct
comparison for the cerebellar
region (p = 0.01). While a higher
mean number of act ive voxels for
MS patients was also observed for
other regions, these trends were
not statistically significant. As for
the whole brain analysis, no
significant correlation was found
between the number of voxels
defined ROIs, and the lesion load,
test score, disability score or age.
Table IV
Signal by region MS patients Controls
Mean Mean p-value
Frontal Left 400 388 0.056
Frontal Right 388 444 0.070
Parietal Left 376 256 0.011
Parietal Right 420 360 0.019
Precuneus region 540 496 0.022
Cerebellum 216 92 0.001
Mean percentages of voxels within ROIs as determined on the group maps, significantly
activated in the individual subjec ts.
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DISCUSSION
In this study we used fMRI to
study brain activation during
performance on the ToL in MS
patients and controls. For both
controls and MS patients we found
activation comparable with
previous fMRI135 and PET
studies9,160,170. Our sample of MS
patients, with mild to moderate
disability, performed worse than a
healthy control group on the
Tower of London task (ToL), but
the accompanying brain activity
measured with fMRI was certainly
maintained in the MS group.
Differences between control and
MS groups did not reach statistical
significance.
Both the MS group and the
controls showed the main centres
of activation in the frontal lobes
(left middle and superior frontal
gyrus and right middle frontal
gyrus), the parietal lobes (the
inferior parietal lobe bilaterally and
the right precuneus region) and the
cerebellum bilaterally. Although
visual inspection of cerebral
activity in MS patients and controls
suggested differences, showing for
the MS group more activation in
the cerebellum and right frontal
lobe area, the groups did not differ
significantly  when a direct
stat is t ica l  comparison wa s
performed. In a second, ROI
based analysis, brain activation was
found to be significantly increased
for the MS patients only in the
cerebellum. In many cognitive and
motor studies cerebellar activity is
being reported. Some explain this
as being related to repeated
activities, but a confounding effect
of motor activity could also be an
explanation.
The areas activated during
per forming t his  test  ar e
comparable with those described
in the literature. In a previous
study using the same test135, healthy
young controls also showed
activity in the middle frontal gyrus
and adjacent part of the inferior
frontal sulcus bilaterally, the
p r e c u n e u s - c u n e u s  r e g i o n
bilaterally, the left supramarginal
and angular gyrus and the
cerebellum bilaterally. In that study
activity was also seen in the lateral
occipital gyrus bilaterally, the
anterodorsal part of the left
cingulate gyrus and the anterior
part of the left insula, regions not
encountered in the group’s mean
of the current study. A major
difference between this and the
previous study is the age and
educational level of the healthy
controls, which indicates that
younger and higher educated
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subjects may use additional brain
areas for additional strategies.
It should be noted that the MS
patients scored significantly worse
than controls on the computerized
version of the ToL we used in our
study. Foong et al.80 describe a
comparison of 42 MS patients with
40, age and education matched,
controls in their performance on
several ‘frontal lobe tasks’,
including the regular ToL. As in
our study, they found impairment
in the frontal lobe functions, which
could not be explained by an
intelligence decline. Some of the
test results, especially those of the
more difficult tests, correlated with
frontal lobe lesion load.
The ToL performance score of our
subjects did not correlate with
frontal lobe lesion load (or total
lesion load). Some studies found a
correlation between frontal lobe
lesion load and impaired frontal
lobe functions44,80,227,250. However,
impaired frontal lobe functions
have also been seen in patients
with relatively low frontal lobe
lesion loads44. An explanation
might be that the frontal lobe
functions (the executive functions)
rely on a wide neural network30.
Another possible explanation may
relate to changes in the normal
appearing white matter71,72.
One of the most intriguing
findings in our study is that MS
patients, although performing
significantly worse than controls,
maintain a similar pattern of
cortical activation during a
planning task. This indicates that
reduced performance is not
necessarily associated with reduced
activation, even though quite a few
of our patients had significant
structural brain abnormalities and
marked disability. This paradox
might be explained by subcortical
fibre disruption in the frontal
circuits subserving planning, even
thoug h cortical activ ity is
maintained (and certainly not
diminished). Apparently, this
adequate amount of cortical
activity in the MS patients is not
translated into adequate executive
function in these mildly to
moderately  disabled patients.
However, the great inter-individual
variation in both groups, could
have limited the statistical power to
detect possible existing differences
between the two groups.
In earlier stages of MS it has
previously been found that patients
with minimal disability have
enhanced cortical activation under
certain conditions, and are thus
able to functionally compensate for
(subcortical) brain damage24,25,206,218.
Some of these studies even indicate
that the amount of brain activation
is significantly associated with T2
lesion load, an observation we can
not confirm on the basis of our
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data. We can only speculate that in
our patients with more advanced
disease and consequently higher
lesion loads these compensatory
mechanisms have been exhausted
or are counteracted by the fact that
tissue damage, once reaching a
certain level, limits the possibility
for more extended activation.
Figure 2
Random effects analysis of the planning versus control stage group map
a) healthy controls
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b) MS patients
Transverse slices of the group activation maps using a random effects analysis (p =
0.05). Left side of the images represents left side of the subject (view f rom above). Note
that the areas that are activated, are roughly similar for both groups, but appear slightly
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We studied the use of functional MRI (fMRI) with visual stimulation.
METHODS
Studied in nine patients with unilateral optic neuritis. Eight healthy
subjects served as controls.
RESULTS
Patients showed reduced activation upon stimulation of the affected eye,
on average 33% (range 0 to 156%) of the average monocular act ivation in
the control group. Decreased activation was also seen for the unaffected
eye (61% of control values, range 3 to 133%). 
CONCLUSION
We conclude that fMRI with visual stimulation is feasible in patients with
optic neuritis and deserves future study.
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INTRODUCTION
O p t i c  n eur i t i s  ( O N )  is
characterized by monocular visual
failure with a relatively rapid onset
(hours to days). Typically, recovery
of the clinical symptoms occurs
within days or weeks. However,
s o m e a b n o r m a l i t i e s ,  l i k e
diminished colour vision and
reduced contrast perception, can
persist for a longer period. In
unilateral ON, not only the
clinically involved eye but also the
other eye usually shows MRI
abnormalities55.
Functional MRI (fMRI) measures
changes in MRI signal that occur
upon brain activation caused by
the changes in the concentration
of deoxygenated haemoglobin169.
We investigated the feasibility of
fMRI of visual activation patterns
in patients with unilateral ON.
METHODS
Subjects
We examined nine patients with
the clinical diagnosis of clinically
strictly unilateral ON, without a
history of previous visual failure
(mean age 33 years, range 23 to 43;
5 men). On the day of scanning,
best-corrected visual acuity
(distance vision) was determined
with the Snellen chart and ranged
from 0.17 to 1.0 for the affected
eye (1.0 is perfect acuity; average
0.75). The unaffected eye had
visual acuity equal to 1.0 in all
patients. Onset of visual failure
occurred 7 days to 12 years before
scanning. Eight patients were
diagnosed with relapsing-remitting
MS (mean time of diagnosis 3.25
years before scanning, range 9
years before to 6 months after).
One patient was examined in two
separate sessions, first in the acute
phase (acuity = 0.60) and 10 days
later after recovery (acuity = 1.0).
Eight healthy volunteers, each with
visual acuity of 1.0, without ocular
refraction anomalies, history of
vision loss, or colour blindness,
served as controls (mean age 31
years, range 21 to 39; 6 men).
Data acquisition
Imaging was performed with a
1.5-T MR unit. For functional
imaging, a gradient echo, echo
planar imaging (EPI) sequence
(repetition time: 4 seconds; echo
time: 64 msec; flip angle: 90/,
resolution: 1.56 × 3.13 mm,
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interpolated to 1.56 × 1.56 mm)
was used. Twelve 5 mm thick slices
(interslice gap 1 mm), positioned
parallel to the calcarine fissure,
were acquired. Structural imaging
was performed with either a 3-D
gradient echo or a multislice spin
echo T1-weighted sequence.
Visual stimulation paradigm
For visual stimulation, the subjects
were wearing light-emitting diode
goggles that emitted a red
homogeneous light flashing at 8
Hz. First, both  eyes were
stimulated simultaneously (BES)
with an on/off paradigm: 12 EPI
scans were acquired at rest
(darkness, 4 seconds per scan, 48
seconds total),  10 during visual
stimulation (40 seconds total), 10 at
rest, 10 during stimulation, 10 at
rest. Second, each  eye was
stimulated separately in a random
order among subjects: 102 EPI
scans with the same on/off
periods were acquired. The first
two EPI scans were discarded for
the analysis.
Table I
Data of activation in the control group (n = 8)
Control no. ACT% left ACT% right ACT% both ASYM%
1 0.85 0.70 0.92 0.10
2 0.61 1.08 0.51 0.28
3 1.08 1.23 1.38 0.07
4 1.40 1.21 1.01 0.07
5 0.97 1.25 1.15 0.12
6 0.86 1.35 0.85 0.22
7 1.18 0.80 0.95 0.19
8 0.24 1.18 1.22 0.66
average 0.21
Relative activation (ACT%) is calculated by dividing the size of each control’s activated
volume by the total average in the control group. The last column shows the relative
asymmetry between left- and right-eye stimu lation (ASYM%).
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Data analysis
A 3-D matching procedure was
performed to correct for small
motion artifact287 and the first and
last image of each scan was
discarded. Activation was detected
by cross-correlating pixel time
curves with a box car function10
shifted in time over 4 seconds (1
scan) at onset and 8 seconds (2
scans) at offset of stimulus to
account for the haemodynamic
response delay. Per voxel,  p = 2 ×
10-5 (assuming Gaussian variance of
noise about the box car function10,
and only clusters of at least 4
side-connected voxels were
included in the activation maps,
thereby increasing statist ical
significance81. Relative activated
v o l u m e s  ( A C T % )  w e r e
determined: with BES, the size of
the activated volume in each
patient was divided by the average
volume activated during BES in
the  control  gro up.  With
stimulation of the unaffected eye
separately (UES) and the affected
eye separately (AES), the size of
the activated volume was divided
by the total average activation in
the control group upon stimulation
of the left and right eye separately.
Furthermore, in each subject the
relative difference between left-
and r ight -eye  s t imu la t io n
(ASYM%) was calculated by (|left
- right|)/(left + right).
RESULTS
Analysis of amplitude and timing
of signal response of activated
voxels did not show differences
between patients and controls or
between UES and AES.
Stimulation of both eyes together.
The average activated volume in
the control group was 15.4 cm3,
ranging from 7.9 to 21.3 cm3 (table
I shows breakdown of relative
contribution). The data of one
patient (no. 1) were lost because of
a computer error. In the total
patient group (patients 2 to 9 [first
observation], patient 1 omitted),
the average ACT% was 68% (range
3 to 150%, table II). Only one
patient (no. 6) had ACT% greater
than 1.0. Patient 9, who returned
for a second examination after 10
days, showed an increase of ACT%
from 3% (first examination, acuity
= 0.60) to 11% (second
examination, acuity = 1).
Recovered patients (patients with
acuity $ 0.80 who also reported
recovery subjectively, nos. 1, 2, 5,
6, 7, 9 [second observation])
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  Table II
   Patient data
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Figure 1
Example of an activation pattern in the occipital regions of 8 of the 12 scanned slices
for control subject 5 of table I (two upper rows, A) and patient 5 from table II with an
acuity of 1.0 (two bottom rows, B) during stimulation of both eyes together. Activation
maps are superimposed on structural images (A: spin echo; B: gradient echo), and the
colour bar on the right shows the colour-coded corre lation coeffic ients. The patients
shows much smal ler activated volumes.
Figure 2
Activated volumes of the control subject (top) and the patient (bottom) in figure 1 in
two slices near the calc arine sulcus. Ye llow areas are activated with both stimulation of
the left and the right eye. Blue areas are only activated with stimulation of the right
(control) or affected (patient) eye, whereas the red voxels show significant signal
increases only with stimulation of the other eye. The healthy control shows more
activation and a smaller di fference between left and right than does the patient.
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showed more activation on average
(ACT% = 75%) than did non-
recovered patients (ACT%= 34%),
although activation remained
reduced compared with controls
(100% by definition) (figure 1).
Monocular stimulation.
The average activated volume in
the control group was 11.8 cm3,
ranging from 2.9 to 16.4 cm3 (see
table I for breakdown of relative
contribution). One patient (no. 8)
showed motion artifacts, and the
data were not used in the analysis.
All controls showed a relative
difference in activation between
left- and right-eye stimulation
(average ASYM% 21%, range 7 to
66%).
With AES in the patient group, the
average ACT% was 33% (see table
II). Also with UES, a smaller
activated volume was seen; ACT%
was 60% on average. ASYM% was
61% (range 8 to 100%). Average
activation was highest in the
recovered group for AES
(recovered: ACT% = 36%; not
recovered: ACT% = 17%) and also
for UES (recovered: ACT% =
60%; not recovered: ACT% =
44%) (see table II). The recovered
patient with ACT% > 1.0 in all
three paradigms (patient 6) was the
only patient showing more
activation with AES than with
UES. Note that patient 9 showed
an increase of activation after
recovery, both for AES (ACT%
increased from 0 to 6%) and UES
(ACT% increased from 3 to 7%).
In figure 2 activation patterns of
left- and right-eye stimulation are
shown for a healthy subject and
the patient in figure 1.
DISCUSSION
In unilateral ON patients,
stimulation of the affected eye
results in a smaller activated
volume in comparison with the
unaffected eye, even when patients
have recovered visual acuity.
Furthermore, stimulation of the
unaffected eye shows a decreased
volume of activation compared
with controls. The results show a
trend for recovered patients to
display more activation than non-
recovered patients, both for the
affected and the unaffected eye.
One recovered patient showed
discrepant data, giving more
activation than controls and more
activation for the affected eye than
the unaffected eye.
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Although differences in activation
between the two eyes are also seen
in healthy subjects (probably
caused by eye dominance225,
patients showed much larger
differences. Disturbed conduction
at the level of the optic nerve of
the affected eye will result in
decreased activation in the visual
cortex. The observed reduced
activation during UES is in
agreement with visual evoked
potential findings84,191. Apparently,
not only the clinically affected eye
but also the other eye shows visual
disturbances. Possibly this optic
nerve is less "unaffected" than
presumed. Another explanation
might be that neurons responding
to input from both eyes show
decreased activity when stimulated
only by the unaffected eye in case
of a history of unilateral ON.
Difficulties remain in drawing
conclusions from these results;
eight of the nine patients suffered
from MS and probably had
different lesions. Time constraints
precluded extensive conventional
imaging, and we therefore could
not correct for this confounder.
Furthermore, visual acuity was
m e a s u r e d  i n  s u b o p t i m al
circumstances with a Snellen chart;
nearby vision, visual field defects,
and other determinants were not
taken into account. By definition,
visual acuity before the ON was
unknown, as  wa s  ocular
dominance225.
However, the purpose of the pilot
was to determine the feasibility of
fMRI with visual stimulation in
patients with ON. The fact that
marked differences were found
between affected and unaffected
eyes as well as between controls
and patients suggests that fMRI
studies may be useful to further
study ON. We suggest that future
studies focus on patients with
acute ON, without a diagnosis of
MS, and include longitudinal
follow-up. Also, more extensive
neurophysiological testing (nearby
vision, visual field, as well as
contrast and colour vision defects),
a n d f a t - su ppress i o n  M RI
techniques for visualizing the lesion
in the optic nerve, may be useful to
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Cannabis is widely used by multiple sclerosis (MS) patients to relieve pain
and spasticity, although the exact effects of Cannabis on brain
functioning are not well known. We performed a pilot study using
functional magnetic resonance imaging (fMRI) to study the effects of
Cannabis on cognitive and motor functions in MS patients.
METHODS
Seven subjects with progressive MS were scanned in a randomized
fashion, after intake of an extract of Cannabis sativa or placebo. The
subjects performed an attention and information processing task, a motor
task and as a negative control, a visual task. Group analyses included the
effects of drug and order of administration. In individual subjects the
spatial extent of activation was studied, and a change of 20% considered
as being significant.
RESULTS
In most subjects the same regions were activated during both
administrations, especially for the visual light flash paradigm. The group
analysis showed no significant effect of Cannabis or order of scanning in
any of the tasks. On an individual level, especially during the cognitive
and motor task, differences in the spatial extent of activation were found:
in some subjects the extent of activation increased after Cannabis intake,
while in others it decreased.
CONCLUSION
No systematic effects of Cannabis could be established at a group level.
In agreement with previous PET studies, our fMRI data suggest that this
may be caused by interindividual differences in brain activity changes,
indicative of a heterogeneity in pharmacological and clinical effects.
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INTRODUCTION
Multiple sclerosis (MS) is a chronic
inflammatory and demyelinating
disease of the central nervous
system. The clinical manifestations
can include almost any neurological
symptom, including motor
p r o b l e m s a n d  c o g n i t i v e
dysfunction. Surveys suggest that
there is widespread use of
Cannabis among patients with MS
for relief of disturbing symptoms,
especially pain and spasticity.
Despite the fact that Cannabis is
known to alter brain functioning,
and is used by many patients, the
exact effects of Cannabis on the
human brain are not well known.
Beneficial effects, mostly on
spasticity or tremor, have been
described in some small groups or
case studies7,45,153,234. Those studies
have suggested a range of
applications for cannabinoids in
MS, including the alleviation of
muscle spasms, tremor, ataxia and
bladder dysfunction. Side effects
have also been recognized,
especially in intoxicated persons,
and those include problems with
short-term memory and attention,
motor skills and reaction time, and
skilled activities (including frontally
localized functions).
In a randomized, double-blind,
placebo-controlled, two-fold cross-
over study of 16 patients120, it was
unable to demonstrate any
significant improvement of signs
and symptoms by treatment with
orally administered cannabinoids.
However, several recent and much
larger studies, using the same
products, show a trend in favour
of active treatment on subjective
outcome measures of pain and
spasticity268,289.
Several recent PET studies
demonstrated significant Cannabis
effects on brain functioning in
healthy subject26,147,148,149,166,272.
However, for obvious reasons this
invasive and time demanding
technique can not be repeated
frequently. This is however a
necessi ty to acquire more
knowledge about the in vivo
effects of Cannabis on cognitive
and motor functions. Therefore we
performed a feasibility study using
functional MRI (fMRI), which is a
non-invasive  brain imaging
technique based on differences of
magnetic properties of oxygenated
and non-oxygenated haemoglobin.
fMRI measurements can be
repeated many times without side
effects.
In this study we investigated in MS
patients brain activity after intake
of Cannabis.  During fMRI
scanning subjects performed three
tests: a cognitive task, a motor task
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and a visual task. We hypothesized,
based on the cannabis effects
described above, to find globally
different patterns of activation
when using cannabinoids in
comparison with a placebo,
especially in the cognitive task and
the motor task. The visual task was
merely used as a control condition.
METHODS
Subjects
We studied 7 MS patients (6 M / 1
F), with a mean age of 49.1 years
(range 42-56 years). All subjects
had a diagnosis of clinically definite
MS192, all more than 10 years ago.
All had progressive disease (5 PP, 2
SP); the median EDSS was 6.5 (4.0
- 7.5). All had previously used
Cannabis for short periods of time,
but all stated not to have used it in
the last six months. The only
regular used medication by four of
the subjects was anti spasm
medication.
The subjects underwent two
identical fMRI examinations, with
a one week interval. One hour
before scanning they took, orally,
placebo or Cannabis sativa plant-
extract (which contained a
s t an dard ized de lt a - 9 - t e t r a-
hydrocannabinol (THC) content
(10 mg), 20 to 30% cannabidiol
and less than 5% other
cannabinoids  (Soc ie ty  fo r
Oncological and Immunological
Research, Germany))120,268,289. The
order of intake of study medication
was blinded and based on
randomization. However, they all
could tell afterwards at which time
they received the Cannabis capsule.
The subjects were selected for
adequate hand function and vision
in order to allow compliance with
study procedures. All subjects were
right-handed.
The ethical review board of the
Vrije Universiteit Medical Center
Amsterdam approved of the study
and all subjects gave informed
consent.
Data acquisition
Imaging was performed on a 1.5 T
MR system with a standard
circularly polarized head coil. A
whole brain echo planar imaging
(EPI) sequence (4 seconds (TR),
64 ms (TE), 1 excitation, flip angle:
90/, matrix size: 64 x 128,
interpolated to 128 x 128 mm, field
of view: 220 x 220 cm, slice
thickness: 4 mm, interslice gap:
1.02 mm, number of slices 23) was
used. The stimuli were projected
on a screen, viewed by the subject
via a mirror placed on top of the
head coil in the magnet bore. 
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fMRI paradigm
During each fMRI session three
tests were performed. The first test
was an attention and information
processing task, an adaptation for
fMRI of the Paced Auditory Serial
Addition Test (PASAT)134. This
fMRI test contrasts a ‘memory-
and-adding’ stage to a control
stage. During the ‘memory-and-
adding’ stage the subject performs
a task in which every digit
presented must be added to the
preceding one. The auditory cues
in the adding stage of the original
PASAT test were replaced by
sequentially presented visual digits
in the center of the screen, and the
subjects were instructed to
mentally process these digits but to
refrain from vocalizing the
answers. During the control stage,
subjects had to fixate on a cross
located in the center of the screen
and were instructed to pay
attention to the moment a digit
was presented again, which was the
moment the adding stage resumed.
T h e  a d d i n g s t age s  we re
administered at four different
speeds, the control stage at one
speed. Each stage lasted 84
seconds (21 scans). The order of
administration was: Add (3.8 sec
per digit) - Add (3.2 sec per digit) -
Cont (2.6 sec per cross
presentation) - Add (2.6) - Add
(1.9) - Cont (2.6) and this whole
sequence was repeated one time.
The motor task was second in line.
Via an instruction on the screen,
subjects were asked to either
per form sequent ia l  f inge r
opposition with both hands
simultaneously, or to lie quietly in
the scanner. The active part was
self-paced to ensure that subjects
were able to maintain the
movements during a block of 40
seconds (10 scans). The movement
stage was performed 5 times, with
4 stages of rest in between (also
lasting 40 seconds).
The third and final task was a
simple visual stimulation test in
which the subjects had their eyes
open, wearing light emitting diode
(LED) goggles (Grass Instruments,
Quincy, Mariland). The goggles
produced light flashes at a
frequency of 8 Hz stimulating the
full field of view of both eyes.
Blocks of visual stimulation lasting
40 seconds (10 scans), were
alternated with equally long periods
of total darkness (4 times each),
beginning with visual stimulation.
Data analysis
The fMRI data were analysed with
S P M 9 9 b  [ A v a i l a b l e  v i a
w w w . f i l . i o n . u c l . a c . u k /
spm/spm99.html]. The MRI EPI
data were realigned and normalized
(and resliced to 3x3x3 mm) to the
standard SPM EPI template
coordinate space approximating
the Talairach and Tournoux space
252. Next, the data were smoothed
using a Gaussian filter set at 6 mm
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full width at half-max imum
(FWHM). The data of each subject
were modelled using a box-car
function, representing the different
test stages, and convolved with the
standard SPM haemodynamic
response function85.
Brain activation during Cannabis
was compared to placebo for each
test a) using a fixed effects analysis
(p < 0.05, corrected for multiple
comparisons)  and b) using
individual contrast images within
the framework of a random effects
analysis with a paired t-test (p <
0.05, corrected for multiple
comparisons).
Secondly, activation maps were
calculated applying a p-value of
0.005 per voxel , with a 3D-cluster
restriction of at least five adjacent
active voxels. The number of
activated voxels during the
Cannabis and placebo session were
compared, for each task, using a
paired sample t-test (p < 0.05).
Thirdly, individuals were analysed:
activat ion change between
Cannabis and placebo on an
individual level was defined
significant when there was more
than 20% difference in the number
of activated voxels between
sessions.
RESULTS
A summary of activation volumes
for all three tests is provided in
table I.
The information processing task was
successfully administered and
scanned twice in six subjects; the
seventh subject was unable to
perform the test. In those six
subjects, the first and second
session showed activation in the
frontal and parietal lobe, as well as
the cerebellum.
No significant differences were
found between Cannabis and
placebo in any of the statistical
tests described in the method
section. Individual analysis learned
that there were less activated
voxels in three subjects and more
activated voxels in one subject
during Cannabis as compared to
the placebo session. As shown in
table I and figure 1, in some
subjects individual changes are very
marked, sometimes exceeding
100% of baseline activation.
The motor task was scanned without
problems in six subjects for both
sessions. In one subject the data
could not be used because of
movement of the head during the
motor stages. This task showed
reasonably consistent sensomotor
cortex and cerebellar activation in
four subjects during both sessions,
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Table I
Activated volumes (number of voxels) during cognitive, motor and visual
stimuli.
Characteristics
nr type EDSS age sex
1 PP 6.5 50 F
2 SP 7 42 M
3 PP 6 53 M
4 PP 7.5 52 M
5 PP 4 46 M
6 PP 4 45 M
7 SP 7 56 M
The patients characteristics describe
the MS type, the EDSS (expanded
disability status scale as measure of
disease severity), the age and the
gender of the subjects. The columns
cognitive, motor and visual describe
the activated volumes during those
tests. In the column comp the session
with the highest volume of activity is
indicated. Whereas Plac or Cann
implicate that the placebo or the
Cannabis session showed more than
20% increase in activated volume
compared to the other session, eq
indicates the absence of a 20%
difference (n.a. is not available). The *
indicates that changes in activation on
the visual task were due to changes in
the areas outside the occ ipital cortex.
Cognitive Motor Visual
nr Cann. placebo comp Cann. placebo comp Cann. placebo comp
1 5352 6281 eq 7061 4457 Cann 1626 2345 eq *
2 4244 4094 eq n.a. n.a. n.a. 15408 3888 eq *
3 3916 12202 Plac 779 1992 Plac 1947 1774 eq
4 3085 4661 Plac 10104 4651 Cann 6830 6950 eq
5 28130 7156 Cann 9842 9304 eq 5714 9907 eq *
6 10423 15578 Plac 5935 10724 Plac 5892 6003 eq
7 n.a. n.a. n.a. 22058 11297 Cann 4404 4977 eq
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Figure 1              Informat ion processing task; example of one pat ient
Results of the information processing task of one subject (nr 5): Cannabis (upper)
and placebo (lower) session. Red and orange are the voxels significantly  activated.
Figure 2             Motor task; example of one pat ient
Results of the motor task of one subject (nr 1): Cannabis (upper) and placebo (lower)
session. Red and orange are the voxels significantly  activated.
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while one subject had only small
areas of significant activation in
both sessions. The extent of the
activation was variable across
sessions and subjects (example
shown in figure 2). None of the
group compar isons revealed
detectable difference between
Cannabis and placebo. Individual
analysis showed more activated
voxels during the Cannabis session
in three subjects, while in two
subjects the placebo session
showed more activated voxels.
The visual task showed consistent
activation of the visual cortex in six
subjects during both sessions. The
seventh subject showed activity
during only one session. No
significant group differences were
found. There were no subjects
with more than 20% difference in
the occipital regions between
sessions. Besides activation in the
visual cortex, some subjects
showed also activation in the other
lobes, especially during the
Cannabis session.
Most subjects could not report
major behavioural or cognitive
changes during both the test
sessions. Only one subject had
experienced some hallucinations
after intake of the test medication
(appeared to be Cannabis).
DISCUSSION
There presently is considerable
interest in the therapeutic use of
cannabinoids in MS. Recently,
several studies have been
performed that address the clinical
effects and mechanisms of action
o f  c a n n a b i n oi d s  i n  MS
8,45,119,120 ,153 ,234. Although the
comp l ex  b iology  o f  t h e
cannabinoid system is becoming
clearer, the understanding of how
these compounds exert their action
in MS is still in its infancy. Building
on previous PET studies in healthy
subjects, we here present the first
study investigating Cannabis effects
on brain functions in MS subjects
with the use of fMRI, a non-
invasive neuroimaging technique
with the possibility of repetition as
great advantage.
The three fMRI tests used,
evaluating cognitive, motor and
visual function resp ectively ,
showed activated areas at expected
locations in most subjects. In
individual subjects differences
when comparing activation after
intake of Cannabis and placebo
were striking, sometimes exceeding
100%. However, not one of the
three tests, showed significant
group differences when comparing
Cannabis with placebo intake.
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Mainly because the Cannabis
effects were not uniform across all
the subjects. The observation that
individuals show d i f ferent
responses on Cannabis is in line
with other observations in clinical
studies7,45,120,121,153,234 and PET
studies26,147,148,149,166,272. We assume
that this individual variability is the
main explanation for the absence
of a global Cannabis effect when
compared to placebo. This is also a
possible explanations for the
differences between the results of
clinical studies and the benefits
most subjects experience.
Relevant factors underlying this
individual variability are the uptake
of Cannabis and its metabolites,
especially after oral intake, the
availability of THC, the way in
which Cannabis and its metabolites
work and the density of the
different types of receptors. The
availability of THC, one of the
major effective compounds of
Cannabis, has a great inter-
individual variability289. The
absorption of THC in the gut is
reasonably good, but the process is
unpredictable in time. The delivery,
therefore, is widely variable103.
Pharmacological studies report a
biphasic dose-dependent effect of
THC. Low dosages mainly inhibit
the CB1 receptors, while high
dosage s h ave  st imu la t in g
effects7,120. Besides THC, the
Cannabis extract used, contains
other cannabinoids which roles
also  a r e  n o t  c o m p le te ly
understood.
Cannabis can induce changes in
blood flow through a variety of
mechanisms. Besides an altered
brain functional activity (diffuse or
more local in origin with secondary
involvement of other brain areas),
this could include relaxation of
vascular smooth muscle and
alterations of the sympathic/
parasympathic equilibrium. In
combination with differences in
spread of Cannabis receptors, this
could explain the difference in
reaction on Cannabis intake. The
effects of the MS disease process
on  receptor density are unknown.
As mentioned, PET studies
focussing on glucose metabolism
and cerebral blood flow, also
showed that Cannabis effects are
not uniform across healthy
subjects. Mathew et al.148, using
15O-water PET as a tracer to
measure CBF, demonstrated an
increase in activity of the brain,
especially in the frontal cortex
bilaterally, the right insula, and
cingulate gyrus, the basal ganglia
and thalamus, after intravenous
THC. For the group receiving a
high dose of THC (0.25 mg/min
iv) this was the case after 30
minutes, and for the low dose
group (0.15 mg/min iv) after 60
minutes. In neither group the
occipital cortex showed an increase
of activation (not at 30 minutes,
nor at 60 minutes). These authors
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also found considerable variation
in the activation across subjects.
The high dose group showed
differences in activated areas after
30 minutes compared to 60
minutes. Another study by Mathew
et al.149 globally described the same
results, again with considerable
individual variation.
Using 18F-FDG to measure glucose
m e t a b o l i s m , Vo lkow an d
colleagues 271 showed an increase
of metabolic activity in the
cerebellum after intravenous THC
injection, while total brain global
changes in cerebral glucose
metabolism were variable: three
subjects showed an increase, three
a decrease, and two showed no
c h a n g e s  f o l l o w i n g  T H C
administration. In a comparable
experiment of PET glucose
metabolism, these authors272
showed a variable Cannabis effect
comparing sessions before and 24
hours after intravenous THC
administration. In 7 subjects an
increase of more than 10% was
found, in 5 subjects a decrease of
more than 10% and in 6 subjects a
smaller change (less than 10%
difference) was found. The results
described above were a l l
performed with the subjects in a
resting state, without them
completing a task.
O’Leary et al.166 performed a PET
CBF study with a dichotic listening
task, with focussed attent ion
instructions, before and after
smoking a Cannabis cigarette. In
three subjects the test showed an
increase of the mean whole brain
blood flow, while in two subjects a
decrease was noticed. As a group,
the five subjects showed an
increase in activation in the
superior temporal gyri bilaterally, as
well as in ventral en mesial parts of
the frontal lobe, the insula,
temporal lobe and the cerebellum,
and a decrease in the motor cortex,
the left precuneus, the right
occipital lobe and the vermis of the
cerebellum. Unfortunately, the
manuscript does not provide
information on how consistent
these findings were between
individual subjects.
In our data we noted that the
Cannabis effects depend upon the
sort of test performed. In a
questionnaire by Consroe et al.45 it
was also noted that subjects report
a high degree of variation over the
total range of symptoms asked for
when using Cannabis. Our
“control test”, a simple visual
stimulation task showed far less
changes in activated voxels,
showing that not all functions
changed in the same degree during
Cannabis use.
Our study was limited by the small
sample size and suggests that
further studies should considerably
increase the number of subjects
studied. Another limitation is the
use of a fixed threshold to
determine the change on an
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individual level and we suggest to
include at least one more session
to determine interindividual
variability on an empirical basis,
which can be easier performed
with fMRI than with PET. Finally,
other Cannabis preparations,
dosing regimes or pharmacological
assessments may be advantageous
to control for interind ividual
variability. A further missing factor
in our study is the THC level in
blood. This is an important factor
when searching for the exact
effects of cannabinoids. However,
in this feasibility study the main
goal was to show difference in
activation after Cannabis use.
In conclusion, our fMRI pilot
study showed individual differences
after Cannabis or placebo intake.
The direction and magnitude of
the difference depends on both the
subject and the type of stimulus.
This is in agreement with other
da t a ,  a l so descr ibing a n
inhomogeneous effect of Cannabis
on brain functioning. Therefore
significant systematic effects could
less likely be found when
comparing Cannabis and placebo
at a group level.
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CHAPTER 5  




For a good treatment of patients,
understanding the cause of the
disease is needed. To help patients
with their symptoms many aspects
of the disease have to be known.
Multiple sclerosis (MS), being a
diffuse central nervous system
(white matter) disease, has, besides
m o t o r  a n d  a u t o n o m i c
dysfunctions, cognitive impairment
as one of the most important
problems.  Cognitive functions
were, although recognized a very
long time ago, underestimated for
a considerable period of time. The
last two decades, this major
problem for MS patients, received
more attention. More knowledge
about the kind of cognitive
impairment in MS has been
collected since, and MRI has been
used extensively to study cognitive
impairment in MS.
At the time the studies described in
this thesis started, functional MRI,
as a relatively easy to use functional
imaging technique to investigate
brain functions in humans,
presented itself. This technique was
used in studies on (cognitive)
functioning in MS patients.
However, to use this technique in
the setting of a new patient group,
some preliminary work had to be
done. First it had to be shown that
the technique was also feasible in a
MS patient group and specific tests
for MS patients had to be
designed. This thesis contains
some of this preliminary work and
the subsequent studies o f
functional deficits in MS patients.
It has been shown that fMRI can
be used in MS studies, but that
much more appreciation is
necessary for the tests and
circumstances, before larger groups
can be successfully investigated. In
the future this technique can be
used as an objective measurement
for cognitive functioning, for
example in medication studies.
Probably it can give more insight
in pathophysiological processes of
cognitive impairment.
The main research goal underlying
this thesis was to describe
impairment, especially cognitive
impairment, in MS patients, in




COGNITIVE IMPAIRMENT IN OUR MS SAMPLES
The prevalence of cognitive
impairment in our study samples
of MS patients was considerable.
However, since data collection did
not have the goal of an
epidemiologic study, they are not
representative of the prevalence in
a general MS population.
As is known from literature,
different cognitive domains were
found to be impaired in our
patients. The ANT data showed
that attentional domains are
impaired. Deficits in various
attentional domains, i.e. divided,
focussed and sustained attention
were found in the MS patients as
was a slower response speed
compared to controls, even for
simple tasks. When higher
cognitive demands were imposed
in the more complex tasks,
differences in speed between
controls and MS patients increased
dramatically. MS patients were
slower in processing visually
presented information. Deficits in
the peripheral processing stages
(visuo-spatial task and response
organization task) were less
obvious. In addition, MS patients
were more susceptible to
distraction than controls: speed of
p e r f o r m a n c e  d e t e r i o r a t ed
disproportionally in the presence
of distracters (memory search task)
and irrelevant targets (focussed
attention task); both results
reflecting a focussed attention
deficit. In the attentional flexibility
task (divided attention) impairment
was found also. High fluctuations
in the  performance le vel
(differences in tempo during the
sustained attention task) were
found in MS patients. However,
the MS patients were in general
not less accurate than controls. As
was shown earlier, this study also
found that when time is permitted,
MS patients can perform (almost)
equally well as healthy subjects on
most cognitive tasks62,110.
Also  differences i n  t a s k
performance across MS subtypes
were found. The differences in task
p e r f o r m a n c e  w e r e  m o r e
pronounced in SP and PP patients
than in RR patients groups.
Attentional flexibility, response
organization, and visuo-motor
coordin at ion seem to  be
unaffected in the RR patients
investigated in this study.
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COGNITIVE IMPAIRMENT AND MR PARAMETERS
Studies investigating the relation
between cognitive impairment and
MR parameters have shown a
reasonable good correlation, in
general better than the correlation
between clinical parameters and
the MR parameters. Cognitive
impairment is, in terms of the tests
used, a much more diffuse cerebral
process than the c l in ical
parameters accounted for in the
EDSS, which are for a great deal
driven by spinal cord involvement.
As a  conse quence better
correlations were found, especially
those representing atrophy of the
brain and to a lesser degree also for
lesion load parameters.
The cognitive test used, the type of
MS and the sort of MR parameter
for scoring lesions are the major
factors contributing to correlation.
In three studies described in this
thesis a further refinement in
correlations was searched for. In
the Magnims A.1.2 study
( p a r a g r a p h 2 . 2 ,  “Neu ro-
psychological impairment in
multiple sclerosis patients: the role
of (juxta)cortical lesion on
FLAIR”) the goal was to evaluate
whether cognitive impairment was
predicted by (juxta)cortical lesions
as depicted by the FLAIR MR
sequence. One of the goals in the
PsyLiq study (paragraph 2.3, “Brain
atrophy and lesion load as
explaining parameters for cognitive
impairment in multiple sclerosis”)
was to the see whether MR
parameters per region better
predicted cognitive impairment.
The ANT task was used in two
s t u d i e s  ( p a r a g r a p h  2 . 4 ,
“ I n f o r m a t i o n p r o c e s s i n g
characteristics in subtypes of
multiple sclerosis” and paragraph
2.5 “Cognitive slowing in MS is
strongly associated with brain
volume reduction”) to describe
more specific aspects of cognitive
impairment, mainly attention
deficits, in MS patients and to
correlate those results with MR
parameters concerning lesion load
and relative brain volume.
T h e  o v e r a l l  n u m b e r  of
(juxta)cortical lesions (as shown
using a FLAIR sequence) showed a
good correlation with a cognitive
impairment index. Also, it was
shown that this was a better
predictor of cognitive impairment
than total number of lesions seen
on T2 sequences (for which no
significant correlation was found).
Other studies also found a better
correlation between cognitive
impairment and cortical or U-fibre
involvement156.
The regional lesions load analysis
used in our PsyLiq study showed a
correlation with the performance
score (of the test using that
cognitive function) for certain
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regions (supposed to subserve a
selected cognitive function selected
on basis of neuropsychological
literature). However, the study did
not find very strong associations,
probably because the size of the
selected region (too big), the
character of MS as a diffuse
pathology disease and the character
of the (in MS for screening
purposes widely used) cognitive
tasks used. Relative brain volume,
as a measure of brain atrophy,
showed better correlations,
underlining the diffuse nature of
histopathology in MS. However,
that the results are not only
d e p e n d e n t  f r o m  d i f f u s e
pathological processes, was shown
by the absence of significant
correlations with the occipital
region (as hypothesized).
The ANT task results, also showed
correlat ions with the MR
parameters, again better for relative
brain volume than for T2 lesion
load. This may come as no
surprise, since the cognitive
domains tested by the ANT are
likely widely distributed, rather
than localized ones. The cognitive
slowing is a general process.
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INTERPRETA TION OF COGNITIVE IMPAIRMENT MR STUDIES
Although the studies from more
recent years showed better
cor re l a t i o n s be t ween  MR
p a r ameters and cogn i t iv e
functioning parameters, both by
new MRI techniques and more
specific cognitive tasks, the
correlations remain relatively low.
Many aspects of the role of
different lesion types have to be
unravelled yet.
Cognitive functions are more
diffuse processes, rather using
networks across the brain than one
single region. In further research
more specific tests should be used
to evaluate correlations between
number of (juxta)cortical lesions in
a certain area and cognitive
dysfunction in MS patients.
Functional MRI can play a role in
this research field, because it can
locate brain areas active during
given task. The lesion load and
other MR parameters in those
areas can be used for correlations
with test results of the specific
cognitive task.
The cognitive tasks used in the
current MS research are testing
wide spread cognitive functions.
This is caused by the fact that most
cognitive tasks are selected for MS
cognitive impairment screening.
The Brief Repeatable Battery is a
good instrument in discriminating
MS patients from healthy subjects.
The tests in this battery are
selected for that purpose, not to
investigate all cognitive domains
equally well or focus on a specific
cognitive domain. That more or
less the whole brain is involved in
those tests is partly represented by
the presence of strong correlations
with measures of atrophy.
Selecting the right cognitive
function to study is important.
Unpaced, unlimited speed tasks are
far less sensitive in picking up
cognitive functional decline in MS.
In daily living, paced strategies are
important and under too much
time pressure, the MS patient’s
performance declines. Cognitive
deficits in MS are not solely based
on slowing, as this would not
explain (e.g.) the frequent failures
on measures of free recall from
long-term memory in this
group255,290. The purpose of the
study must therefore determine
the sort of task chosen.
Also difficult in investigating the
influence of lesions in cognitive
impairment in MS patients is the
type of lesions that can be made
visible with MRI. Besides T2
visible lesions and brain atrophy,
there exists MS pathology involves
the normal appearing white matter
(NAWM), but also the gray matter,
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and is characterised by resolving
lesions (due to local healing
processe s)  and  func t ional
resolution of lesions (by brain
adaptative processes). Other MR
techniques have to be used to
evaluate those sorts of changes.
Some pathological processes may
be difficult to visualize with MR,
play also a role. For example with
the FLAIR technique, an improved
detection of cortical lesions was
possible, leading to better
correlations with cognitiv e
performance scores.
Finally the type of MS is
impor tant , f i rst ly  becaus e
progressive patients have in general
a longer disease duration, but
secondly because the MS types
have distinctive characteristics in
terms of cognitive impairment; for
example PP type patients have a
distinct cognitive impairment
profile (for example 17,58,101,290).
FMRI TEST DEVELOPMENT
fMRI as a tool in studying brain
function has been introduced more
than ten years ago. Different
neurologic functions, like motor
functioning, visual functions and
different sorts of cogn itive
functions, have been evaluated
using fMRI. Initially no (suitable)
tests were available to test
cognitive functions, let alone tests
that specifically focus on those
areas mostly impaired in MS
patients. To study MS patients
cognitive tasks for use with fMRI
had to be developed first.
Therefore we adapted a well
known cognitive task that
especially needs those cognitive
areas impaired in many MS
patients, the Tower of London
task238. A planning task, such as the
Tower of London, has proven to
be sensit ive to prefrontal
lesions171,210,238. Our adaptation of
this task for fMRI purposes
showed activation during the
planning stages in the dorsolateral
prefrontal cortex, the anterior part
of the cingulate cortex, the cuneus
and precuneus, the supramarginal
and angular gyrus in the parietal
lobe and the frontal opercular area
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of the insula. Areas also found to
be active during the task by
previous PET studies9,171. The
activated areas in those studies and
our study are quite comparable,
although small differences in areas
activated were seen across studies;
a pointer to the influence of
variables like subjects variables and
small test differences on cognitive
functioning. For example some
studies showed, more than others,
activity in areas probably not
activated by the planning process
itself, but by the motor and visual
processes needed to perform a
cognitive task like this. Differences
in this respect have to be mainly
sought in the “rest” (control)
condition of the test.
Before the use of fMRI, a
performance score was the only
outcome measure that was
available. With the advent of fMRI
the size and location of activated
areas are the major outcome
p a r a m e t er s .  H o w e v e r ,  a
performance score is always
welcome to interpret the results. A
disadvantage of outcome scores
can be the influence on the task
results in terms of activated
cognitive areas, because the
production of the performance
score can be also a cognitive
process. Those advantages and
disadvantages have to be weighted
against each other.
In our Tower of London task, we
found it of major importance, also
because of the different levels of
difficulty that can be applied. The
test score is thereby of assistance
in determining whether the subject
has performed the test well.
The second task we developed, was
an adaptation of the PASAT. This
task has often been used in MS
patients and is part of one of the
major scoring systems in MS. We
adapted this test, that assesses
attention, information processing,
visual memory, working memory
and primary calculating abilities for
fMRI. In this adaptation we
choose not to use a performance
score, because this interferes to
much with the test in an fMRI
setting in which certain output
channels, like speech, are much less
easier to use than outside the MR
(because of movement artefacts).
Another problem in the fMRI
block paradigm setting, is the need
for a “resting” (control) stage;
especially problematic in an
attention task. To overcome this
problem as much as possible we
used longer block durations. In the
light of the plausibility of the
activated areas found, we
succeeded in a suitable adaptation.
The brain activity found was
located bilaterally in the superior
and inferior parietal lobe, bilaterally
in the superior frontal gyrus, in the
left medial frontal gyrus, left
inferior frontal gyrus and adjacent
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part of the insula, the cingulate
gyrus (anterior part), and several
cerebellar areas. Areas that are
supposed to be active during such
a task, and comparable with other
studies.
A specific aspect of this attention
task, adding the last digit to the
preceding one for every number
seen, draws heavily on executive
control, because each addition has
to be suppressed and working
memory content  has to be
continuously updated to produce
the correct answers. Brain
networks associated with executive
control include the anterior
cingulate cortex and supplementary
motor area, the orbitofrontal
cortex, dorsolateral prefrontal
cortex, parts of the basal ganglia
and the thalamus23,67,178,193. Visual
information processing has been
found to activate the precentral
gyrus of the frontal lobe, parietal
lobe areas and part of the temporal
lobes46,47,189. Sustained attention,
also needed in this task, is
subserved by right frontal-parietal
areas (right parietal cortex (BA7),
right dorsolateral and middle
frontal lobe and anterior cingulate
g y r u s )  a n d  t h e  l o c u s
coeruleus48,49,102,137,174. Mathematical
functions are supposed to be
subserved by the left parietal lobe.
To investigate changes in brain
activation patterns as a result of
increased task demands, i.e. when
the information processing system
is put under more pressure, we
have applied a parametric design in
which two different speeds of digit
(stimulus) presentation were used.
Comparing the two speed stages,
activation in the right inferior
frontal gyrus, the medial frontal
gyrus (BA6, BA10) bilaterally, the
right cingulate gyrus (BA24), the
left superior parietal lobe (BA7),
the right cuneus/ precuneus
region, the left pulvinar, the right
caudate nucleus and the cerebellum
bilaterally was seen. However, the
individual variation of the speed
contrast was considerable. This
might indicate that the processing
speed is important, and that the
optimal processing speed is not the
same for all individuals. This again
is an indication that fMRI studies




FMRI TEST APPLICATIONS IN PATIENTS
The main problem evaluating
disease pathology with clinical
fMRI studies, is the possibility that
different levels of energy needed
for task performance is the main
explaining factor for differences in
activated areas. The first clinical
MS fMRI studies are mainly
descriptive in nature. The number
of studied patients is in almost all
studies (so far) small. The
presented studies showed globally
the same areas as in healthy
controls are activated in MS
patients, but that the volume of
active tissue is different and
sometimes additional areas are
(more) active. Most of the times in
patients the extent of the
activation is larger, probably
because that brain area has to work
harder, i.e. recruit more neurons,
to compensate for the pathologic
condition. This is also seen in
motor function paradigms218. This
idea is supported by the fact that in
more impaired patients (i.e. higher
lesion loads), who subsequently
need more stamina or 'energy' to
perform the task, larger activated
areas are seen. Some studies have
shown also that brain areas not
activated in healthy subjects
become active (above a certain
threshold), another kind of
adaptive process. This also is seen
especially in more impaired
patients, until this compensating
mechanism also fails because of
the proceeding pathological
process.
Most studies using fMRI in MS
patients have evaluated motor
functioning. Mainly because those
fMRI studies can be performed
with a relatively simple paradigm,
like the movement of one or more
fingers. In more complex tasks the
activity is also situated in some
associated motor areas, which are
less  ac t ive during s imple
movement tasks. A simple task in
healthy controls can be a complex
task for patients, or the patient can
actually not perform the task. In
healthy controls, performing a
simple motor task, fMRI showed
activation in the contralateral and
to a lesser extent ipsilateral primary
sensorimotor and premotor
cortices in the frontal lobe, the
supplementary motor cortex area
(SMA), the insula and cerebellum
bilateral70,71,73,123,136,172,197,206,208. Those
activation patterns are reasonably
reproducible in subjects over time.
In motor studies on MS patients,
performing different paradigms
with more or less selected MS
patient groups, roughly the same
brain areas as in healthy subjects
become activated, when a patient




216,218,221,222. Mainly depending on
the functional state of the limb
investigated (and difficulty of the
task), the extensiveness of the
activated areas differs considerably.
When hand motor impairment was
complete (paralysis), fMRI showed
no activity in the normal brain
areas40. But a greater activated area
was also observed in MS patients
that had no paresis, nor have had
functional impairment, globally for
all MS types. It was seen in patients
who are in the progressive stages
of the disease, both in secondary
progressive MS patients136,206,217 as
well as in primary progressive MS
patients71,218, and also in relapsing
r e m i t t i n g  M S  p a t i e n t s
70,136,206,207,215,221 and even in patients
with a clinically isolated syndrome
suggestive for MS74,213,214,219,220.
The lateralisation index, the ratio
of activated volume on one side
compared to the total activated
area, shows less lateralisation in MS
patients than in healthy subjects,
mainly because of excessive
ipsilateral  ac t iva ted motor
cortex136,206.
When a partial motor impairment
existed, fMRI showed (in
comparison to healthy controls) a
greater activated volume. The
activation was situated in the
primary motor cortex bilaterally,
the supplementary motor area
bilaterally and some areas of the
associate cortex (cingulate motor
cortex) and along the fissura Sylvii,
corresponding to the secondary
somatosensory motor cortex
(SII)40,69,136,172,173,206,207,208.
Besides motor paradigms for fMRI
experiments in studies with MS
patients, visual paradigms have
been used also, especially in optic
neuritis patients. Light flashes are a
relatively easily to perform
paradigm, with only light intensity,
flash rate and the visual field
stimulated as factors in the task
design. In studies on healthy
controls, the normal pattern of
activation is located in the occipital
lobes154,226,229,257,277. When the light
illuminates just one visual field, the
cont ra l a t era l  pr imary an d
secondary visual cortical fields, the
so called visual (or striate) cortex is
activated. When one or both eyes
are stimulated, both occipital lobes
are activated. Small differences are
seen comparing the dominant eye,
with the non-dominant eye225.
In unilateral optic neuritis patients,
stimulation of the affected eye
resulted in a smaller activated
volume in comparison with the
unaffected eye, even when patients
had recovered visual acuity.
Furthermore, stimulation of the
unaffected eye shows a decreased
volume of activation compared
with controls. The results showed
a trend for recovered patients to
display more activation than non-
recovered patients, both for the
affected and the unaffected eye.
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One recovered patient showed
discrepant data, giving more
activation than controls and more
activation for the affected eye than
the unaffected eye. The reason for
this is unknown, but can be the
result of adaptational mechanisms.
Although differences in activation
between the two eyes are also seen
in healthy subjects (probably
caused by eye dominance), patients
showed much larger differences.
Longitudinal studies and more
extensive neurophysiologic testing
(nearby vision, visual field, as well
as contrast and colour vision
defects) have been performed by
others87,154,155,226,229,257,277. In general
the patients showed reduced
activation upon stimulation of the
affected eye. In a study of our
research group, an average of 33%
of the activated area of the control
group was seen226. Decreased
a c t i v a t io n ,  a l t h o ug h  l e s s
pronounced, was also seen at
stimulation of the clinically
unaffected eye (in that particular
study 61% of the activated area of
the control group226). Recovered
patients, i.e. visual acuity > 0.8,
showed on average a greater
activation area at bas eline
compared to non recovered
patients, but still smaller than in
the healthy controls. One patient,
first scanned in the acute phase,
and again scanned after 10 days,
showed an increase in activation
from 3% to 11% of the activated
area of the control group (with an
increase in visual acuity from 0.6 to
1.0 at the same time). Although
those results can be interpreted as
a correlation between visual acuity
and size of the active brain area,
the 11% score at time of a visual
acuity of 1.0 shows this is an
oversimplification.
Cognitive functions are more
difficult to study than simple
motor tasks or visual paradigms,
mainly because a cognitive
function is more complex in nature
(it requires for example input and
output processes). Importantly not
only the active stage of the task is
of great influence for the fMRI
results, but also the “rest” (control
condition) activity. Those facts
cause that far less is known about
the situation in healthy subjects,
and thereby it is harder to interpret
the differences in patients, when
not exactly the same task is used.
In this stage of brain research, a
study paradigm is only by
approximation described in terms
of cognitive processes needed, and
normal active brain areas are not as
steady over all studies as for the
more simple motor and visual
paradigms.
As planned, the for fMRI adapted
Tower of London task was used in
a group of MS patients. Our




They performed worse (lower
outcome score) than a healthy
c o n t r o l  g roup ,  b u t  t h e
accompanying brain activity
measured with fMRI  was
maintained. As expected, the main
centres of activation were located
in the frontal lobes (left middle and
superior frontal gyrus and right
middle frontal gyrus), the parietal
lobes (the inferior parietal lobe
bilaterally and the right precuneus
region) and the cere bellum
bilaterally. No statistical significant
differences in activation between
control and MS groups were
observed. Age and educational
level of the healthy subjects were
confounding factors between
groups. The small differences seen
between the activation areas in
both groups indicate that younger
and higher educated subjects may
use additional brain areas for
additional strategies.
Studies with a simple motor
paradigm have shown that subjects
with brain pathology probably use
additional  brain areas  t o
compensate for their impairment,
so that functional impairment is
not becoming evident. This occurs
as long as the healthy brain
capacity is sufficient for this
adaptation. In cognitive studies this
seems to be more difficult to
observe34. In our patients with
more advanced disease these
compensatory mechanisms might
have been exhausted or are
counteracted by the fact that tissue
damage, once reaching a certain
level, limits the possibility for more
extended activation.
The brain areas used do not
g u a r a n t e e  a  g o od  t a s k
performance, because although the
MS patients showed the same areas
active, the performance score was
significantly worse than controls.
The scores of the task did not
correlate with lesion loads in the
frontal region, nor with the total
lesion load. This is in concordance
with the results seen in the
structural imaging studies, in which
most of the times none or only
low correlations between regional
lesion load and task performance
of many tasks were seen. Small
differences in essential network
pathways will be critical in the
performance of the task.
We performed a small feasability
study of Cannabis intake effects in
MS patients. As a spin-off from a
Cannabis trial in MS patients, a few
patients underwent certain fMRI
tasks. The three fMRI tasks we
used, evaluating cognitive, motor
and visual function respectively,
showed activated areas at expected
locations in most subjects. In
individual subjects, differences
when comparing activation after
intake of Cannabis and placebo
were striking, sometimes exceeding
100%. However, not one of the
three tests, showed significant
DISCUSSION
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group differences when comparing
Cannabis with placebo intake,
probably due to the small sample
size and because the Cannabis
effects were not uniform across all
the subjects. The inter-individual
variation is also a possible
explanations for the discrepancy
between the results of clinical
studies and the benefits most
subjects experience. The visual
stimulation task showed, as
expected, less variation in size of
the activated area after use of
Cannabis compared to placebo,
than the cognitive task.
The main conclusion after this
study is that, especially with an
complex pharmacological biology
agent like Cannabis, larger study
groups, more uniform MS patients
and more physiological identical
subjects are necessary, besides
registering more parameters. After
that, the advantage of fMRI, the
numerous times it can be repeated
without danger, can be more fully
utilized.
AMBIGUOUS INTERPRETATION OF THE FMRI STUDIES
The exact nature of the “active”
brain tissue seen in fMRI
exper imen ts is  not  fu l l y
understood. Differences are
believed to be caused by more
oxygen consumption (with regard
to the paradox that the venous
system behind active brain tissue
has a higher oxygen percentage
because of overcompensation of
the blood flow; questions remain if
this is the case for all brain areas
and how localised the process is)
and therefore represents more
neuronal activity. But this neuronal
activity can be excitatory or
inhibitory. If it is excitatory the
question can be raised if it is useful
activity. The assumption that more
activity means better performing of
an area might be an over-
simplification. Also, it can be
questioned if in MS patients, with
lesions around the venes254, the
normal brain regulatory processes
are active.
fMRI brain activity differences
between MS patients and healthy
subjects always have the problem
of differences in task performance
and task complexity for the
subjects as explanation. This aspect
has to be accounted for by
multiple difficulties and better
understanding of the effects of
complexity on the brain areas
active.
The reason for the activity in a
greater brain volume and the
activity in other brain areas
compared to healthy subjects
performing the same test is
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therefore speculative. It has been
suggested that this might be caused
by the presence of subcortical
structural damage, so that simple
tasks become more complicated.
The regions that become active are
the areas activated in healthy
subjects especially during the
performance of more complex
tasks.  Also the plast ic ity
(adaptational possibilities) of the
brain is an explanation; other areas
take over functions when the
original area can only perform
inadequately. This is also known
from other diseases, like stroke.
The significant correlation between
the time since clinical onset and
activation in motor areas found
s u g g e s t s  t h a t  c o r t i c a l
reorganization develops gradually
in concomitance with the
subclinical accumulation of tissue
damage. Extension of cortical
activation into areas not (primarily)
dedicated to a given function is
described for motor and visual
function. Further evidence for the
plasticity of the brain in MS
patients is the results of studies of
motor functioning during relapses
and recovery, in which is shown
that recovery of funct ions is
associated with volume of activated
cortex. Adaptation of the brain to
overcome cognitive impairment, is
at least in the first stages of the
disease, a possible explanation for
the discrepancy between lesion
load and cognitive function scores.
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5.2 FUTURE DIRECTIONS
For future research it  is
necessary to get a better
understanding of the parameters,
especially physiological ones, that
determine brain activity. In MS
patients, especially the relationship
with disease activity (lesion loads,
atrophy, normal appearing white
matter, cortical lesions, etc.) has to
be further investigated to develop
therapeutic strategies and control
their effectiveness.
To acquire such knowledge various
research steps have to be
undertaken.
First, further understanding is
needed about the brain areas
involved in specific cognitive
function. It is even better to speak
about the brain areas involved
during performance of a specific
cognitive test than during a
cognitive function. The step from
cognitive task to specific test is
most of the times involving various
(unproven) assumptions.
Most important is the further
investigation of the inter-individual
and intra-individual differences.
Probably much more factors than
accounted for in studies so far, are
needed to describe better the signal
differences. Factors that must be
taken into account are gender (and
hormonal status), handedness,
dominant eye, education, IQ,
neuropsychological test experience,
food and drinking before the task
(especially coffee, tea, other
caffeine containing dr inks),
medication, activities before the
task, fatigue, sleepiness, emotions
(especially depression) and time of
performance during the day.
Therefore much more parameters
in and around the subject have to
be registered. Also studies of basic
brain functioning have to be in
concordance with the fMRI study
results. Only when, in healthy
controls, it is proven that the same
brain areas consistently are active,
the next steps can be taken. A
larger number of subjects studied is
a first step compensating for those
differences. Brain lesion studies
can be used also, as they were used
in neuropsychological tests studies
in earlier days. Individual patients,
with a disease affecting only a
circumscribed brain area (vascular
incident, chirurgical removed brain
tissue), and with specific cognitive
problems (tested with a specific
cognitive test) can be selected and
compared with the normal pattern
of brain activity. In those
individual patients the validity of
the test can be investigated.
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The fMRI task designs are adapted
versions of existing cognit ive tasks.
However, the basis for those tests
are the performance score. The
tasks were developed with the
hypothesis of certain cognitive
function to be active during such a
task. For fMRI purposes in
general, tasks have to be developed
that activate as few as possible
areas in the brain, independent of
the cognitive function(s) needed. It
is uncertain whether this is
possible, because brain function is
a network activation rather than a
single area at work. For fMRI
experiments, especially in MS
patients, another regime can
probably be followed as well. Tasks
that demand many cognitive
functions, and thereby large areas
of the brain are active, can be used.
The size of the active area is than a
measure for how much effort the
patient makes. But this is probably
only true in the beginning in
phases of the disease.
Studies on cognitive functions have
a great inherent problem, from the
perspective of the brain research.
The functions investigated always
need more than one brain area to
be active and the connecting
pathways are equally important in
fulfilling the task adequately as are
the areas processing the function.
If the information does not reach
the area or is corrupted, the
receiving brain area can not
process any useful information and
therefore no useful output can be
generated.
In MS especially the connecting
pathways are affected. Functional
brain imaging at this point in time
can only detect cellular areas that
use energy, not the pathways in
between. The lesion load in a
“cognitively involved” area can be
low, while the brain area is not
performing the test, and the
cognitive score is below normal,
because no information reach the
area. If a patient can not perform a
test at all, few conclusions can be
made about the relation with
specific lesions. In that respect,
some form of performance score is
necessary, but makes the task also
more complicated and thereby
possibly making more areas active.
The MS patient group studied
should be as homogenous as
possible (type of MS, disease
duration, functional impairment)
and must be as compatible as
possible with the healthy control
groups or the influence of
(neuro)physiological parameters
have to be fully known. A
disadvantage of such a very
selected MS groups is, that the
results can not be extrapolated to
the whole MS population at large.
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The group size is also important.
Small numbers have the main
problem that coincidence plays a
role, especially because fMRI is
always a statistical exercise.
Another main problem for the
researcher, although very helpful
for patients, is the great adaptive
capacities of the brain. When a
brain area is damaged, its functions
may be overtaken by other brain
areas, that can be located almost
a n y w h e r e i n  t h e  b r a i n .
Performance results are than the
same, while completely different
brain areas are active.
Especially in MS patients the tasks
have to be repeated a number of
times during the evolution of the
disease, including the exacerbations
periods (pre-, during and post-).
The subjects can be used as their
own controls. In group analysis,
the clinical and/or cognitive
i m p a i r m e n t  du r i ng  s uc h
exacerba t ions h a s  t o  be
preferentially the same across the
group, to see if all subjects of that
group show the same evolution.
This approach might not only lead
to better understanding of MS as a
disease, but also to the role of
certain  areas in cognitive
impairment. Lesion oriented
studies are only a rough technique
for determining the place of
functional activity in the brain.
Adaptative mechanisms can be
shown by longitudinal design.
To investigate networks, new
techniques like connectivity studies
can be applied. The areas active at
the same time or after a same time
delay are thereby recognized. This
will show networks,  which
probably are in MS less well
organized and represen ts a
measure of the severity of the
disease.
The end in MS research has not
yet been reached. New MR
techniques, especially one like
fMRI, can not only help with a
better understanding of MS and
problems MS patients experience,
but also gives more basic
neurological knowledge. In that
respect the studies not only help
MS patients, but many other
patients with neurological diseases
as well.
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CHAPTER 6  




MS is a chronic inflammatory
demyelinating disease of  the
central nervous system. Besides the
well known and characteristic
somatic disability, MS patients may
experience cognitive problems.
The impact of these cognitive
problems during daily life activities
is variable. Severe cognitive
disturbances occur in about 10%
of the patients. The cognitive
impairment itself is heterogeneous,
with attention, informat ion
processing speed and visuo-spatial
working as examples of more often
affected domains, while language
and praxis are rarely. One could
state that the cognitive dysfunction
in MS has been "rediscovered",
since in fact Charcot already
described the problem when
describing the disease in 1868.
The purpose of the studies in this
thesis was to better understand
cognitive impairment in MS, by
studying the relation with structural
and functional MR parameters.
After a general introduction in
chapter 1, in chapter 2 the studies
describing a relation between some
structural MR parameters and
co gnit ive  impa i rmen t  a r e
presented. It has been known for
quite a time that lesions on
standard PD, T2 and T1 weighted
images (both number and volume)
are not strongly correlated with
clinical findings. In the studies
described in chapter 2 a somewhat
stronger relation between cognitive
impairment and these parameters
becomes clear by using a special
MR technique that identifies
(juxta)cortical lesions better. Also
is described that atrophy and
regional lesion load help to
improve the clinicoradiological
association, although it still remains
not very strong. To a certain
extent, this reflects the non-
s p e c i f i c  n a t u r e  o f  t h e
neuropsychological tests used. At
the end of chapter 2 studies
focussing especially on attention
and information processing speed
and the characteristics in MS
patients are described. The
impaired attention and information
processing speed in MS patients
was found to be associated quite
strongly with the MRI findings
(especially for cerebral atrophy).
Chap t e r  3  des c r i b es  an
introduction on the technique and
implementation of fMRI in our
research c e n t r e  a n d the
development and application of
two for fMRI adapted tests, the
Tower of London test and the
PASAT. Both original tests are
especially suitable for MS research,
because they probe more than one
cognitive domain. The fMRI
version of the Tower of London
test produces (in young and
healthy subjects) activity located in
the dorsolateral prefrontal cortex,
the cingulate cortex and the cuneus
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and precuneus regions, comparable
with results from PET studies. The
brain activity during the PASAT,
also in healthy young individuals, is
mainly located in areas in the
frontal lobe and the superior and
inferior parietal , bilaterally.
Although, the adaptations made in
both tests to make them suitable
for fMRI research, may have
changed the main principles of  the
tests in some way, the activated
brain areas are in line with the
theoretical expectations derived
from the clinical studies with these
tests.
In chapter 4 the same tests are
used in studies in MS patients and
also a study using a light flash
paradigm on optic neuritis patients
is presented. Using the Tower of
London test, MS patients were
noted to have activated areas not
significantly different from those
found in healthy controls with
comparable age and education.
Also the results do not differ very
much from the aforementioned
study in young healthy educated
subjects. However, the individual
results in the MS patients group
are much more variable than those
in the other groups. Interestingly
this occurred in the context of
n o n - r e d u c e d  b e h a v i o u ra l
performance, indicating possible
compensatory brain activity to
maintain function.
The optic neuritis study showed a
definite decrease in activity in the
occipital cortex in the earlier stages
of optic neuritis. At the end of the
chapter a very small fMRI
feasabil i ty study observin g
Cannabis effects is presented. The
results of this study showed quite
variable effects of Cannabis
between subjects, with no
significant effect on group level.
The brain activity during more
"elementary" brain functions,
shows less variation than the
activity during the paradigms that
make use of more cognitive
domains.
The, in this thesis, presented
studies have shown that with other
than the standard MRI techniques,
intriguing results can be achieved
in MS research, opening new
avenues to the understanding of
cognitive processes in MS. To use
fMRI in future MS research it is of
great importance to know more
about the processes that cause
brain activity (changes) on fMRI,
to more strictly select patient
groups and to account for more
psycho-physiological parameters
(such as time of day, tiredness, use
and time of food and drinking,
emotional status, and so forth).
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Samenvatting
MS is een chronisch inflammatoire
demyeliniserende aandoening van
het centraal zenuwstelsel. Deze
a a n d o e n i n g  g a a t ,  n a a s t
uiteenlopende andere mogelijke
problemen van lichamelijke aard,
bij een groot deel van de patiënten
g e p a a r d m e t  c o g n i t i e ve
stoornissen. De ernst daarvan, en
daarmee de invloed op het
dagelijks functioneren, is zeer
variabel, maar is in zo'n 10% van
de gevallen ernstig te noemen. De
cognitieve stoornissen vertonen
een heterogeen patroon, waarbij
sommige cognitieve domeinen,
zoals  a t t en t ie ,  i n f o r mat ie
verwerkingssnelheid en visuo-
spatiële functies, vaker gestoord
zijn dan andere, zoals taal en
praxis. De laatste jaren zijn deze
funct ies toorn issen bi j  MS
"herontdekt", nadat ze al in 1868
door Charcot, bij de beschrijving
van dit ziektebeeld, beschreven
waren.
Doel van de in dit proefschrift
beschreven onderzoeken bestond
uit het verkrijgen van meer inzicht
in de cognitieve functiestoornissen,
door bestudering van structurele
en functional MR-afwijkingen.
Na een introductie in hoofdstuk 1,
worden in hoofdstuk 2 de studies
besproken die de relatie tussen
enkele parameters verkregen uit
structurele MR scans en cognitieve
functies onderzoeken. Zoals al
langere tijd bekend, zijn de laesies
(zowel qua aantal als volume) op
"standaard" PD, T2 en T1
gewogen opnamen niet sterk
gecorrele e rd met kl inische
neurologische parameters. Uit de
beschreven studies wordt duidelijk
dat cognitieve functiestoornissen
een iets sterkere correlatie
vertonen met deze MR parameters,
dan de gebruikelijke klinische,
motorische parameters, door het
gebruik  van speciale MR
technieken die (juxta)corticale
laesies beter zichtbaar maakt.
Verder in het hoofdstuk wordt
getoond dat met andere MR
parameters, zoals atrofie en
regionale lesion load, de klinisch-
radiologische associatie beter is,
alhoewel nog steeds niet erg sterk
aanwezig. Tot slot worden in
hoofdstuk 2 nog twee studies
besproken die keken naar met
name attentie en informatie
verwerkingssnelheid  en de
karakteristieken daarvan bij MS
patiënten. De vaak gestoorde
a t t e n t i e  e n  i n f o r m a t ie
verwerkingssnelheid bij MS
patiënten bleek sterk geassociëerd
met enkele MR parameters (vooral
cerebrale atrofie).
In hoofdstuk 3 wordt een
introductie van de techniek van
functional MRI (fMRI) en de
implementatie daarvan beschreven.
De ontwikkeling van twee voor
fMRI gebruik aangepaste testen
wordt beschreven, de Tower of
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London test en de PASAT. Beide
oorspronkelijke testen zijn met
name geschikt gebleken voor
onderzoek bij MS patiënten,
doordat deze testen een beroep
doen op meerdere cognitieve
domeinen. De voor fMRI gebruik
aangepaste versie van de Tower of
London test toont in jonge
gezonde individuen met name
activiteit in de dorsolaterale
prefrontale cortex, de cingulaire
schors en de cuneus en precuneus
regio's, overeenkomend met
eerdere PET studies.  De
hersenactiviteit tijdens de PASAT,
eveneens in jonge gezonde
per so n e n ,  i s  m e t  nam e
gelokaliseerd in meerdere gebieden
in de frontale lob en de superior en
inferior parietale lob beiderzijds.
Opgemerkt dient te worden dat de
aanpassing voor fMRI de
grondbeginselen van de test wel in
enige mate kan hebben veranderd.
De actieve gebieden zijn echter
o v e r e e n k o m e n d  m e t  d e
theoretische verwachtingen.
In hoofdstuk 4 worden deze testen
v e r v o l ge n s  g e b r u i k t  b i j
onderzoeken bij MS patiënten en
tevens wordt een studie met een
lichtflits paradigma bij neuritis
optica patiënten beschreven.
Gebruik van de Tower of London
test toont aan dat bij MS patiënten
de geactiveerde gebieden niet
significant verschillen met die zoals
gevonden bij een qua leeftijd en
opleiding vergelijkbare controle-
groep. Ook verschillen de
resultaten niet wezenlijk met de
eerder onderzochte jonge gezonde
individuen. Wel blijken de
individuele resultaten van de MS
groep veel meer van elkaar te
verschillen dan de individuele
resultaten in de andere groepen.
De MS patiënten scoren daarbij
niet slechter dan gezonden,
hetgeen doet vermoeden dat
c o m p e n s a t o i r e  a d a p t i e v e
mechanismen een rol spelen.
In de discussie volgt een korte
bespiegeling van de mogelijke
oorzaken van het ontbreken van
duidelijke verschillen tussen de
groepen, zoals een te heterogene
groep MS pat iënten, een
onvoldoende  begrip van de
invloed van allerlei fysiologische
parameters en het niet bestaan van
een een-op-een relatie fMRI
activiteit en goed functionerend
hersengebied. De studie van de
neuritis optica patiënten toont een
duidelijk verminderd functioneren
van de occipitale cortex in het
begin stadium van neuritis optica.
Tot slot van het hoofdstuk wordt
er een Cannabis studie met gebruik
van fMRI bij een zeer kleine groep
beschreven. De resultaten daarvan
zijn niet eenduidig. Wel tonen ze
dat fMRI een hulpmiddel kan zijn
b i j  h e t  b e s tude r e n  v a n
hersenactiviteit  veranderingen
onder invloed van medicatie.
Vanuit de fMRI resultaten valt op
dat de reactie op Cannabis variabel
is. Het blijkt dat de hersenactiviteit
t i jdens meer "eenvoudige"
hersenfuncties minder variatie
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vertoont dan tijdens paradigma's
die gebruik maken van meerdere
cognitieve domeinen.
D e  i n  d i t  p r o e f s c h r i f t
gepresenteerde studies tonen aan
dat met andere dan de standaard
MRI technieken, vooruitgang in
het MS onderzoek is te boeken,
met nieuwe wegen voor een beter
begrip van cognitief functioneren
van MS patiënten. Voor het slagen
van verder onderzoek van MS met
behulp van fMRI zal het van groot
belang zijn, dat de processen die
leiden tot (veranderingen van) de
hersenactiviteit op fMRI beter
worden begrepen, dat geselecteerd
wordt op meer homogene ziekte-
groepen en dat meerdere
psycho-fysiologische parameters
(b.v.  t i jdst ip op de dag,
vermoeidheid, gebruik en tijdstip
van eten en drinken, emotionele
toestand, etc.) mee worden
genomen.
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AES affected eye stimulated
AFNI software package
ANT Amsterdam Neuropsychological tasks
ASYM% asymmetry percentage
BA Brodmann area
BDI Beck depression inventory
BES both eyes stimulated simultaneously
BOLD blood oxygenation level dependent
BRB brief repeatable battery (MS cognitive screening test battery)
CBF cerebral blood flow
CII cognitive impairment index
CNS central nervous system
CSF cerebrospinal fluid
CSE conventional spin echo MR sequence
CT computer tomogram
CTRL controls
EDSS expanded disability status scale
EPI echo planar imaging MR sequence
fMRI functional magnetic resonance imaging
FLAIR fluid attenuated inversion recovery MR sequence
FSE fast spin echo MR sequence
FSS fatigue severity scale
FWHM full width half maximum
GPI global performance index of VLGT
IQ intelligence quotient
MRI magnetic resonance imaging
MS multiple sclerosis
MS-FS multiple sclerosis fatigue severity scale
MT magnetization transfer MR sequence
NAWM normal appearing white matter
ON optic neuritis
PASAT paced auditory serial addition task
PD proton density
PET positron emission tomography
PP primary progressive type MS patients
PVSAT paced visual serial addition task
PRI post response interval
RBV relative brain volume
ROI region of interest
RR relapsing remitting type MS patients
RT reaction time
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SII secondary somatosensory motor cortex
SDMT symbol digit modalities test  of brief repeatable battery
SD standard deviation
SMA supplementary motor cortex area
SP secondary progressive type MS patients
SPECT single photon emission computer tomography
SPM software package
SPR 10/36 spatial recall  test  of brief repeatable battery
SR stimulus response
SRT selective reminding task of brief  repeatable battery
T Tesla
T1 T1 weighted MR images
T2 T2 weighted MR images
TE echo time (of MR sequence)
THC delta-9-tetra-hydrocannabinol
ToL Tower of London task
TR repetition time (of MR sequence)
UES unaffected eye stimulated
VAS visual analogue sca le (of pain)
VF verbal fluency
VLGT verbal learning and memory test (Dutch)
WLG word list generation task of brief repeatable battery
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DANKWOORD
Het doen van onderzoek is zeker niet iets dat je alleen doet. In al die jaren
hebben veel mensen in meerdere of mindere mate, allen op hun eigen
manier, een aandeel aan het onderzoek geleverd. Mijn grote welgemeende
dank daarvoor. De belangrijkste groep die ik daarvoor bedank zijn
natuurlijk de patiënten en gezonde proefpersonen, die allemaal vrijwillig
meewerkten, terwijl dat niet voor iedereen even gemakkelijk was en voor
hen geen direct resultaat opleverde. Mijn grote dank en bewondering
daarvoor.
Daarnaast wil ik enkele personen specifiek noemen, zonder dat dat
betekent dat anderen die niet bij naam genoemd worden, ook niet erg
belangrijk zijn geweest voor (delen van) mijn onderzoek, of het leven
daaromheen. Wetenschap doen is leuk, zeker als dat met gezellige en
aardige mensen gebeurd.
Beste Philip (Prof. Dr. Ph. Scheltens), Ik ben jou op meerdere manieren
mijn dank verschuldigd en ben je zeer erkentelijk. Jij gaf, samen met Chris
Polman, mij de kans om onderzoek te gaan doen. In eerste instantie
gepland op het terrein van de hippocampus metingen en een medicatie
studie bij MS. Na enige tijd deed de kans zich voor om fMRI onderzoek
te gaan doen bij MS patiënten. Deze switch ondersteunde jij eveneens
zeer, ondanks de problemen die dat voor jou opleverde. Al die tijd bleef
jij samen met Serge Rombouts en Frederik Barkhof de drijvende kracht
achter het fMRI onderzoek aan de VU. Hier heb ik heel veel profijt van
gehad.
Beste Frederik (Prof. Dr. F. Barkhof), Dank voor al jouw aanwijzingen en
correcties en de altijd maar weer nieuwe ideeën waarmee je geprobeerd
hebt het onderzoek naar een hoger plan te tillen. Met name jouw kennis
op vele terreinen is bijzonder. Mijn soms optredende pessimisme over de
onderzoeksresultaten, was soms erg moeilijk voor je, maar je hebt nooit
opgegeven. En uiteindelijk heeft het dan toch een resultaat opgeleverd.
Beste Serge (Dr. S.A.R.B. Rombouts), Jij was (en bent) voor mij de fMRI
man in Nederland. Jouw enthousiasme en de vele tijd die je gestoken hebt
in de ontwikkeling van de fMRI in het VU medisch centrum zijn een
voorbeeld voor iedereen. Het is een basis waarvan nog steeds velen
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gebruik maken, en waarvan ik als een van de eerste gebruik heb kunnen
maken en heel veel baat bij heb gehad. Weergaloos!
Beste Chris (Prof. Dr. Ch. H. Polman), Als sturende kracht op de MS
afdeling heb jij mij direct en indirect zeer geholpen. De kansen die jij mij
bood, de rustige en vriendschappelijke sfeer waarin je het onderzoek
begeleidde en de hardloop samenkomsten zijn mij zeer dierbaar geweest.
Hoewel loop-technisch van wat minder invloed, heb ik ook veel steun
gehad aan de besprekingen met Bernard (Dr. B.M.J. Uitdehaag), die altijd
zeer goed de finesses van onderzoek weet bloot te leggen, maar ook
vrijwel altijd oplossingen weet aan te geven. Jullie beider invloed op mij is
groter dan jullie denken.
Beste Willem (Drs. W. Machielsen), Vele leuke, maar soms ook moeilijke,
momenten hebben wij op onze kamer gedeeld. Met name de niet direct
aan ons onderzoek gerelateerde discussies hebben mij meer inzicht
gegeven op vele terreinen. Jij bent een echte filosoof, waardoor jij je
minder thuis voelde in het klinisch toegepast wetenschappelijk onderzoek.
Maar zoals je ook je ziekte overwon, zo zal jij ook een plaats vinden waar
je helemaal tot je recht komt. Bedankt voor de gezellige tijd.
Beste Sander (Dr. S. Daselaar), Jij voegde je bij twee discussiërende
onderzoekers op een te kleine kamer, maar liet je daardoor niet verstoren
snel te promoveren. Misschien juist wel omdat je snel uit die kamer weg
wou zijn? De vriendschappelijke en sociale kanten hield je echter zeker in
het oog, zodat het ook een heel gezellige tijd was. Ook op sportief vlak
hebben wij samen ons beste beentje voor gezet, al was die van jou
meestal beter. Ook jij bedankt voor deze leuke tijd.
Beste Hans (Dr. H. Schrijver), Als eerste kamergenoot, hebben wij samen
de eerste stappen op het pad van onderzoeker zijn gezet. Het was een
geweldige tijd, waar ik nog graag aan terug denk. Naast het squash als
uitlaatklep, was ook jouw Snoeck een enkele keer een gezamenlijke
bezigheid. Ik vond het heel leuk om te doen.
Beste Els van Deventer, Heel hartelijk dank voor jouw nimmer aflatende
energie om artikelen op te sporen en te kopiëren. Ieder boek in de
bibliotheek weet je altijd te vinden, en ook nu weer tijdens mijn opleiding
tot neuroloog, heb ik nooit van jou gehoord dat je iets niet wist te vinden.
Ik hoop dat de neurologie website van de VU uiteindelijk van de grond
zal komen, zodat jouw moeite niet verloren gaat. Op administratief gebied
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heeft m.n. ook Regina de laatste t ijd mij zeer geholpen. Dat waardeer ik
zeer.
De MRI laboranten, m.n. Karin Barbiers en het secretariaat MRI, Jullie
allemaal ben ik zeer erkentelijk voor de ondersteunende activiteiten bij de
MRI. Het leren scannen, het plannen van scans en het begeleiden bij het
scannen zelf, het waren meestal zeer gezellige momenten, hoewel de
tijdstippen meestal niet optimaal voor ons waren.
Beste Nynke (Dr. N. F. Kalkers) en Joep (Dr. J. Killestein),  Ik kan haast
niet anders dan jullie in één adem noemen. Jullie enthousiasme, ieder op
zijn eigen manier, was geweldig. Zowel in wetenschappelijk opzicht,  als in
sportief opzicht. De sfeer bij de onderzoekers, en later in de opleiding is
daar grotendeels door bepaald. Zonder jullie was het heel anders geweest.
Beste Jan (Drs. J. Boringa) en Leo (Dr. L. de Sonneville), De cognitieve
onderzoeken leveren niet van die flitsende gekleurde plaatjes op, maar de
waarde van dit onderzoek is er niet minder om, mede dankzij jullie
betrokkenheid daarbij. In dit opzicht heb ik ook veel te danken aan Ilona
Reulings die veel van de cognitieve testen heeft uitgevoerd.
Carla Verstappen, Judith Eikelenboom, Kambiz Nasseri, Sarja de Pijper,
Marianne van Walderveen, Jan-Hein van Waesberghe, Geert Lycklama à
Nijeholt, Liesbeth Bergers, I Leng Tan, Joost Bot, Hugo Vrenken, Frank
Hoogenraad, Petra Pouwels, Joost Kuijer en al die anderen met wie ik
heb samengewerkt. Het was geweldig om met zoveel verschillende
mensen op verschillende manieren samen te werken.
Natuurlijk wil ik alle medeauteurs bedanken voor hun inzet om de
artikelen te optimaliseren en gepubliceerd te krijgen, hetgeen niet altijd
even gemakkelijk was. En daarbij horen natuurlijk ook de overige MS
onderzoekers en onderzoeksters, een steeds groter wordende groep, die
hun steentje hebben bijgedragen aan een groots MS MRI centrum in de
VU.
De studenten Marcel Schouten en Mark Dop hebben geholpen bij enkele
onderzoeksprojecten. Helaas hebben deze niet allemaal geleid tot een
publicatie, maar mijn dank is er niet minder om.
Alle collega's bij de neurologie en alle poli medewerkers, alsmede enkele
mensen bij ondersteunende diensten als de KFI / DAI / IPO ook mijn
dank.
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De Stichting Vrienden MS dank ik voor de financiële steun, zonder welk
deze onderzoeken nooit tot stand waren gekomen
Als laatste op deze pagina, maar zeker niet in mijn gedachten, dank aan
mijn ouders, die mij altijd van kinds af aan gesteund hebben. Zonder hen
zou dit boekje er zeker nooit geweest zijn (en ik ook niet trouwens).
Dank allemaal, en ik hoop nog vele jaren op een of andere manier jullie te
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